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Considering the rise in risk factors such as 
obesity and arterial hypertension, together 
with the increasingly ageing Western 
population, it is evident that cardiac and 
cardiovascular disease will remain at the 
forefront of the global healthcare agenda 
for the foreseeable future. Several trials 
and registries are currently running to 
provide better insights through imaging 
(chapters 3, 13).
Nevertheless, the progress that has been 
made in the last 50 years is nothing short 
of astonishing. Procedures like heart trans-
plants, complex valvular interventions 
and treatment of coronary artery disease 
have, among others, made such spectac-
ular advances that they are now routinely 
performed in specialised centres all over the 
world. However, timely detection of disease, 
correct evaluation of its extension, and the 
outlining of possible treatment options still 
predicate the eventual success of many pro-
cedures. It is here that cardiac imaging plays 
an often-pivotal role, guiding the referring 
physician to the best possible patient out-
come. For the cardiac radiologist, computed 
tomography (CT) and magnetic resonance 
imaging (MRI) are the main tools for non-in-
vasive cardiac imaging (chapter 1).
While there has been continuous develop-
ment of imaging techniques in other sub-
specialties, the progress made during the 
last decade in non-invasive cardiac imaging 
stands out among other achievements. 
Today, we can routinely and safely inves-
tigate potential coronary artery disease in 
patients; earlier, classic invasive angiog-
raphy was the only available method for 
direct coronary artery visualisation (chapter 
8). Our understanding of risk stratification 
and prognosis prediction, even in asymp-
tomatic patients, using simple tools like 
the non-invasive quantification of coronary 
calcium is developing significantly as the 
results of large trials come in (chapter 2). 
The integration of CT during the triage of 
patients with acute chest pain has proven 
beneficial, resulting in quicker and safer 
discharge of patients in selected cases 
(chapter 4).
Beyond coronary arteries, MR imaging 
today provides valuable information for 
correctly characterising myocardial tissue, 
as such helping the clinician with, among 
other things, the evaluation of athlete’s 
heart, infectious/inflammatory disease, 
prevention of sudden death, and the evalu-
ation of ischaemic heart disease (chapters 
5–7, 16–17). Also, this book will shed more 
light on, what may at first glance appear as, 
unsuspected connections like the heart-
brain axis (chapter 12).
Radiology has always been one of the first 
specialties to incorporate new technologies 
to achieve better results. New tissue map-
ping MRI techniques, evolving application 
like pre- and post-procedural evaluation 
of prosthetic heart valves, and of course 
the introduction of artificial intelligence as 
diagnostic tool will be addressed (chapters 
9–11, 15).
Finally, since there is no ‘I’ in a team, several 
chapters further explain insights from and 
the important role of radiographers and 
medical physicists, who form an essential 
part of every radiology department (chap-
ters 18–21).
EDITORIAL 
BY JENS BREMERICH AND RODRIGO SALGADO
“a hot, dry organ –  
the centre of vitality of the body”
That is how Aristotle described the heart in the fourth century B.C. 
Although it was then thought to be a three-chambered structure, the 
heart was already identified as being the most important organ of the 
body. Our understanding of the anatomy and physiology of the heart 
has evolved since then, but it remains without question one of the most 
cherished human structures, a marvel of nature’s engineering, and the 
referenced source of so much more than its role as the engine behind 
our blood circulation.
With such a central place in our existence, it was inevitable that humans 
would soon try to uncover its structure and function, and from there its 
relationship with human wellbeing. Mankind had, however, to wait until 
William Harvey’s 1628 publication Exercitatio Anatomica de Motu Cordis 
et Sanguinis in Animalibus (An Anatomical Study of the Movement of 
Heart and Blood in Animals), commonly referred to as De Motu Cordis, 
for the discovery of the blood circulation. Today, scientific research and 
education focusing on the pathophysiology of the heart forms one the 
most important pillars of modern medicine, and for good reason.
Ever since the Framingham Heart Study commenced in 1948, in the city 
of Framingham (Massachusetts, USA), modern medicine has tried to 
understand how heart disease affects our physical condition, quality of 
life and long-term survival, being constantly motivated by the devastat-
ing effects of unrecognised and/or untreated disease. Cardiovascular 
disease remains the main global cause of death, currently accounting 
for about 17 million deaths annually; this number is expected to increase 
to more than 23 million by 2030. 80% of these deaths occur in low- to 
middle-income countries. Heart disease accounts for almost 52% of the 
total $7.28 trillion cumulative economic loss from non-communicable 
disease (which also includes respiratory disease, cancer and diabetes). 
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The European Society of Cardiovascular 
Radiology (ESCR) is, as always, devoted to 
promoting cardiac radiology and assuring 
the high-quality performance of our mem-
bers through accreditation (chapter 14). 
With this book, together with the European 
Society of Radiology (ESR), we thank you 
for your interest in the International Day of 
Radiology 2018, and we hope that you enjoy 
reading this publication.
Further reading:
 Laslett LJ et al. The Worldwide Environment of Cardi-
ovascular Disease: Prevalence, Diagnosis, Therapy, and 
Policy Issues: A Report From the American College 
of Cardiology. J Am Coll Cardiol. 2012 Dec 25;60(25 
Suppl):S1-49. doi: 10.1016/j.jacc.2012.11.00.
 World Health Organization. Cardiovascular Disease: 
Global Atlas on Cardiovascular Disease Prevention and 
Control. WHO, Geneva, Switzerland (2012).
 S.C. Smith Jr et al. Our time: a call to save preventable 
death from cardiovascular disease (heart disease and 
stroke). J Am Coll Cardiol, 60 (2012), pp. 2343-2348.
 GHSi. Shifting paradigm: how the BRICS are  








In the last decade, computed tomography 
(CT) and magnetic resonance imaging (MRI) 
have gained a prominent role in the non-in-
vasive imaging of cardiac and cardiovascu-
lar disease, and as such have become the 
two most important non-invasive imaging 
modalities for a cardiac radiologist. As their 
underlying physical principles and therefore 
clinical application differs significantly, this 
first chapter offers an introduction into what 
constitutes the ‘basic building blocks’ of 
each imaging modality with regards to car-
diac imaging. Specific applications will later 
be described in detail in dedicated chapters. 1
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BASIC ASPECTS OF 
CARDIAC CT
Adequate patient selection and preparation 
are mandatory factors to obtain optimal 
image quality cardiac CT examinations3. 
From a clinical perspective, CCTA is currently 
mostly indicated in symptomatic patients 
with a low to intermediate risk of CAD (Fig-
ure 1). There are some contraindications to 
cardiac CT. These include renal insufficiency, 
a known history of severe contrast reaction, 
clinical instability and pregnancy. Other 
patient-related variables that may also affect 
the diagnostic accuracy of the test include 
morbid obesity, an inability to collaborate 
with breath-hold instructions and/or scan 
acquisition, heart rate variability and arrhyth-
mia, and contraindications to beta-blocker 
medication or nitrates.
Even if more recently developed CT systems 
allow for the scanning of patients with high 
and irregular heart rates, slow heart rates are 
preferred for cardiac CT imaging, not just 
because of the improved image quality. This 
approach also allows significant dose savings 
by applying sequential or even single heart-
beat CCTA acquisition techniques (Figure 2).
In general, beta-blocker premedication is 
used to lower the heart rate below 60 beats 
per minute. Among different drugs, meto-
prolol has become the standard. In subjects 
weighing less than 80 kg an initial dose of 50 
mg of metoprolol is administered, whereas 
for heavier subjects, 100 mg of metoprolol is 
administered one hour before the examina-
tion4. If the heart rate remains high, additional 
metoprolol may be given intravenously. An 
alternative approach to oral premedication 
BASIC BUILDING BLOCKS IN  
NON-INVASIVE CARDIAC IMAGING 
Part I:
WHAT CAN WE 
EXPECT FROM A 




Cardiovascular disease (CVD), and in particular coronary artery 
disease (CAD), is the leading cause of morbidity and mortality in 
developed countries. According to the European cardiovascular 
disease statistics in 2017, it is estimated that CVD causes 3.9 million 
deaths in Europe each year and accounts for 45% of all deaths in 
Europe1. Conventional coronary angiography is the gold standard 
to image the coronary vasculature and to assess the presence and 
severity of CAD. However, this technique is not without complica-
tions. It is estimated that coronary catheterisation causes major 
complications in 1.3% of cases and has a 0.05% in-lab mortality 
rate2.
Advances in cardiac computed tomography (CT) and significant 
improvements in spatial and temporal resolution have allowed for 
accurate and rapid, yet non-invasive evaluation of the coronary 
vasculature. In particular, since the advent of 64-row multidetector 
computed tomography scanners, coronary CT angiography (CCTA) 
holds the key to replacing diagnostic cardiac catheterisation in vari-
ous clinical scenarios.
Figure 1
Coronary CT angiography per-
formed on a 58-year-old man 
with atypical chest pain. (A) 
3D-cinematic rendering. Curved 
planar reformats of the right 
coronary artery (B), left circum-
flex coronary artery (C), and left 
anterior descending coronary 
artery (D). The study showed mild 
luminal irregularities and allowed to 




Chapter 1 | BASIC BUILDING BLOCKS IN NON-INVASIVE CARDIAC IMAGING 15
THE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONS
14 Chapter 1 | BASIC BUILDING BLOCKS IN NON-INVASIVE CARDIAC IMAGING
THE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONS
unnecessary conventional coronary angio-
graphy procedures9.
Initial recommendations for when the use 
of CT in cardiac imaging was considered 
appropriate were endorsed by American 
and European cardiac and cardiac imaging 
societies10, 11, noting that, in general, cardiac 
CT should be performed in symptomatic 
subjects, especially if the symptoms, age and 
sex were suggestive of a low or intermediate 
probability of suffering significant coronary 
stenosis.
Most recent recommendations extend the 
appropriate use of cardiac CT to different 
clinical scenarios, confirming the previously 
established indications and increasing their 
number12. In the field of detection of CAD in 
symptomatic patients without known heart 
disease, CCTA is appropriate in patients with 
interpretable ECG, who are able to exercise 
and who are presenting with an intermediate 
pre-test probability of CAD. Similarly, it is 
appropriate in individuals with uninterpret-
able ECG or who are unable to exercise and 
have low or intermediate pre-test probabil-
ity of CAD (Figure 3). In patients with acute 
symptoms, CCTA is appropriate in cases of 
normal ECG and cardiac biomarkers and 
low or intermediate pre-test probability of 
CAD, and in patients with uninterpretable 
ECG or non-diagnostic or equivocal cardiac 
biomarkers and low or intermediate pre-test 
is the intravenous administration of the drug, 
usually starting with 5 mg. In patients with 
contraindications to beta-blockers, short-act-
ing calcium channel blockers or ivabradine 
may be viable alternatives. The use of nitrates 
(400–800 mg of sublingual nitro-glycer-
ine) just before the CT examination is also 
highly recommended in the absence of 
contraindications, so as to achieve coronary 
vasodilatation4.
Cardiac CT should only be performed in 
cases where the results have the potential to 
influence patient management or prognosis5. 
Thus, besides the clinical benefit, radiation 
exposure should also be considered when 
ordering the test and carrying out the exam-
ination. From a technical perspective, the 
radiation dose should be kept to a minimum 
and all available strategies to avoid the use 
of unnecessary radiation should be applied. 
These include tailoring the tube voltage6 and 
tube current7 to patient habitus and using 
automated radiation exposure control tech-
niques (i.e. ECG-based tube current modu-
lation), limiting the scan range to the clinical 
indication, and using the optimal cardiac 
ECG-gating technique for each case (ret-
rospective, prospective or single-heartbeat 
acquisition)8.
CARDIAC CT IN THE 
CLINICAL SETTING
The clinical indications of cardiac CT are 
predominantly based on its high neg-
ative predictive value. CCTA allows for 
CAD to be ruled out with great certainty 
in symptomatic individuals, thus avoiding 
Figure 2
Coronary CT angiography per-
formed using single-heartbeat 
high-pitch spiral acquisition in a 
46-year-old woman with atypical 
chest pain and shortness of breath. 
(A) 3D-cinematic rendering. Curved 
planar reformats of the right 
coronary artery (B), left anterior 
descending coronary artery (C), 
and left circumflex coronary artery 
(D). The study allowed for the 
exclusion of significant coronary 
artery disease. A radiation dose 







Coronary CT angiography performed on a 57-year-old 
man with atypical chest pain and intermediate pre-test 
probability of CAD. (A) 3D-cinematic rendering. Curved 
planar reformats of the right coronary artery (B), left 
anterior descending coronary artery (C), and left circum-
flex coronary artery (D). The study showed scattered cal-
cified and non-calcified plaques (arrows) predominantly 
involving the left anterior descending and left circumflex 
coronary arteries. The study allowed ruling out significant 
coronary artery stenosis.
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probability of CAD. Non-contrast cardiac CT 
performed to quantify coronary artery calcifi-
cation is appropriate to detect CAD and to 
assess risk in asymptomatic patients with a 
family history of premature coronary heart 
disease and in individuals with no known 
CAD and intermediate global coronary heart 
disease risk.
CCTA is also encouraged to detect CAD in 
other clinical scenarios, such as newly diag-
nosed or newly established clinical heart 
failure in patients without known coronary 
disease and low or intermediate pre-test 
probability of CAD, and in the preoperative 
evaluation of the coronary arteries in patients 
with intermediate pre-test probability of CAD 
undergoing non-coronary cardiac surgery.
After prior test results, CCTA should be 
performed when exercise ECG and imaging 
results are discordant, when stress imaging 
results are equivocal or in cases with normal 
previous stress imaging results and new or 
worsening clinical symptoms. In the clinical 
scenario of risk assessment after surgical 
or percutaneous coronary revascularisa-
tion, CCTA is considered appropriate in the 
evaluation of graft patency after CABG in 
symptomatic patients (Figure 4), and in the 
assessment of prior left main coronary stent 
with stent diameter ≥3 mm (Figure 5).
Finally, CCTA is considered appropriate in 
the assessment of coronary anomalies and 
complex adult congenital heart disease, in 
the evaluation of left ventricular function fol-
lowing acute myocardial infarction or in heart 
failure patients when inadequate images 
have been obtained from other non-invasive 
methods, in the assessment of morphology 
and quantification of right ventricular func-
tion, in the characterisation of native and 
prosthetic cardiac valves in cases of clinical 
suspicion of significant valvular dysfunc-
tion with non-diagnostic images from other 
techniques (Figure 6), and in other clinical 
scenarios, such as the evaluation of cardiac 
Figure 4
Coronary CT angiography performed on a 69-year-old man 
with chest pain and prior history of coronary artery bypass 
surgery. (A) 3D-cinematic rendering. (B) Colour-coded per-
fusion map of the left ventricle in the three-chamber view. 
(C) Colour-coded perfusion map of the left ventricle in the 
short axis view. (D) 3D-volume rendered perfusion recon-
struction. The study revealed occlusion of the saphenous 
vein to left anterior descending coronary artery graft (arrow 
in A). Myocardial perfusion images demonstrated hypoper-
fusion of the mid and apical inferolateral segments (arrow in 
B) and the apical anterior segment (arrow in C) in keeping 
with prior myocardial infarction. The patient also had a left 
apical thrombus (*). Volume rendered images nicely showed 
the perfusion deficit (arrowheads in D).
Figure 5
Coronary CT angiography 
performed on a 64-year-old 
asymptomatic patient with prior 
stent implantation in the left main 
coronary artery. (A) Cross-sectional 
image of the left main coronary 
artery. (B) Para-sagittal view of 
the left main coronary artery. (C) 
Oblique axial view of the left main 
coronary artery. (D) 3D-volume 
rendered image. The stent was pat-
ent (arrows) and only showed mild 
intimal hyperplasia causing less than 









CT angiography of the aorta per-
formed on a 37-year-old man. (A) 
3D-cinematic rendering. (B) Multi-
planar reformat of the aortic valve. 
The study revealed mild dilation of 
the ascending aorta and a bicuspid 
aortic valve (arrow in B). Incidentally, 
a coronary anomaly consisting of 
abnormal origin of the right coronary 
artery from almost the sinotubular 
junction was also noted (arrowhead).
A B
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Figure 8
Coronary CT angiography performed on a 56-year-old man with atypical chest pain and prior inconclusive stress test. (A) 
3D-cinematic rendering. (B) Curved planar reformat of the left anterior descending coronary artery. (C) 3D-cinematic render-
ing of the coronary vasculature. (D) CT-derived fractional flow reserve (CT-FFR). A 70–99% stenosis was depicted in the mid 
left anterior descending coronary artery segment (arrows) (CAD-RADS 4A). CT-derived FFR value obtained with a research 
prototype (ctFFR, syngo.via Frontier, Siemens Healthineers) was 0.71, reflecting that the coronary stenosis was likely haemody-
namically significant.
Figure 7
Cardiac CT performed on a 
74-year-old man with paroxysmal 
atrial fibrillation requiring pulmo-
nary vein ablation. Normal anatomy 
of the pulmonary veins was 
observed.
masses, evaluation of pericardial anatomy, 
assessment of pulmonary and coronary vein 
anatomy prior to interventional procedures, 
such as radiofrequency ablation or pace-




Recent development has allowed a wide-
spread use of cardiac CT. From the begin-
ning, CCTA showed its usefulness in a certain 
number of clinical scenarios in individuals 
with known or suspected CAD. Nowadays, 
clinical indications are mostly based on its 
high negative predictive value, i.e. on its 
ability to confidently rule out significant cor-
onary artery stenosis. Besides evaluating the 
coronary vasculature, cardiac CT has also 
been shown to be useful in the evaluation of 
cardiovascular anatomy and morphology. 
Ongoing research points towards compre-
hensive assessment of ischaemic heart dis-
ease. Strategies based on complex compu-
tational methods (i.e. CT-derived fractional 
flow reserve) (Figure 8) and CT myocardial 
perfusion may fulfil this integrative approach 
to coronary artery disease. Furthermore, 
recent publications also emphasise the prog-
nostic value and cost-effectiveness of car-
diac CT. Significant research is still warranted 
to further evaluate the full clinical potential 
of this imaging technique.
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contraction. In clinical practice, all 
sequences could be useful to detect ana-
tomical abnormalities. However, anatom-
ical parameters are particularly crucial in 
defining thoracic aorta aneurysm and the 
indications to treat thoracic aorta aneu-
rysm are based on anatomical measure-
ments. To assess the ascending aortic 
anatomy, 3D bright blood free breathing 
steady state free precession sequences 
yield multiplanar reconstructions. 
Ascending aortic aneurysm measure-
ments should be taken perpendicular to 
the vessel of interest. The largest diame-
ter perpendicular to the great axis is con-
sidered as the reference diameter (Figure 
1). Exploration of the ascending aorta 
should include exploration of the aortic 
valve in particular to detect constitutional 
abnormalities such as bicuspid valves or 
valvular regurgitation or stenosis.
MR FUNCTIONAL 
ASSESSMENT
Left ventricular (LV) volumes and mass 
assessment are well-known markers of 
LV systolic function. Steady state free 
precession (SSFP) sequences are the 
gold standard for assessing chamber 
volume and mass. SSFP sequences 
require k-space sampling over several 
heartbeats and must be performed with 
short breath holds (usually from 8–12 
seconds). SSFP sequences have a high 
signal to noise ratio and provide a T2/T1 
BASIC BUILDING BLOCKS IN  
NON-INVASIVE CARDIAC IMAGING 
Part II:
WHAT CAN WE 
EXPECT FROM A 
BASIC  CARDIAC  
MR EXAMINATION
BY FARAH CADOUR, AXEL BARTOLI AND ALEXIS JACQUIER
WHY CARDIAC MR?
With technical progress, cardiac magnetic resonance (CMR) imaging has 
become part of mainstream cardiology imaging practice. The develop-
ment of increasing magnetic field strengths and surface coil channels, 
rapid k-space sampling, postprocessing techniques, and sophisticated 
sequences for myocardial characterisation have made cardiac MR a pow-
erful tool in the workup of many complex cardiac disorders. Consensus 
statements from several international cardiac associations include car-
diac MR as a primary imaging technique. In this chapter, we will outline 
the CMR biomarkers assessable in clinical practice that give an optimal 
evaluation of anatomy, function, perfusion, flow, and tissue characterisa-
tion. This chapter will also provide an overview of the CMR capabilities in 
cardiac imaging, but it does not intend to be exhaustive.
BASIC MR ANATOMY EVALUATION
All cardiac imaging sequences are acquired using electrocardio-
graphic gating to overcome image-blurring secondary to cardiac 
Figure 1
This figure shows an example of a 3D bright blood sequence (free breathing, 6 min acquisition time). (A) A native image of the 
3D stack is displayed. (B) shows a reconstructed view perpendicular to the great axis of the aortic root. Note that the aortic 
valve is bicuspid without raphe. A 3D volume rendering of the ascending aorta is displayed in (C).
A B C
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signal. Furthermore, SSFP also quantifies 
chamber volume and LV mass; for that 
purpose, a stack of short-axis SSFP cine 
sequences should be acquired from the 
annulus to the apex. Interobserver and 
intraobserver variability is around 5% and 
3% respectively for volume quantification. 
Expert consensus panels consider CMR 
to be the most precise and reproducible 
technique to assess LV volume, mass and 
ejection fraction. Other cardiac chamber 
volumes can also be assessed using SSFP 
sequences. Cine sequences are the basis 
of all cardiac magnetic resonance images 
(Figure 2). Besides the functional param-
eters, cine sequences can also depict 
abnormal segmental contraction or any 
abnormal aspect of the left ventricle such 
as excessive trabeculation phenotypes.
MR FLOW QUANTIFICATION
Velocity-encoded cardiac magnetic reso-
nance measures flow in vessels of the car-
diovascular system without the use of intra-
vascular catheterisation, ionising radiation 
radioactive tracers or gadolinium injection. 
Velocity maps are generally displayed on 
a grey scale with stationary tissue shown 
in mid-grey, velocities in forward (positive) 
and reverse (negative) directions being 
represented as higher (towards white) 
Figure 2
This figure shows a four chamber 
view steady state free precession 
(SSFP) image in the diastolic phase. 
Note the high contrast between 
blood and myocardium.
Figure 3
This figure shows velocity-encoded images in (A) and the corresponding aortic flow profile in (B).
A B
and lower (towards black) pixel intensities 
(Figure 3). Velocity-encoded CMR meas-
ures valvular regurgitation accurately and 




Myocardial perfusion imaging assesses 
the blood supply to the myocardium and 
plays an increasing role in the diagnosis of 
ischaemic heart disease. In order to assess 
myocardial perfusion, blood passing into 
the myocardium needs to alter the image 
signal intensity so that areas of reduced 
perfusion can be detected. This is typically 
achieved using a signal enhancing con-
trast agent. The contrast agent is injected 
intravenously whilst multiple images of the 
heart in the same anatomical position and 
at the same point in the cardiac cycle are 
acquired in successive heartbeats. Typi-
cally, short-axis images are acquired but a 
long axis image is sometimes also acquired 
in order to cover the apex of the heart. 
In general, the acquisition of a dynamic 
series of MR images during the passage 
of contrast agent through the body is 
known as dynamic contrast-enhanced MRI 
(DCE-MRI). DCE-MRI can be used after the 
injection of a vasodilator drug at rest and 
Chapter 1 | BASIC BUILDING BLOCKS IN NON-INVASIVE CARDIAC IMAGING 25
THE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONS
24 Chapter 1 | BASIC BUILDING BLOCKS IN NON-INVASIVE CARDIAC IMAGING
THE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONS
under stress to detect myocardial ischae-
mia. Recent European recommendations 
consider DCE-MRI as precise as other ref-




Late gadolinium enhancement (LGE) 
imaging has revolutionised the role 
of CMR for both ischaemic and 
non-ischaemic disease. LGE involves intra-
venous administration of 0.1 to 0.2 mmol/
kg gadolinium-based contrast agent 
followed by the acquisition of T1 weighted 
images of the myocardium using an 
inversion recovery technique. In ischaemic 
disease, LGE depicts areas of myocardial 
infarct that typically involve the sub-en-
docardium, and depending on the size of 
the infarct, extend up to the epicardium. 
This method is referred to as ‘viability 
imaging’, as the absence of scar indicates 
that the myocardium is viable, retaining a 
capacity to recover its contractile function 
Figure 4
This figure shows a patient with a huge left ventricular (LV) apical aneurysm in (A) with transmural enhancement after late 
 gadolinium enhancement (LGE) in (B).
Figure 5
This figure shows a patient with a 
sarcomeric hypertrophic cardiomy-
opathy. The maximal end diastolic 
thickness of the interventricular 
septum is 21mm (A). T1 mapping 
in (B) showed up an area of higher 
signal, matching with area of highly 
fibrosed myocardium on late gado-






following revascularisation (Figure 4). LGE 
not only defines the location and extent 
of infarction, but also differentiates areas 
that show failure of tissue perfusion after 
revascularisation, the so-called no-reflow 
phenomenon. In non-ischaemic disease, 
LGE characterises hyper-enhancement 
patterns that are characteristic of several 
disorders such as hypertrophic cardiomy-
opathy (Figure 5), inflammatory or stor-
age diseases such as cardiac sarcoidosis 
(Figure 6) or amyloidosis (Figure 7).
PARAMETRIC MAPPING  
AND TISSUE 
CHARACTERISATION
Parametric mapping is a new technology 
in clinical CMR practice. On conventional 
MR imaging techniques, signal intensity is 
expressed on an arbitrary scale that differs 
from one imaging examination to another 
and therefore is unsuitable for direct 
signal quantification. T1 and T2 mapping, 
in contrast, yields signal quantification in 
milliseconds on a standardised scale. In T1 
and T2 mapping techniques, after prepa-
ration, pulse signal recovery is sampled 
from a series of multiple measurements, 
and the associated T1 or T2 relaxation time 
is calculated for every pixel of a paramet-
ric image referred to as a T1 or T2 map. T1 
maps yield measurements of myocardium 
and blood T1 values before and after gado-
linium contrast enhancement. The native T1 
value (without contrast) is used to char-
acterise myocardial infiltration by fibrosis 
or protein such as in amyloidosis (Figure 
7). T1 mapping has demonstrated its value 
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Figure 7
This figure shows a patient with overall myocardial hypertrophy involving the left ventricular (LV), right ventricular (RV) and 
both atrial walls on (A). On (B) the T1 map shows high signal intensity of the entire LV whole with a T1 value measured at 1542ms 
(normal 1150ms (3T machine)). The LGE image in (C) depicts diffuse myocardial enhancement with a higher signal in compari-
son to LV blood. Amyloidosis was confirmed on biopsies.
Figure 8
This figure shows a patient with a global disseminated left ventricular (LV) hypertrophy in (A) and (B). In (C) T1 mapping 
revealed a low value at the level of the septum with a T1 value measured at 798ms and a high signal area on the lateral wall 







This figure shows a patient with an acute cardiac sarcoidosis involvement depicted by a large oedema shown as an orange area 
on the T2 mapping sequence in (A) and matching with the late gadolinium enhancement (LGE) myocardial area on (B).
A B
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in assessing myocardial involvement in 
Fabry’s disease and shown a decrease in 
T1 value in the myocardium (Figure 8). T2 
mapping is less sensitive to motion and coil 
artefact compared to T2 weighted images 
and is used to quantify oedema and for 
follow-up (Figure 6).
CONCLUSION
Over the past decade, CMR has developed 
from an exciting novelty to become an 
integral part of today’s clinical routine. The 
unique ability of CMR to comprehensively 
assess cardiac morphology, function, and 
tissue structure has provided new pathophys-
iologic insights, improving our understanding 
of ischaemic cardiomyopathies and non-is-
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(CT). Coronary calcium scanning was first 
made possible in the late eighties with 
electron-beam tomography. Nowadays, any 
CT system with at least 16 detectors can be 
used for this purpose. The CT calcium scor-
ing protocol is highly standardised (Figure 1) 
and involves an electrocardiographically 
(ECG)-triggered CT scan. A CT scan for 
calcium scoring involves a radiation dose of 
typically 1 mSv or less. This dose is insig-
nificant compared to annual background 
radiation.
The amount of coronary calcification is 
typically expressed as a calcium score 
according to Agatston’s method (Figure 2). 
With the use of semi-automated software, 
a calcium score can be calculated within 
a couple of minutes by radiology tech-
nicians. The variability in calcium scores 
within and between observers is low. 
However, there are differences in calcium 
scores between CT systems from different 
vendors that can result in a difference in 
risk classification in some individuals. At 
the very least, it is important to perform 
repeated calcium scoring as much as pos-
sible on the same CT system.
A positive calcium score indicates the 
presence of coronary atherosclerosis. 
While CT-detected coronary calcification 
only allows evaluation of the calcified 
component of coronary plaques, a good 
correlation has been found between the 
calcium score and the total coronary 
plaque burden as determined by intravas-
cular ultrasound and histology. Therefore, 
the calcium score is a good measure for 
the total extent of coronary atherosclero-









In the coming decades, a continuing increase in the number of cases of 
coronary heart disease (CHD) is expected. This is caused by, amongst 
others, the increasing prevalence of obesity and diabetes, and the rising 
numbers of elderly citizens. The morbidity and mortality toll of CHD is 
high. In many cases, a coronary event occurs acutely, without earlier signs 
suggesting CHD. So how can we identify individuals in the asymptomatic 
population at high risk of CHD, and prevent coronary events? Cardiovas-
cular risk estimation in the general population is based on determining risk 
factors such as hypertension and smoking. Risk factor levels can be used 
to calculate a risk-scoring algorithm, like the European SCORE, and guide 
medical therapy. Unfortunately, risk factor based algorithms are neither 
highly sensitive nor specific. Accurate identification of asymptomatic indi-
viduals who will develop a coronary event is challenging.
Evaluation of the extent of atherosclerotic plaque, which underlies CHD, 
can improve cardiovascular risk evaluation. Amongst the non-invasive 
measures of atherosclerosis, focus has turned to assessment of coro-
nary calcification by non-contrast-enhanced computed tomography 
Figure 1
Standardised protocol for CT 
 calcium scoring
Figure 2
Calculation of the calcium score 
according to Agatston’s method
CALCIUM SCORING:  
METHODOLOGY
• At least 16-MDCT system
• Standardised protocol
Axial scan mode
Prospective ECG  triggering
Tube voltage 120 kVp
Reconstructed slice  
thickness 3 mm
Calcium score according to 
Agatston
• Radiation dose typically  
1 mSv (< 3 mSv)
CALCIUM SCORING:  
AGATSTON’S METHOD
Score per calcified lesion:




(voxel with  
highest HU)




1 = 130 – 199 HU
2 = 200 – 299 HU
3 = 300 – 399 HU
4 = ≥ 400 HU
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Figure 3 shows some examples of CT cal-
cium score scan results.
The calcium score increases with age, 
and is generally higher for men than for 
women. About 50% of men have some 
detectable coronary calcification at age 50 
years, compared to approximately 25% of 
women. Often, the calcium score is divided 
into four categories (Figure 4): 0 (none), 
1–99 (mild), 100–299 (moderate), and at 
least 300 (severe coronary calcification). 
These cut-points were chosen based on 
the risk of significant coronary artery 
disease at invasive coronary angiography. 
Another commonly used approach is to 
calculate an age- and gender-matched 
percentile, where a calcium score of at 
least the 75th percentile indicates prema-
ture or accelerated plaque development.
Multiple screening and population-based 
studies have shown the strong prognos-
tic value of the calcium score for coronary 
events. The calcium score predicts the 
occurrence of CHD in men and women, and 
in younger and older populations. Already 
in individuals with a positive, low calcium 
score (1–100), the risk of coronary events 
is doubled compared to those with a zero 
calcium score. Around two thirds of coronary 
events are concentrated in the quarter of the 
population with a calcium score above 100. 
Compared to individuals without coronary 
calcification, those with a calcium score 
above 1,000 have more than 10 times the risk 
of CHD. These individuals should be consid-
ered high risk. The relative risks for increasing 
calcium score categories are much higher 
than those reported for cardiovascular risk 
factors or other non-invasive measures of 
atherosclerosis.
When considering the utility of calcium 
scoring, it is important to assess the abil-
ity of the test to improve discrimination 
between those who do and who do not 
develop an event. There is clear evidence 
that calcium scoring improves this discrim-
ination, in particular in the intermediate risk 
category (based on risk factors). Studies 
have shown that up to two thirds of those 
with intermediate risk were more correctly 
classified in the low- or high-risk category 
when the calcium score was added to risk 
stratification. Thus, the calcium score can 
have a major impact in risk stratification of 
the asymptomatic population.
Apart from a high calcium score, a clinically 
very relevant finding is a calcium score of 0. 
In over 70,000 individuals, a zero calcium 
score conferred a risk of CHD of only 0.5% 
in four years, suggesting that the risk of cor-
onary events is negligible in case of absent 
coronary calcification. A calcium score of 0, 
in asymptomatic individuals and in sympto-
matic patients, is a very reassuring finding 
with a warranty period of up to 15 years. 
Whether it is safe to downregulate preven-
tive medication in case of a calcium score of 
zero is still unknown.
So far, randomised controlled trials on the 
impact of calcium scoring on CHD are lack-
ing. This information is generally considered 
essential to determine the value of a new 
Figure 3
Calcium score scan results for four 
individuals with no, mild, moderate 
and severe coronary calcification
Figure 4
Classification of calcium score into 
cardiovascular risk categories






≥ 300 moderate to  
 severly increased
Score Cardiovascular risk
> 75 % increased risk  
 compared to  
 persons of same  
 sex and age
diagnostic marker for integration in risk 
assessment. However, this evidence is similarly 
lacking for currently used risk scoring algo-
rithms based on risk factors and other non-in-
vasive markers of atherosclerosis such as the 
ankle-brachial index. Currently, a randomised 
trial on the role of calcium scoring in primary 
prevention is ongoing in the Netherlands 
(ROBINSCA trial).
What do current guidelines mention about 
the calcium score? Recent guidelines on 
cardiovascular risk assessment and CHD 
prevention (ACC/AHA 2013; ESC 2016) 
agree on an indication of calcium scoring in 
asymptomatic individuals at intermediate risk 
based on risk factors. In these cases, adding 
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the calcium score as a risk modifier can lead 
to upward or downward risk reclassification. 
This assists in decision-making regarding 
the start of preventive medication. In the US 
guideline, the recommendation is to reclas-
sify an individual into the higher-risk cate-
gory in case of a calcium score of at least 
300, or at least 75% percentile for their age 
and gender. The 2016 SCCT/STR guideline 
states that because of its strong prognostic 
value, coronary calcification should be eval-
uated and reported on all routine non-con-
trast, non-ECG-triggered chest CT scans. In 
this setting, the amount of coronary calcium 
can be visually estimated as none, mild, mod-
erate and severe (Figure 3).
In conclusion, CT calcium scoring is an 
increasingly important radiological examina-
tion. CT calcium scoring is limited to a very 
low radiation dose, can be performed in a 
high throughput fashion, is a technician only 
examination, and has virtually no contrain-
dications. Strengths of CT calcium scoring 
include the high level of standardisation, the 
extensive evidence base for its risk stratifi-
cation potential in the general population 









Low-intermediate-risk chest pain at the emergency 
department, including low-positive troponins 
Excluded: history of CAD
7 sites  
in the Netherlands
30-day follow-up: 
cardiac CT vs standard care 
Revascularizations (primary): 17% vs 13% (p=0.40)
Invasive angiography: 17% vs 13% (P=0.20) 
ACS at discharge: 9% vs 7% (NS) 
Length of stay: 6.3 vs 6.3 hours (NS) 
Discharge from the ED: 65% vs 59% P=0.16) 







Admitted with acute on-set chest pain and indication 
for non-invasive diagnostic testing
Patients were recruited 
from a single center in the 
greater Copenhagen area, 
Denmark
Results
CT more frequently identified CAD (12% vs. 4%, p=0.001)
CT increased the revacularisation rate (10% vs 4%, p=0.005)
At intermediate term follow-up  
CT reduced cardiac events (11% vs 16%, p=0.04)  
(cardiac death or hospitalisations for acute myocardial 





bicycle test or 
SPECT
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Patients were randomised to either cardiac 
computed tomography (CT) or standard care. 
Results showed that cardiac CT led to reduc-
tions in diagnostic costs (Figure 1).
THE CATCH I TRIAL2
CArdiac cT in the treatment 
of acute CHest pain 
The CArdiac cT in the treatment of acute 
CHest pain (CATCH) trial included 600 
patients admitted to Hvidovre hospital, 
Copenhagen with acute onset chest pain, 
but normal electrocardiogram and troponins. 
Patients were randomised to either outpatient 
evaluation with computed tomography (CT) 
or a functional stress test (exercise bicycle test 
or single photon emission computed tomogra-
phy (SPECT)). Results showed that cardiac CT 
identified more patients with significant coro-
nary artery disease (CAD) and more coronary 
revascularisations were performed. Cardiac 
CT reduced subsequent cardiac events within 
a median follow-up period of 18.7 months 
(Figure 2).
IMAGING TRIALS: 
THE FUTURE OF  
CARDIAC IMAG-




The future of cardiac imaging will be greatly influenced by the results of 
imaging trials. This is because health insurers mainly rely on evidence from 
randomised imaging trials when deciding about the coverage of novel imag-
ing techniques. In such trials, patients are randomly (by chance) assigned 
to undergo the novel imaging technique or the previous standard of care, 
which may or may not include imaging. To give a broad overview of recent 
and current cardiac imaging trials, we invited all trialists to provide a graph-
ical abstract of their trial. The figures in this chapter are graphical abstracts, 
mainly from the trials’ chief investigators, and provide an easy-to-understand 
overview of how these trials will shape the future of cardiac imaging.
THE BEACON TRIAL1
Better Evaluation of Acute Chest pain with computed 
tomography angiography – a randomised cONtrolled trial
The BEACON trial included 500 patients at seven sites in the Netherlands 




The CATCH I trial
600 Patients
Admitted with acute on-set chest pain and indication 
for non-invasive diagnostic testing
Patients were recruited from 
a single center in the greater 
Copenhagen area, Denmark
Results
CT reduced invasive angiographies (14% vs. 30%, p<0.001)
CT reduced total revascularisation rate (7% vs. 14%, p=0.0045)
At intermediate term follow-up no difference in safety measures 
was found (death or hospitalisations for acute myocardial 





and myo cardial 
CT perfusion
268 patients
With stable chest pain (PTP > 10%)
Excluded: known CA, pregnancy, allergies, 
contraindications to adenosine
4 sites  
in the Netherlands
8-months follow-up: cardiac CT vs functional testing
Proportion invasive angiograms with an ESC class I indication 
for PCI (primary endpoint): 88% vs 50% (P=0.017) 
Secondary noninvasive testing: 1% vs 28% (P<O.05) 
Adverse events: 3% vs 3% (NS)







With low-to-intermediate risk of coronary artery disease
Patients from all over 
Europe
Outcomes that matter to patients
Reduction in cardiovascular death? 
Better acceptance of CT imaging test by patients?
Reduction in major and minor procedural complications?
Better quality of life? Reduced health care spending?






With intermediate risk of coronary artery disease
Fewer angiographies one year after MR (18%) and MPS (16%) 
compared with UK NICE guideline (43%) 
Fewer unnecessary angiographies after MR (8%) and MPS (7%)  
compared with UK guideline (29%) 
Similar major adverse cardiovascular events (2.5%)
Images taken from: Greenwood JP et al (2012) Cardiovascular magnetic resonance 
and single-photon emission computed tomography for diagnosis of coronary heart 
disease (CE-MARC): a prospective trial. Lancet. 2012 Feb 4;379(9814):453-60.  





UK NICE  
guideline
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THE CRESCENT II TRIAL5
Comprehensive Cardiac CT Versus Exercise 
Testing in Suspected Coronary Artery 
Disease Randomized Controlled trial 
The CRESCENT II trial randomly assigned 268 
patients with a pre-test probability (PTP) of 
more than 10% to either a tiered CT proto-
col including calcium score, CT angiography 
and CT perfusion or functional testing. This 
resulted in a greater proportion of invasive 
angiograms with an ESC class indication in 
the CT group and less secondary non-invasive 
testing (Figure 5).
THE DISCHARGE TRIAL6
Diagnostic Imaging Strategies for 
Patients with Stable Chest Pain and 
Intermediate Risk of Coronary Artery 
Disease: comparative effectiveness 
research of existing technologies
The DISCHARGE trial randomly assigns more 
than 3,500 patients across Europe to undergo 
either computed tomography (CT) or invasive 
coronary angiography. Outcomes that matter 
to patients will be collected at follow-up in a 
blinded fashion to generate highest levels of 
evidence (Figure 6).
THE CATCH II TRIAL3
CArdiac cT in the treatment of acute 
CHest pain – myocardial CT perfusion II 
The CArdiac cT in the treatment of acute 
CHest pain 2 (CATCH II) trial included 600 
patients admitted to a hospital in the Greater 
Copenhagen area with acute onset chest 
pain for either computed tomography (CT) 
or computed tomography in combination 
with myocardial CT perfusion (CTP). Results 
showed a significant reduction in the referral 
rate for invasive coronary angiography and 
reduced revascularisation rate in the CT + 
CTP group. However, the revascularisation 
rate among patients referred for invasive 
coronary angiography was similar in the 
two groups. Follow-up will be conducted to 
examine the implications of the diagnostic 
approaches (Figure 3).
THE CE-MARC II TRIAL4
Clinical Evaluation of MAgnetic Resonance 
imaging in Coronary heart disease II
The CE-MARC II trial randomly assigned 
more than 1,200 patients to either magnetic 
resonance (MR) imaging, the procedure 
according to the UK NICE guideline, or to 
myocardial perfusion scintigraphy (MPS). 
There were fewer angiographies after MR and 
MPS, reducing unnecessary angiographies, 
while major adverse cardiovascular events 
were similar in the three groups (Figure 4).
Figure 3
The CATCH II trial
Figure 4
The CE-MARC II trial
Figure 5





Typical angina and positive exercise test  
or 2 cardiovascular risk factors
Patients from 16 sites  
in 4 European countries
Similar MACE rate of 3.3 vs. 3.9%  
(death, myocardial infarction, or repeat target  
vessel revascularisation) 
Reduced negative angiography rate  






With suspected angina  
due to coronary artery disease
Change in diagnosis in 25%
Change in investigations in 15% 
Change in treatments in 23% 
50% reduction in  
myocardial infarction
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CONCLUSION
The randomised imaging trials outlined above 
show that the future of cardiac imaging looks 
bright. Cardiac CT is expected to play a cen-
tral role in the management of patients with 
suspected coronary artery disease while car-
diac MRI will enable us to better understand 
the clinical implications of myocardial ischae-
mia and infarction for individual patients, thus 




THE MR-INFORM TRIAL7, 8
Randomised Non-inferiority Multicenter 
Trial Comparing MR Perfusion Imaging 
and Fractional Flow Reserve (FFR) to 
Guide Management of Patients With 
Stable Coronary Artery Disease
The MR-INFORM trial randomly assigned more 
than 900 patients to undergo decision making 
informed by either magnetic resonance (MR) 
or invasive fractional flow reserve (FFR). There 
were similar major adverse cardiovascular 
event (MACE) rates while MR reduced negative 
angiography rates (Figure 7).
THE SCOT-HEART TRIAL9, 10
Role of Multidetector Computed 
Tomography in the Diagnosis and 
Management of Patients Attending 
a Rapid Access Chest Pain Clinic
The SCOT-Heart trial randomly assigned 
4,146 patients in Scotland to undergo 
either standard care or standard care plus 
computed tomography (CT). There was a 
relevant change in diagnosis, investigations, 
and treatments in the CT group leading to 
a 50% reduction in myocardial infarction 
(Figure 8).
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In the context of ACS, clinical suspicion 
is supported by early risk stratification 
through clinical history, electrocardiogram, 
cardiac biomarkers and criteria such as the 
TIMI risk score. However, this doesn’t make 
it possible to detect patients who can be 
discharged from ED earlier and safely. 
This leads to prolonged stays, saturation 
of hospital services and high costs for 
patients who do not really require it, since 
up to 85% of patients with chest pain do 
not have ACS.
Recent efforts have focused on the reduc-
tion of the length of stay as a result of accu-
rate early identification of patients who can 
safely be discharged from ED versus those 
who require in-hospital observation. Of 
particular interest is the group of patients 
with ACP, negative first troponin, negative/
non-diagnostic ECG and low to intermediate 
risk (TIMI risk score <4).
Coronary CT angiography may help to 
reach this goal, since it has proven to 
be clinically useful as an alternative or in 
addition to functional tests (according to 
several prospective trials such as PROMISE 
and SCOT-HEART) and has also proved 
to be a powerful tool in safely identifying 
patients who can be discharged from ED 
(supported in 4 large randomised trials: 
CT-STAT, ACRIN-PA, ROMICAT II and 
CT-COMPARE), due to its high sensitivity 
(86–100%) and a high negative predictive 
value (93–100%).
Up to 8% of patients with ACS may have 
negative ECG and negative cardiac bio-
markers, which leads to a missed diagnosis 
and an increase not only in morbidity and 
mortality but also in malpractice litigation. 
In these cases, coronary CT angiography 
may help clinicians to guide management. 
In this chapter, we are going to focus on 
coronary CT angiography rather than aortic 
or pulmonary CT angiography.
EVOLUTION OF  
CARDIAC CT
Imaging the heart using CT is a technolog-
ical challenge, since it requires scanning 
very small vessels (coronary arteries) that 
are in constant motion, therefore a high 
spatial and temporal resolution is needed. 
In the 1980s, the use of electron beam CT 
made it possible to obtain images of the 
heart with a high temporal resolution but 
low spatial resolution, even so it was the 
essential modality to establish the basis for 
a calcium score. In the 1990s, single-slice 
helical CT systems were introduced, utilising 
new slip-ring technology. Multi-detector 
row CT (also known as MDCT or multi-slice 
CT) followed soon thereafter, increasing 
the coverage in z-plane, and since then, the 
number of detectors has increased from 4 
(1998) to 320 (2008) allowing a coverage 
of up to 16cm within a single rotation, which 
has made it possible to scan the entire heart 
in a single gantry rotation. At the same 
time, rotation speed increased from 1 to 
0.25 seconds which increases the tempo-
ral resolution significantly. Dual source CT 
further improves the temporal resolution by 
a factor of 2, without increasing the rota-
tion speed. New detector systems allow 
spatial resolutions closer to conventional 
angiography. These incredible technological 
I WANT TO LIVE  
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BY HAROLD GOERNE AND SUHNY ABBARA
INTRODUCTION
Chest pain is the second most common cause of admission to 
emergency departments (ED) in the United States after abdominal 
pain according to data from the National Center for Health Sta-
tistics. It is estimated that around 9 million patients per year are 
admitted to the ED for this reason, costing up to $15 billion. One 
of the biggest concerns for doctors and patients is to ascertain 
whether the chest pain is due to a life-threatening cardiovascular 
condition, such as acute coronary syndrome (ACS) (ST segment 
elevation myocardial infarction = STEMI, NSTEMI = non-STEMI, 
unstable angina), acute aortic syndrome (dissection, intramural 
haematoma, penetrating atherosclerotic ulcer) or acute pulmonary 
embolism. In most of these scenarios, prompt intervention is essen-
tial, especially in STEMI, in which early identification and treatment 
is fundamental to changing the course of the disease, which could 
otherwise be fatal.
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motion abnormalities. This mode is ideal 
for patients with high HR or arrhythmias; it 
is also the mode of choice when assessing 
motion of mechanical prosthetic valves. 
Its disadvantage is the higher radiation 
dose need, this can, however, be signifi-
cantly reduced with tube current modu-
lation technique. A third mode, high-pitch 
helical, has a very low radiation dose but 
can only be performed on second and 
third generation dual-source scanners 
and most sites only use this mode at HR 
<60bps. Iterative reconstruction is an 
option offered by all vendors as a strat-
egy for significant dose reduction without 
sacrificing signal to noise ratio.
CORONARY CTA  
IN EMERGENCY 
DEPARTMENTS
It is very important to establish strategies 
between the ED team and the cardiovas-
cular imaging team to ensure the correct 
use of coronary CTA, which in turn allows 
for more efficient patient care. The oral 
β-blocker can be administered in ED one 
hour prior to the study (usually metopr-
olol 50–100mg) or intravenously in the 
CT room (metoprolol 5mg every 5 min-
utes for up to 5 doses) until reaching a 
heart rate of less than 60bps. Sublingual 
nitro-glycerine (0.8mg) is given in the CT 
room 5 minutes prior to the scan acquisi-
tion. Serum creatinine value is necessary 
to evaluate renal function. Good intravas-
cular access is important because high 
injection flow rates of contrast medium 
are used (usually 6 ml/s). The iodine 
advances make it possible for CT coronary 




For coronary CTA, it is recommended to 
use at least a 64 detector CT scanner, but 
the quality of the study depends not only 
on the number of detectors and rota-
tion speed, but also on multiple technical 
factors. These include aspects relating to 
the patient such as their ability to maintain 
apnoea breath hold, which is essential to 
perform the study, otherwise it would be 
an absolute contraindication; their weight, 
which will determine the kVp and the 
amount of contrast medium; their heart 
rate, which ideally should be less than 60 
beats per second, for which it is neces-
sary to use β-blockers (oral or intravenous 
metoprolol) and the use of vasodilators 
such as nitro-glycerine, which helps to bet-
ter visualise coronary arteries. It is impor-
tant to check for possible contraindications 
with these medications.
Prospective ECG-triggering is currently 
the most common acquisition mode; it 
obtains images in one or several phases 
of the cardiac cycle with a step and 
shoot method. It has the advantage of 
emitting a low dose and the disadvan-
tage of not recording all phases of the 
cardiac cycle. In contrast, retrospective 
ECG-gating collects data throughout the 
entire cardiac cycle, making it possible 
to evaluate ventricular function and wall 
concentration should usually be high, at 
about 350–370 mg/ml.
CT acquisition should be performed by 
cardiac trained technical and nursing staff 
and reviewed by an expert in cardiovascular 
imaging. Once the study is done, communi-
cation between the cardiovascular radiology 
staff and the emergency department staff 
is important, so as to make decisions and 
establish management of the condition as 
soon as possible.
The study should be reviewed in a ded-
icated workstation with adequate post-
processing software for coronary CT angi-
ography, allowing for evaluation of DICOM 
data in axial plane, multiplanar reformation 
(MPR), maximum intensity projection 
(MIP), curved planar reconstruction (CPR), 
volume rendering technique (VRT) and 
cardiac function analysis for retrospective 
mode scans.
Coronary arteries are evaluated at their 
origin and course; coronary CTA is an 
excellent modality to demonstrate anom-
alous origins that may be cause of ischae-
mia, such as the interarterial course (Fig-
ure 1). A normal CTA coronary confirms the 
absence of coronary disease. The presence 
of atherosclerosis requires the assessment 
of two parameters: the degree of stenosis 
and the characteristics of the plaque.
Recently, the introduction of CAD-RADS 
as a standardised system for report-
ing coronary CTA makes it possible to 
avoid a lexicon variability, in addition to 
the fact that it provides management 
recommendations.
Figure 1
50-year-old male with recurrent 
chest pain after exercise. (A) VRT of 
coronary tree, (B) VRT of the heart, (C) 
MIP, (D) MPR, shows anomalous origin 
of right coronary artery from left sinus 
of Valsalva with interarterial course 
and extrinsic compression in proximal 
segment with severe stenosis (arrows). 
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obstructive disease) ACS likely (Figures 5 
and 6)
 − CAD-RADS 5 (100% total occlusion) ACS 
very likely (Figure 7)
 − A CAD-RADS N is reserved for non-di-
agnostic studies. Some factors are taken 
into account and added to the category as 
modifiers, which include not fully evaluable 
(N), stent (S) (Figure 8), graft (G) (Figure 
9), vulnerable plaque (V)
Coronary CTA provides information not 
only for coronary arteries, but also allows 
to evaluate the structure of the cardiac 
chambers, integrity of atrial and ventricu-
lar septum, aorta (Figure 10), pericardium, 
pulmonary vessels and lungs. There is a 
CAD-RADS classifies cardiac CT results into 
five categories depending on the degree of 
maximal coronary stenosis:
 − CAD-RADS 0 confirms the absence of 
coronary artery disease (0% stenosis) 
ACS highly unlikely (Figure 2)
 − CAD-RADS 1 (minimal, 1–24% stenosis) ACS 
highly unlikely (Figure 3)
 − CAD-RADS 2 (mild, 25–49% stenosis) ACS 
unlikely
 − CAD-RADS 3 (moderate, 50–69% stenosis) 
ACS possible (Figure 4)
 − CAD-RADS 4A (severe, 70–99% stenosis) 
or 4B (left main >50% or 3-vessel >70% 
Figure 2
47-year-old male, acute chest pain, low risk for ACS. (A) Cinematic rendering, (B) Curved planar reconstructions and 
cross-section of RCA, LAD and LCX, shows normal coronary arteries with no plaque or stenosis (CAD-RADS 0).
A B
Figure 3
60-year-old male, acute chest pain, intermediate risk for 
ACS. (A) VRT of coronary tree shows multiple calcified 
plaques in coronary arteries. Calcified plaques with minimal 
stenosis in (B) RCA, (C) LAD and (D) LCX.
Figure 4
Two different patients with acute chest pain. (A) Obtuse 
marginal branch with non-calcified plaque with 50–69% 
moderate stenosis (yellow arrow), (B) Mid segment RCA 









56-year-old male, stable chest pain. (A) VRT of coronary tree 
shows high take-off of RCA (yellow arrow), anomalous origin 
of LCX from right sinus of Valsalva with retroaortic course 
(red arrow), LAD from left sinus of Valsalva (blue arrow). 
(B) CPR of RCA shows high take-off (yellow arrow), severe 
stenosis in distal RCA (orange arrow) and PDA (green arrow), 
(C) subocclusive predominant non-calcified plaque in mid 
LAD (blue arrow), (D) retroaortic LCX with diffuse partially 
calcified plaques with severe stenosis (red arrow). 3 vessel 
obstructive disease (CAD-RADS 4B).
A B
Figure 6
61-year-old female, recurrent chest pain even after recent stent 
placement. (A) MIP and (B) VRT shows severe stenosis of LM 
(yellow arrow), stent in proximal LAD (green arrow), severe 
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triple-rule-out protocol for the assessment 
of coronary arteries, thoracic aorta and 
pulmonary artery at the same time, pro-
viding good intravascular contrast in both 
right and left side of the heart, but it is not 
routinely used because it requires a greater 
amount of contrast medium, longer breath 
hold times and a higher radiation dose, 
while studies have not shown significant 
incremental yield.
THE FUTURE OF 
CARDIAC CT IN THE 
EMERGENCY ROOM
The latest advances allow us to obtain 
images of the heart and coronary arter-
ies with no or little motion artefact even at 
higher heart rates. The objective in the future 
will be to achieve images without motion 
artefact at any heart rate, even greater than 
100bps, or with arrhythmias. This repre-
sents an important technological challenge 
related to the improvement of the temporary 
resolution. Spectral CT is a technique prom-
ising to be useful in cardiovascular appli-
cations allowing for tissue characterisation 
(such as in plaques) and for quantification 
of enhancement such as in the myocardium. 
In summary, cardiac computed tomography 
is posed to be a modality for evaluation of 
cardiac structure, function, and myocardial 
perfusion and tissue characterisation, an all 
in one study with a low dose of radiation and 




55-year-old male with chest tightness. (A) VRT and (B) 
CPR shows normal appearance of patent stent in mid LAD 
(yellow arrow), calcified plaque with minimal stenosis in 
proximal LAD (green arrow) (CAD-RADS 1/S).
Figure 9
69-year-old male with prior history of 3 coronary grafts. 
Patent arterial LIMA graft to mid LAD (yellow arrow). Pat-
ent venous graft to OM1 (green arrow). Occluded venous 
graft to PDA (red arrow).
A B
Figure 10
21-year-old male with Marfan syndrome. (A) axial MPR, (B) coronal oblique MPR and (C) VRT shows type A aortic root dissec-
tion (blue arrow) with flap at the ostial border of left coronary artery (yellow arrow).
A B C
Figure 7
70-year-old female with shortness 
of breath. (A) Cinematic render-
ing and (B) CPR of LCX shows 
occluded stent (yellow arrow), 
absence of contrast in distal LCX 
(blue arrow), (C) thickening polar 
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Cardiac MRI is now a standardised examination5. 
It includes at least the following pulse sequences:
 − Multiplanar CINE imaging, allowing the 
evaluation of ejection fraction and other 
ventricular functional parameters including 
volumes and myocardial mass
 − First-pass perfusion imaging under vasodi-
lator stress (stress perfusion imaging)
 − Delayed enhancement pulse sequences 
are acquired, in order to detect myocardial 
infarction or fibrosis
The principle of stress first-pass perfusion MR 
imaging is to induce a vasodilatation of healthy 
coronary arteries pharmacologically. Adeno-
sine or regadenoson are mainly used for this 
purpose after contra-indications have been 
excluded. They are being used off-label for this 
purpose. At the peak effect of the vasodilator, 
a bolus of gadolinium chelate is administered 
while a real-time T1-weighted sequence is run.
In case of stenosis of one or several of the 
three main coronary arteries, the blood flow 
is redirected towards the healthy territories 
(vascular steal phenomenon) and decreased 
perfusion of the subendocardial myocardium 
is observed in the diseased segments.
Analysis of first-pass perfusion is usually qualita-
tive, although quantification is possible. This may 
allow for microvascular disease to be detected.
It is also possible to complete the examination 
with a rest first-pass study after the vasodilator 
effect was suppressed (spontaneously after 
adenosine or after aminophylline injection for 
regadenoson).
Rest perfusion imaging is normal in case of 
reversible ischaemia.
The results of perfusion imaging need to be 
compared to other pulse sequences and in 
particular to delayed enhancement imag-
ing that can detect the scar of a myocardial 
infarction. Hence, it is possible to assess both 
myocardial ischaemia and viability during the 
same 30–40 minutes MR session. Comparing 
the results of the MR scan to the coronary 
angiogram (if available) is also helpful for the 
management of the patient.
If substantial areas of inducible ischaemia 
are detected by stress MR, this represents a 
strong argument for revascularisation (either 
by percutaneous transluminal coronary 
angioplasty or by bypass grafting). Inducible 
ischaemia and/or myocardial infarction have a 
high prognostic value regarding cardiac death 
or major cardiovascular events.
Obviously, this examination needs to be 
performed under optimal safety conditions. 
Pre-procedural ECG is required as well as con-
tinuous monitoring of the patient’s vital param-
eters during the examination and particularly 
during the stress test. In our institution, two 
physicians attend the examination; one takes 
care of the patient’s safety, while the other one 
pilots the examination with the technician.
Considering all those advantages, we wonder 
why stress MRI is not practised more often 
worldwide to detect coronary artery disease. 
We already mentioned its limited availability. 
While MR scans are routinely used for brain 
studies, this is not currently the case for the 
heart. Another reason is probably that physical 
exercise, the most physiological stress, cannot 
TOO LITTLE TOO 
LATE: IMAG-




Coronary artery disease (CAD) remains a  
major cause of mortality in the western world. 
During the twentieth century, radiology as a medical specialty was barely 
involved in the detection and treatment of CAD. Technical innovation in MRI 
and CT has completely changed the situation on the turn of the century.
Coronary artery disease/stenosis can induce ischaemia. Ischaemia is 
defined as an insufficient delivery of oxygen to the myocardium. Until 
recently, gated SPECT (a relatively expensive technique delivering ionising 
radiation) was the only diagnostic tool available to reach this diagnosis.
Since 2013 and the new statement on stable angina issued by the Euro-
pean Society of Cardiology1, MRI was recognised as a valid and at least 
equivalent alternative to isotope studies. A number of studies and 
meta-analyses even claim that MR is superior to SPECT. The absence of 
radiation and radioactive effluent are strong arguments for using MRI in 
addition to its spatial and temporal resolution, while its main drawback lays 
in its limited availability.
This recommendation was grounded on multiple studies2–4 that showed 
correlation between MRI and the reference studies of CAD that are coro-
nary angiography and fractional flow reserve.
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yet be used in MRI. Also, there is a large and 
old amount of scientific evidence pleading for 
gated SPECT. Many cardiologists still consider 
MRI as a research tool. Finally, cardiac MRI is 
insufficiently recognised and reimbursed by 
health systems in Western countries and this is 
probably one of the most problematic features.
CONCLUSION
In summary, nowadays a stress cardiac MRI is a 
safe alternative to other stress tests in cardiol-
ogy used to detect ischaemia. The examination 
is quite short, requires the use of a vasodilator 
drug and its diagnostic capabilities are excellent. 
The limited costs, the absence of radioactive 
effluent and the absence of radiation are unique 
advantages of cardiac MRI over gated SPECT. 
Cardiac MR should definitely be employed more 
often by cardiologists worldwide.
Figure 2
Abnormal stress perfusion imaging in a 48-year-old 
male patient complaining of chest pain while exercising. 
Systolic function was impaired (ejection fraction: 35%). 
Stress perfusion imaging showing decreased signal in the 
sub endocardium of the inferior basal segments (right 
coronary artery territory) (green arrows) (A). Vasodilation 
had been obtained after intravenous injection of 400 μg 
Regadenoson for 10 seconds. Subsequent rest perfusion 
(B) after an injection of 125mg IV aminophylline was 
normal. Delayed enhancement did not show scarring (C). 
Percutaneous angioplasty of the right coronary artery 
was performed. Six months later, the patient was free of 





This 32-year-old man with a long history of hypertension was 
referred to CT for chest pain. A severe dual stenosis of the left 
anterior descending artery (LAD) was disclosed (A). Stress 
MR (400 μg Regadenoson) was positive in the apical septum 







Normal stress perfusion imaging in a 45-year-old female 
patient with chest pain and normal systolic function. Vas-
odilation occurred after an intravenous injection of 400 μg 
Regadenoson for 10 seconds. Heart rate increased from 70 
to 90 beats per minute. Four successive short axis views 
of the same dynamic sequence (saturation recovery) are 
shown.
(A) Baseline image (prior to gadolinium chelate bolus). 
(B) Enhancement of the right ventricle. (C) Enhancement 
of the left ventricle and lung. (D) Synchronous (normal) 
enhancement of the myocardium. Both CINE and delayed 
enhancement pulse sequence (not shown) were normal.
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common cause of myocarditis in Europe and 
North America, with Parvovirus B19 and human 
herpes virus 6 (HHV 6) being the most fre-
quent in myocardial biopsy. Unfortunately, the 
rate of endomyocardial biopsy (EMB), which 
is required for definitive diagnosis, is relatively 
low, so the true prevalence, aetiology and 
outcome for viral myocarditis is poorly under-
stood. The diagnosis is usually suspected in 
younger patients without risk factors for cor-
onary artery disease who present with chest 
pain and malaise, often following a prodromal 
viral illness. Clinical findings are often absent 
or non-specific, ECG changes are variable, and 
biomarkers such as cardiac troponin do not 
differentiate from ischaemic myocardial disease 
and may be normal. The European Society of 
Cardiology guidelines2 have, none-the-less, 
recommended clinical and diagnostic criteria 
for the diagnosis of myocarditis. The diagnos-
tic criteria include ECG, troponin, functional or 
structural abnormalities on imaging, and tissue 
characterisation by CMR.
CARDIAC MRI CRITERIA FOR  
THE DIAGNOSIS OF MYOCAR - 
DITIS (LAKE LOUISE CRITERIA)
The ability of CMR to identify myocardial 
inflammation and scar as well as function 
has given it a unique role in establishing the 
diagnosis of myocarditis3. These diagnostic 
tools include;
1. Function 
Steady-state free precession (SSFP) cine 
imaging is the gold standard to access 
cardiac morphology and function. Patients 
with myocarditis may show regional wall 
motion abnormalities involving the right 
ventricle (RV) and the left ventricle (LV) or 
more global ventricular dysfunction. When 
present, impaired ventricular function has a 
worse prognosis. Cine MRI plays an impor-
tant role in the exclusion of other causes 
of raised troponin such as hypertrophic 
cardiomyopathy. Transient increases in 
myocardial thickness are however seen in 
myocarditis and reflect myocardial inflam-
mation and increased intra- and extracellu-
lar volume. 
 
Cine images are also useful in identifying 
pericardial thickening and effusion, indicat-
ing pericarditis, which is present in 30–50% 
of patients with myocarditis.
2. Oedema 
Tissue characterisation sequences, such 
as T2 weighted imaging, with or with-
out fat suppression, visualise myocardial 
oedema. A myocardial signal intensity 
(SI) to skeletal muscle SI ration of >2.0 is 
consistent with myocardial oedema. These 
sequences tend to be susceptible to arte-
fact and field inhomogeneity which can 
make achieving diagnostic image quality 
challenging (Figure 1).
3. Hyperaemia 
Early post gadolinium contrast images 
(EGE) help identify myocardial inflamma-
tion. T1 weighted images early post gado-
linium, showing a global SI enhancement 
ratio of myocardium over skeletal muscle 
of >4.0 or an absolute myocardial enhance-
ment of >45% is consistent with myocarditis. 
THE HEART 
CAUGHT A COLD: 




Chest pain is a common cause of presentation to medical services with a 
wide differential diagnosis. Patients are triaged according to the nature of 
the chest pain, clinical findings, ECG, and cardiac biomarkers1. Those with 
ST elevation and positive troponin levels (5–10%) follow an established 
clinical pathway for acute myocardial infarction with early revascularisation 
strategies involving Primary Percutaneous Coronary Intervention (PPCI) 
or thrombolysis (if PPCI is unavailable). At the other end of the spectrum, 
many patients are diagnosed with non-cardiac chest pain and are managed 
appropriately. A significant proportion of patients (40%) will have troponin 
positive chest pain but no ST elevation and the differential lies between 
non-ST elevation MI, unstable angina, or other forms of acute myocardial 
injury such as myocarditis. Prior to the widespread availability of cardiac 
MR (CMR), most of these patients would undergo an invasive coronary 
angiogram with 10–15% having normal coronary arteries. The ability of CMR 
to identify and characterise myocardial inflammation has revolutionised 
the diagnosis of myocarditis. This chapter will illustrate the appearance of 
myocarditis with standard and more advanced CMR techniques.
MYOCARDITIS AETIOLOGY
The causes of myocarditis include three main groups; infection, immune 
mediated, and toxic myocarditis. Viral infections are thought to be the most 
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In practice, cine images obtained follow-
ing contrast often demonstrate areas of 
increase myocardial signal reflecting EGE 
and myocardial hyperaemia (Figure 1).
4. Necrosis/Fibrosis 
Late post gadolinium enhanced images 
(LGE) visualise the presence and distribu-
tion of myocardial scar/fibrosis. Images are 
obtained 8–10 minutes after administration 
of contrast using an inversion-recovery pre-
pared T1 weighted sequence to suppress 
normal myocardial signal. In theory high 
signal on LGE images denotes irreversible 
myocardial necrosis and scarring, however, 
in practice, areas of myocardial oedema 
may also show increased signal on LGE 
sequences in acute myocardial injury with 
subsequent resolution during recovery. 
 
The pattern of LGE in myocarditis is typ-
ically patchy and predominantly involves 
the sub-epicardial myocardium and the 
mid myocardium. Importantly, it usually 
spares the sub-endocardium allowing dif-
ferentiation from an ischaemic myocardial 
injury (Figure 2). 
 
Pericardial inflammation may also be 
demonstrated on LGE images (Figure 3).
Figure 3
LGE images showing pericardial 




This illustrates the typical appearances of acute myocar-
ditis. (A) SSFP cine image following gadolinium showing 
areas of increased signal indicating hyperaemia. (B) and 
(C) T2 weighted images showing increased myocardial 
signal compared to skeletal muscle indicating myocardial 
oedema. (D) and (E) LGE images showing a diffuse mid 







Typical LGE appearances of myocarditis in 3 cases (A) 
and (B), (C) and (D), (E) and (F), with patchy areas of scar 
sparing the subendocardium (white arrows). Conversely 
case (G) and (H) shows an inferior wall MI with transmural 










The Lake Louise Criteria allow for a diagno-
sis of myocarditis in the appropriate clinical 
context if two or more of the diagnostic 
tissue markers (oedema, EGE or typical scar) 
are present. A diagnostic accuracy of 78% is 
quoted.
NEWER CMR TECHNIQUES
Techniques to identify myocardial oedema 
are currently hampered by issues with signal 
to noise ratio and image quality. In addition, 
myocardial oedema is often diffuse, making it 
difficult to visualise as all of the myocardium 
may be affected. The Lake Louise Criteria 
therefore used the degree of signal intensity 
compared to adjacent skeletal muscle as a 
quantitative cut off for myocardial oedema. 
Likewise, the distribution of EGE may be very 
diffuse and subsequently not easily discerni-
ble to visual assessment.
The re-introduction of quantitative tech-
niques to measure myocardial T1 and T2 
relaxation times in the form of ‘parametric 
mapping’ sequences has significantly added 
to diagnostic accuracy as they are able to 
identify global (and regional) changes in 
myocardial signal with greater sensitivity. 
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There are a plethora of sequences and 
measurement parameters available includ-
ing native T1, T1 post contrast, T2, extra- 
cellular volume (ECV) and synthetic EVC. In 
addition, the values for each technique vary 
with field strength and individual scanners 
making universally comparable results 
difficult to obtain. None-the-less, numer-
ous authors have shown an improvement in 
diagnostic accuracy and confidence if map-
ping sequences are applied to this patient 
cohort. Diagnostic accuracy for myocarditis 
improved from 79% with the Lake Louise 
Criteria to 90% when combining ECV and 
LGE4. It seems likely that new diagnostic 
criteria incorporating parametric map-
ping techniques will be published shortly 
(Figure 4).
PROGNOSIS AND TEMPORAL 
CONSIDERATIONS
The majority of patients with acute myo-
carditis show spontaneous resolution in the 
first 2–4 weeks, but about 25% will develop 
persistent cardiac dysfunction and 12–25% 
may acutely deteriorate or develop DCM1. 
Myocarditis is diagnosed in up to 20% of cases 
of unexpected sudden death and viral myo-
carditis is implicated in up to 60% of cases of 
dilated cardiomyopathy. These factors have a 
number of implications for clinicians investi-
gating possible myocarditis; firstly, making a 
positive diagnosis of myocarditis is important 
as it will allow appropriate therapy and follow 
up, and avoidance of risk factors such as vig-
orous exercise in the acute phase. Secondly, 
Figure 4
A case of acute myocarditis performed 5 days after presentation (A–E) and 3 months later (F–J). The myocardial oedema seen on 
T2 weighted images (A) and T1 mapping sequences (B) and (C) has resolved after 3 months (F–H). Likewise, the extent of LGE (D) 





myocardial inflammation associated with 
myocarditis is usually transient and will reduce 
over time in the majority of patients (Figure 
4). Timing of the initial MRI scan is therefore 
important in achieving a positive diagnosis. 
There is some evidence that patients scanned 
within the first 24–48 hours of presentation 
may have not elicited enough inflammatory 
response to be visible on CMR. Likewise, 
patients scanned more than six weeks follow-
ing presentation will have a lower diagnostic 
rate as both oedema and LGE subside over 
time. Ideally therefore a scan time of 5–10 
days following presentation is ideal. Follow up 
CMR at three months is also recommended in 
order to access resolution and identify those 
patients at risk of progressing to DCM and 
chronic cardiac dysfunction.
CONCLUSION
Myocarditis is an important cause of chest 
pain and, whilst most patients recover well, 
a minority result in sudden cardiac death 
and dilated cardiomyopathy. CMR has an 
established pivotal role in the diagnosis and 
management of patients with myocarditis. 
The advent of parametric mapping tech-
niques will further enhance the role of CMR 
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A completely different clinical setting con-
cerns the so-called population of adult 
athletes (i.e. >35 years old), usually including 
middle-aged or elderly participating in infor-
mal or recreational sports, on either a regular 
or an inconsistent basis1.
In this cohort of individuals, cardiovascular 
screening should predominately aim to rule 
out coronary arteries disease, which is the 
main cause of events occurring during physi-
cal activity.
The present article aims to review morpho-
logical and functional features of athlete’s 
heart, with particular emphasis on the impor-
tance and respective strengths of CT and MR 
imaging which have been recognised as novel 
central tools for cardiovascular prevention in 
young and adult athletes.
THE ATHLETE’S HEART
The observation that the cardiovascular 
system of highly trained athletes would differ 
structurally and functionally from the general 
population has been known for more than 100 
years.
THE ATHLETE’S  
 HEART: 




BY MARCO FRANCONE, ANNA PALMISANO  
AND ANTONIO ESPOSITO
INTRODUCTION
Sudden cardiac death (SCD) prevention in athletes has been an object of 
extensive debate among the media, scientists and sports communities 
(Figure 1), due to the tremendous social impact of those events usually 
occurring in healthy and well-trained individuals.
Initial general conviction that elite competitors would represent a special 
cohort of healthy individuals with negligible cardiovascular risk has been 
gradually replaced by the evidence that athlete’s heart is a sort of sep-
arate entity in which cardiovascular adaptations to sport often lead to 
overlapped manifestations with a series of pathological conditions.
There is, in particular, an increasing demand for systematic screening of 
young competitive athletes (i.e. <35 years old), who are deemed to be the 
paradigm of health. The heart of a young athlete has been clearly recog-
nised to differ from the heart of a non-athlete and these changes have 
been structured into the definition of athlete’s heart syndrome, in which 
differentiation from potentially lethal pathological conditions requires 
careful global assessment.
Figure 1
Sudden cardiac death (SCD) occur-
rence in top-level athletes is a rare 
but highly exposed event, producing 
significant media interest and social 
awareness, with subsequent social 
pressures on the medical community.
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young population, considering the signif-
icantly larger impact of road accidents, 
infections, suicide and many other causes.
It is estimated that approximately 
3.6/100,000 young athletes die per year, 
among which 1/100,000 is a result of cardi-
ovascular death, which is more common in 
males. SCD in young athletes usually occurs 
on the athletic field in the absence of prior 
symptoms4.
The aetiology of SCD in athletes <35 years is 
mostly inherited and is due to structural heart 
diseases, mainly hypertrophic cardiomyopathy 
(HCM) and arrhythmogenic right ventricular 
dysplasia/cardiomyopathy (ARVD/C). In con-
trast, the vast majority of SCD in athletes >35 
years is a consequence of acquired disease, in 
particular coronary artery disease (CAD).
A large number of congenital and often clini-
cally silent cardiovascular diseases have been 
‘Athlete’s heart’ was firstly described in 
18992 when Dr. Henschen empirically 
reported the enlargement of the heart in 
a cohort of cross-country skiers, by sim-
ply using chest percussion. He concluded 
that both dilatation and hypertrophy were 
present.
The impact of training on cardiac remod-
elling was better defined in the last two 
decades, as a result of greater accessibility to 
large populations of trained athletes studied 
with advanced non-invasive imaging tech-
niques, but, unfortunately, a certain degree 
of overlap exists between the normal adap-
tation to intensive training and pathological 
conditions that may lead to increased risk of 
sport-related SCD.
Athlete’s heart is generally regarded as a 
benign physiological adaptation with an 
increase in cardiac mass and volume, with 
normal systolic function, diastolic function 
and high-energy phosphates (PCr, ATP) 
content3. Different types of conditioning 
usually induce different degrees and forms of 
cardiovascular system remodelling. Endur-
ance training, sometimes also described as 
dynamic, isotonic or aerobic training, such 
as long-distance running and swimming, 
predominantly produces a volume overload. 
Strength exercises, also referred as static, 
isometric, power or anaerobic training, such 
as weightlifting, cause largely a pressure 
overload. Finally, sports such as cycling and 
rowing are examples of combined endurance 
and strength exercises.
Left (LV) and right ventricles (RV) remod-
elling develop relatively rapidly and are 
most impressive in endurance athletes. 
Remodelling is dynamic in nature, being 
reversible with cessation of training. 
Cross-sectional studies of endurance athletes 
demonstrate that LV wall thickness is 15% 
to 20% greater than in sedentary controls, 
and LV volume is 10% larger. The RV is also 
enlarged, with elite athletes demonstrating 
10% increases in RV dimensions. These struc-
tural changes are favourable and necessary 
to compete (Figure 2).
Training-induced cardiovascular remodelling 
may be associated with ECG abnormalities, 
occurring in approximately 40% of trained 
athletes. Most common ECG abnormali-
ties include early repolarisation patterns, 
increased QRS voltages, diffuse T-wave 
inversion, and deep Q waves. The height-
ened vagal tone that accompanies train-
ing may lead to innocent arrhythmias and 
conduction alterations (sinus bradyarrhyth-
mias, junctional rhythm, and first-degree 
AV block), but it is fundamental to be aware 
that exercise may act as a trigger for lethal 
ventricular tachyarrhythmias in patients with 
susceptibility due to underlying and unsus-
pected cardiac diseases.
PREVENTION OF SCD 
IN YOUNG ATHLETES
SCD of young trained athletes, usually 
during sport activity, is an event with an 
impressive media resonance due to a 
devastating emotional impact to the com-
munity at large; it leads subsequently to 
a substantial increase in awareness about 
the underlined clinical conditions, although 
it represents a minor cause of death in a 
Figure 2
These illustrations show differences in the mechanisms of cardiac adaption to endurance vs. strength sports.
Normal heart
Endurance training
Mild to moderate LV and  
RV enlargement and hypertrophy
Normal or slightly reduced LV EF
Strength training
Concentric LV hypertrophy
Normal ro hyperdynamic LVEF
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causally linked to SCD in young athletes at 
autopsy. In the United States, HCM has been 
consistently reported to be the single most 
common cardiovascular cause, accounting 
for approximately one third of the deaths. 
The second most frequent cause of these 
deaths in athletes is a congenital coronary 
artery anomaly of wrong sinus origin (most 
commonly, left main coronary artery origin 
from right sinus of Valsalva with inter-arterious 
course; Figure 3). Diagnosis requires a high 
index of suspicion in young athletes present-
ing with exertional chest pain and/or syncope, 
but symptoms are present in <50% of cases. 
Other conditions account for a much smaller 
proportion (5% to 8%) of the cardiovascular 
deaths in young athletes: they include myo-
carditis, valvular heart disease, ARVD/C and 
ion-channel disorders3.
An alternative demographic profile has 
emerged from the Veneto region of 
north-eastern Italy, in which ARVD/C is 
reported to be the most common cause of 
athletic field deaths. Such results, contrasting 
sharply with the results in the U.S., could be 
based on a unique regional genetic substrate.
A multi-modality imaging approach to 
athlete’s heart aims to differentiate physi-
ological changes due to intensive training 
from serious cardiac diseases with similar 
morphological features. A truly comprehen-
sive assessment of the athlete’s heart should 
begin with an exercise ECG and echocardio-
graphic examination. Abnormal ECG pat-
terns are present in ≈40% of trained athletes, 
occurring twice as often in men than women, 
and particularly in those participating in 
endurance sports. Therefore, most athletes 
have ECGs that are within normal limits or 
that show only minimal alterations. Standard 
echocardiography has a pivotal role in mor-
pho-functional assessment of athlete’s heart, 
in differentiating physiological and patholog-
ical LV hypertrophy and in the identification 
of regional wall motion abnormalities. For 
inconclusive echocardiography or findings 
suspected for cardiomyopathies, the execu-
tion of cardiac magnetic resonance (CMR) is 
indicated.
CMR offers the advantage of a highly repro-
ducible morpho-functional evaluation, a 
higher capability to detect regional wall 
motion abnormalities also of the right ven-
tricle, and an undisputed advantage in tis-
sue characterisation. The Late Gadolinium 
Enhancement (LGE) technique allows char-
acterising the myocardium in relation to the 
presence of myocardial scars and definition of 
scars pattern, providing diagnostic informa-
tion with high sensitivity and specificity. The 
detection, quantification and pattern analysis 
of fibrosis results are useful for the risk stratifi-
cation, being directly correlated to major car-
diac adverse events. Moreover, CMR is useful 
for the identification of reversible conditions 
due to the capability to detect myocardial 
oedema (Figure 4).
Hence, CMR may be a valuable support in the 
difficult differentiation of a physiologically 
adapted athlete’s heart from subtle patho-
logical conditions potentially underlined as a 
sport-related SCD. A particularly difficult dif-
ferential diagnosis is between a physiological 
ventricular hypertrophy and the early stage of 
an HCM.
HCM is characterised by the presence of LV 
or biventricular pathological wall thickening 
Figure 3
‘Inter-arterial’ malignant course 
of right coronary artery arising 
from the left sinus of Valsalva in 
a 16-year-old football player with 
recent syncope during intense 
training. Functional malignancy 
is attributable to the anomalous 
course of the vessel leading to arte-
rial compression during the systolic 
phase, enhanced by the inotropic 
and chronotropic effect of intense 
physical activity.
Figure 4
CMR comprehensive multiparametric approach in three different forms of left 
ventricular hypertrophy.
Top row (A) shows a case of physiological concentric hypertrophy observed 
in a 27-year-old professional rower (mean myocardial wall thickness 12–14mm). 
Increased wall thickness is not associated with pathological accumulation of 
gadolinium on LGE images nor with substantial changes of native T1 on map-
ping sequences (T1 normal value: 950–1000 msec).
In the middle row (B), an asymmetric form of hypertrophic cardiomyopathy is 
displayed occurring in a 26-year-old asymptomatic amateur tennis player. CMR 
images show a remarkable pathological asymmetric anterio-septal hypertrophy 
(anterior-septal wall thickness: 16–21mm), matching with extensive myocardial 
damage consistent with the presence of multiple patchy areas of non-ischaemic 
LGE (see arrows) associated with remarkably increased values of native T1 
(average of 1,176 msec).
Lower row (C) is a case of cardiac primary amyloidosis manifesting with a 
severe concentric biventricular hypertrophy in a 42-year-old marathon runner 
with occasional depiction of abnormal low voltage on limb leads at ECG. 
Parietal wall thickness is severely increased (ranging between 12–16mm in all 
segments), and is associated with a typical inhomogeneous appearance of the 
myocardium on LGE, depending on the extracellular deposition of amorphic 
amyloid material. Presence of extensive intra-cellular amyloid accumulation. 
Native T1 is also increased (average of 1,289 msec), reflecting the widespread 
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non-sustained by increased afterload. It 
causes reduction and obstruction of LV 
lumen and a high risk of SCD mainly related 
to life-threatening arrhythmias occurring on 
a scar substrate characterising the disease.
In the differentiation of an early HCM from a 
physiological hypertrophy, CMR may play a 
fundamental role, first of all with a detailed 
morpho-functional evaluation of both ventri-
cles that may detect an unbalanced hyper-
trophy not compatible with a physiological 
adaptation to sport activities. Moreover, the 
CMR ability to detect myocardial scars with 
typical HCM pattern, visible on LGE images 
in about half of HCM (range 33–79%), is very 
useful. LGE has a high sensitivity (1 gram 
focal myocardial damage can be depicted) 
and strong correlation with histology, but 
the absence of LGE cannot be used to 
reliably exclude the possibility of an HCM. 
Novel CMR techniques may also provide 
useful information, first of all the native 
and post-contrast T1-mapping, which can 
assess the total extent of myocardial extra-
cellular space, rather than the detection of 
regional dense scars identified by traditional 
LGE. T1-mapping may emerge as a reliable 
diagnostic imaging marker in differentiating 
pathologic from physiologic hypertrophy, but 
further investigations are needed to eventu-
ally define this role.
In athletes who present with unexplained 
chest pain or syncope, anomalous origin of 
the coronary arteries from the wrong sinus 
should be suspected. An anomalous course 
of either the right or left coronary from the 
opposite sinus with a course between the 
great vessels is associated with potentially 
increased risk during intense activity. The 
majority of these patients have a normal 
12-lead ECG, hence a high index of suspi-
cion is often needed to prompt testing for 
diagnosis. In this regard, the role of CMR is 
limited, seeing as coronary MR angiography 
is not widely available. Otherwise, coronary 
computed tomography angiography makes 
non-invasive depicting of the coronary tree 
with a very low radiation exposure possible.
CMR is also a fundamental tool for the diag-
nosis of ARVD/C, being capable of providing 
an accurate evaluation of RV volumes/global 
function and a detailed assessment of RV wall 
regional motion abnormalities, associated 
with the unique possibility to detect fibrous/
fatty replacement of the RV free wall. CMR 
can be particularly advantageous given the 
limitations inherent in assessing the RV on 
echocardiography. Moreover, the capability 
of myocardial characterisation offered by the 
CMR, although not included in the official 
diagnostic criteria, could be relevant in par-
ticular with athletes, since RV dilation is usu-
ally observed as part of the benign remod-
elling induced by training, while RV free wall 
fatty/fibrotic replacement is a finding not 
associated with athlete’s heart.
Acute myocarditis is implicated in 5–22% of 
athletes’ SCD in <35. Early symptoms may 
be very subtle. When diagnosis is verified, 
athletes are declared ineligible for com-
petitive sport for at least 6 months. CMR is 
fundamental for the diagnosis allowing for 
the detection of oedema, hyperaemia and 
myocardial necrosis, typically localised in the 
midmyocardial or epicardial layer with a non-
coronary distribution.
PREVENTION OF SCD 
IN ADULT ATHLETES
The main cause of SCD in adult athletes is 
coronary artery disease (CAD). The relation-
ship between intense exercise training and 
CAD is controversial. Although ischaemic 
heart disease is the final common mani-
festation, triggers are likely multifactorial 
being dependent on sympathetic activation, 
electrolyte and metabolic factors, activation 
of the haemostatic system, and haemody-
namic effects on vulnerable coronary plaque. 
In particular, plaque rupture is considered to 
be an important mechanism of SCD in older 
athletes, that occurs among coronary lesions 
that bring about mild to moderate stenoses 
and is likely attributable due to the mechani-
cal effect and parietal wall stress induced by 
the activity itself5.
Screening of individuals at risk should 
therefore necessarily include a combination 
of luminal and plaque assessment, not only 
to simply rule-out severe lesions but, most 
importantly, to identify high-risk plaques 
in a pre-clinical phase. In adult competitive 
athletes, timely detection of atherosclerotic 
lesions by coronary CT angiography (CCTA) 
has been proved to be superior to traditional 
non-invasive techniques.
Clear guidelines for screening athletes to 
CCTA are still lacking in the literature. This 
is due to the lack of prospective studies in 
large athlete populations. There is, however, 
a growing clinical utilisation of this technique 
in adult athletes in a series of clinical scenar-
ios including screening after resuscitation, 
in asymptomatic competitive athletes with 
positive ECG or in the presence of equivo-
cal symptoms for ischaemic heart disease 
in competitive athletes with normal or near 
normal ECG.
The so-called ‘sub-millisievert’ new gener-
ation of CT scanner will certainly bring to a 
further expansion of the utilisation of CCTA 
also in this specific clinical setting, due to a 
substantial reduction of the procedural bio-
logical risk.
CONCLUSION
Imaging plays a primary role in screening, 
diagnosis and follow-up of an athlete’s heart, 
bringing new light into the so-called ‘grey 
zone’ between physiological adaptation of an 
athlete’s heart and pathologic expression of 
cardiac diseases.
Wider availability and recent outstanding 
technical implementation of both CT and MR 
imaging have further enhanced our under-
standing of the complexity of an athlete’s 
heart.
Advanced imaging techniques became a 
routine part of the comprehensive pre-par-
ticipation eligibility screening which is 
performed in selected apparently healthy 
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Clinically, with its high negative predictive 
value ranging from 97–99%, CCTA repre-
sents a reliable diagnostic imaging tool to 
rule out obstructive CAD, especially in low 
to intermediate risk settings2–5. As such, 
large-scale registries and prospective trials 
have shown that CCTA serves as a valuable 
alternative to invasive diagnostic testing in 
patients with stable angina6–8 and low- to 
intermediate pre-test likelihood of CAD 
(e.g. asymptomatic, younger patients) and 
in those with less extensive coronary artery 
calcification, especially in patients who are 
unable to undergo stress testing for func-
tional testing5, 8. An example of a negative 
coronary CT angiography in a relatively 
young female patient with suspected CAD is 
provided in Figure 1.
There is strong evidence that CCTA 
improves the efficiency of clinical deci-
sion making in the emergency department 
in the case of acute chest pain, resulting 
in a shorter length of hospitalisation and 
reduced costs9. Furthermore, CCTA is being 
used for the visualisation and assessment of 
coronary atherosclerotic plaque, three-di-
mensional vessel trajectories and anatomical 
features of the coronary vessel segments 
as well as detection of pathological coro-
nary artery alterations such as calcifications 
or occlusions. CCTA is therefore rapidly 
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CLINICAL VALUE OF  
CORONARY CT ANGIOGRAPHY
Coronary artery disease (CAD) still is one of the leading causes of 
death worldwide and remains responsible for approximately 610,000 
deaths per year in the United States1. Technical developments such as 
wide detectors, dual source configuration, low kV scanning and high-
pitch acquisitions as well as iterative reconstruction algorithms have 
allowed coronary CT angio graphy (CCTA) to become established as 
an imaging modality that provides high temporal and spatial resolu-
tion at low radiation exposure, for motion-free cardiac imaging and 
detailed visualisation of coronary or myocardial pathology. Conse-
quently, CCTA has emerged as a non- invasive, robust and well-estab-
lished diagnostic tool for the assessment and evaluation of patients 
with known or suspected CAD. There is a large body of evidence, 
demonstrating a high diagnostic accuracy with a sensitivity ranging 
from 94–99% and a specificity of 64–83% for the detection of coro-
nary stenosis2.
Figure 1
Coronary CT of a 48-year-old female with exertional atypical chest pain. The CT reveals the absence of coronary atherosclerotic 
plaque or stenosis. (A) Axial slice demonstrating the left main coronary artery (asterisk) and the left anterior descending coronary 
artery (arrowhead). (B) Origin of the right coronary artery (white arrow) and proximal segment of the left anterior descending cor-
onary artery (arrowhead) and left circumflex coronary artery (open arrow). (C) Volume rendered three-dimensional reconstruction 
showing the left anterior descending coronary artery as well as the branch of the right coronary artery and the circumflex coronary 
artery. (D–F) Multiplanar curved reconstructions of the right coronary artery (D), the left anterior descending coronary artery (E) 
and the circumflex coronary artery (F) demonstrating the absence of coronary atherosclerotic plaque or coronary artery stenosis.
AA=ascending aorta, LA=left atrium, RV=right ventricle.
A CB D FE
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Given its high spatial resolution, CCTA offers 
the unique potential to non-invasively visual-
ise, characterise and quantify atherosclerotic 
plaque15. The notion of vulnerable plaques is 
a rather complex concept; however specific 
high-risk plaque features can be identified 
on standard CCTA datasets. Several adverse 
features associated with vulnerable plaques 
have already been identified and include the 
presence of positive remodelling, low-atten-
uation plaque, spotty calcifications and the 
napkin ring sign (see a typical low-attenua-
tion plaque in Figure 3) 16–19. In contrast, larger 
calcification is more likely to be found in sta-
ble coronary lesions. Although the evidence 
is still very limited, detailed assessment of 
plaque morphology for the presence of high-
risk plaque features in patients presenting 
to the ED with acute chest pain but nega-
tive initial electrocardiogram and troponin 
provides incremental diagnostic value as the 
presence of high-risk plaque increases the 
likelihood of ACS, independent of significant 
CAD and clinical risk assessment, including 
age, sex, and number of cardiovascular risk 
factors20. Thus, identification of such high-risk 
plaques may improve risk estimates for the 
individual patient and may be of use in the 





Given its established value in morphologic 
imaging of CAD, much research efforts over 
the last years have focused on providing 
information beyond the assessment of cor-
onary stenosis and plaque. To date, CCTA 
offers two different approaches to assess 
the functional relevance of a given stenosis: 
a) myocardial perfusion imaging and b) the 
calculation of a CT-based fractional flow 
reserve (CT-FFR). CT myocardial perfusion 
is based on the first-pass effect of iodinated 
contrast media through the myocardium 
during vasodilator stress (pharmacologically 
induced using regadenoson, adenosine, or 
dipyridamole). The study can either be per-
formed by obtaining one single scan during 
maximum enhancement (also referred to as 
acquisitions, given that high anatomical 
resolution with short examination times can 
be combined with low radiation exposure. 
Specifically, high-pitch CT (pitch >3), low 
kV (as low as 70 kV), and iterative recon-
struction algorithms have resulted in cardi-
ovascular exams with radiation exposure of 
<1 mSv13. Nowadays, for a detailed visual-
isation of the cardiac anatomy, ECG-trig-
gered protocols are recommended, 
although it has also been demonstrated 
that the detection of the coronary arteries 
even in a non-ECG-triggered spiral mode 
with high temporal resolution is possible14. 
Most paediatric cases will be scanned in a 
prospective ECG-triggered sequential scan 
(‘step-and-shoot mode’) or high-pitch scan 
whereas retrospective ECG-gating should 
be avoided due to high radiation exposure 
(see a low dose coronary CT angiography 
of a 6-month-old girl with Kawasaki Dis-
ease in Figure 2).
useful imaging tool in the pre-procedural 
planning of cardiovascular interventions, 
providing improved success rates for revas-
cularisation and post-procedural outcome 
after percutaneous techniques10. Besides its 
diagnostic value, there is also an increasing 
role of CCTA to predict cardiovascular risk 
over time, as several follow-up studies report 
an excellent prognosis for patients negative 
in CCTA for any CAD or coronary athero-
sclerosis, whereas outcome in patients with 
obstructive and also non-obstructive CAD is 
substantially worse11, 12.
LOW DOSE CORONARY 
CT ANGIOGRAPHY AND 
PAEDIATRIC IMAGING
Paediatric imaging has emerged as a par-
ticularly valuable setting for low dose CCTA 
Figure 2
6-months-old girl with Kawasaki disease and suspected 
coronary artery aneurysms in echocardiography. Coronary 
CT scanned in ECG-gated high-pitch mode revealed aneu-
rysms in the right coronary artery (RCA; white arrow) and 
the left anterior descending artery (LAD; white arrowhead). 
Note the good image quality despite an average heart rate 
of 154 beats per minute. Scan parameters: 70 kVp, 149 eff. 
mAs with automated dose-modulation leading to a DLP of 
5.8 mGy*cm resp. an effective dose of 0.5 mSv. (A) curved 
multi-planar reconstruction (MPR) of the RCA; (B) curved 
MPR of the LAD; (C) Volume rendering technique (VRT) of 
the heart with view on the RCA; (D) VRT of the heart with 







Coronary CT of an atherosclerotic 
plaque in the LAD, demonstrat-
ing high-risk plaque features, 
including low-attenuation and 
positive remodelling in the prox-
imal segment of the left anterior 
descending coronary artery. (A) 
curved multiplanar reformat and 
corresponding cross-section of the 
vessel (B).
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CONCLUSION
Cardiac CT imaging and coronary CT 
angiography have developed incredibly 
quickly over the past 10–15 years. Today, 
this technique is readily and widely avail-
able and has reached a point of great 
robustness and, together with the potential 
of low-dose acquisition at the same time, it 
will become ever more important in clinical 
routine management of cardiac patients. 
New insights into the functional assessment 
of coronary blood flow and myocardial 
perfusion are fascinating and will make this 
technique even more valuable in the future.
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‘static’ or ‘snapshot/single-shot’ perfusion 
imaging) or by acquiring multiple scans dur-
ing contrast passage (i.e. ‘dynamic’ imaging 
of perfusion). The benefit of the ‘snap-
shot’ protocol is the reduction of radiation 
exposure, whereas the ‘dynamic’ protocol 
enables the quantification of absolute myo-
cardial blood flow and volume. Perfusion 
defects as obtained by these techniques are 
identified as areas of hypo-attenuated myo-
cardium compared to perfusion at baseline. 
While reversible malperfusion indicates 
ischaemic myocardium, persistent perfusion 
defects are considered to represent myo-
cardial scar tissue21, 22.
The calculation of the FFR using flow 
dynamics from coronary computed 
tomography angiography (CCTA) images 
is another non-invasive method for the 
assessment of flow dynamics23. This novel 
approach allows lesion-specific flow 
analysis throughout the coronary tree 
without additional imaging or vasodi-
lator stress. The currently most widely 
used technique (known as FFR-CT) uses 
a complex reconstruction algorithm to 
create a three-dimensional (3D) model 
of the coronary arteries and assess the 
left ventricular mass, which is directly 
proportional to the total blood flow at 
rest. By combining the information of 
branch diameter from the 3D model 
and resting blood flow, it is possible to 
specifically calculate the blood flow for 
each coronary segment (see an example 
in Figure 4). Freely available and simpli-
fied approaches using a one-dimensional 
(1D) analysis (cFFR) are currently being 
investigated24.
Figure 4
Example of a CT-based derivation 
of fractional flow reserve model 
(CT-FFR, upper bar) and source 
coronary CT datasets demonstrating 
diffuse calcified and non-calcified 
plaques with haemodynamically 
relevant coronary stenosis present 
in the distal left anterior descending 
coronary artery (also A) and a large 
diagonal branch (red colour-coding 
in the FFR model) whereas the 
right coronary artery and the left 
circumflex coronary artery (C and B, 
respectively) have diffuse coronary 
artery disease without haemody-
namically-relevant coronary lesions.
A B C
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chapter reviews established (see Table) and 
evolving clinical applications, limitations, and 
future developments of parametric mapping.
PHYSIOLOGY AND 
MICROSTRUCTURE
Magnetic resonance probes density and mag-
netic microenvironment of water protons. 
Moreover, fluid-shifts between intra- and 
extracellular myocardial compartments are 
reflected in the biodistribution of standard 
extracellular contrast agents. Many cardiac 
pathologies are associated with alterations of 
intra- and extracellular structures and char-
acteristic effects on magnetic parameters. 
The shortening of native T1 time is observed 
in glycosphingolipid deposition such as in 
Anderson-Fabry, the shortening of T2 and 
particularly T2* are typical features of iron 
deposition such as in primary or secondary 
haemochromatosis. Parametric T2* mapping 
is now accepted as a clinical tool to moni-
tor iron deposition in thalassaemia and to 
guide therapy (Figure 1). The prolongation 
of T2, on the other hand, is found in oedema 
as an indicator of acute disease (Figure 2). 
Extracellular volume expansion is found in 
interstitial amyloid deposition or replace-
ment of infarcted myocardium by collagen 
also referred to as replacement fibrosis e.g. 
after infarction (Figure 3). Reactive or diffuse 
fibrosis may occur in oncologic patients 
during chemotherapy with cardiotoxic med-
ication. Several studies support the notion 
that parametric mapping might be useful to 
identify myocardial damage before functional 
abnormalities occur. Early detection might 




Longitudinal relaxation is the process of 
proton spins returning to equilibrium after 
excitation. This process is described by 











Parametric mapping is another dimension of cardiac MR beyond morphol-
ogy and function. It enables quantitative characterisation of myocardial 
tissue. For more than a decade, T2* mapping has been established as a 
clinical tool for quantification of iron deposition in the heart and to guide 
chelation therapy in patients with haemochromatosis or thalassaemia. 
Moreover, T2-mapping has been applied to distinguish acute from chronic 
diseases such as myocarditis. More recent developments are T1-mapping 
before and after contrast injection. Knowledge of T1 times before/after 
contrast and haematocrit enable the calculation of extracellular volumes 
(ECV). Expansion of ECV is found in interstitial accumulation of fluids 
in oedema, collagen in fibrosis, or amyloid in amyloidosis. Shrinking of 
ECV may occur in athlete’s heart when myocytes are hypertrophied. This 
Table
Pathologies with typical parameter alterations
PARAMETER DECREASE MILD INCREASE SEVERE INCREASE
T1 native Anderson-Fabry, iron overload, fat,  
athlete’s heart,  
haemorrhage
Diffuse fibrosis, scar,  
subacute/chronic inflammation
Acute infarct,  
acute inflammation,  
amyloidosis 
ECV Athlete’s heart Diffuse fibrosis Scar, amyloidosis
T2 Iron overload, haemorrhage Subacute inflammation Acute inflammation,  
acute ischaemia, acute infarct
T2* Iron overload, haemorrhage
Chapter 9 | NEW MR MYOCARDIUM MAPPING TECHNIQUES 9998 Chapter 9 | NEW MR MYOCARDIUM MAPPING TECHNIQUES
THE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONSTHE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONS
cerebrospinal fluid, short T1 times in fluids 
containing protein or Gadolinium. Longitudi-
nal relaxation is probed by repeated meas-
urements with inversion and/or saturation 
prepared sequences with variable delays 
between preparation and excitation pulses. 
Recovery values are subsequently fitted with 
an exponential curve to obtain T1 time. These 
repeated measurements are time-consuming 
and various pulse sequence schemes have 
been explored to shorten acquisition and 
enable breath-hold imaging. Please note that 
the choice of pulse sequence scheme has an 
effect on T1 times because of confounders 
such as longitudinal relaxation, magnetisa-
tion transfer, preparation pulse efficiency, flip 
angle, heart rate, and off-resonance effects. 
Extracellular volumes may be calculated 
based on pre- and post-contrast T1. This 
calculation, however, requires knowledge of 
haematocrit from blood samples. Techniques 
using a synthetic haematocrit based on MR 
data without blood sampling are currently 
under investigation but still require validation. 
Transverse relaxation is the process of coher-
ence loss of proton spins after excitation. 
Measurement of transverse relaxation time is 
based on acquisition with variable echo times 
and/or with T2 preparation pulses. The fitting 
of signal decay curves with an exponential 
fit provides T2 or T2* times. Relevant con-
founders are susceptibility to off-resonance 
and T1 effects. Given these confounders for 
longitudinal and transverse relaxation, ranges 
of normal values shall be defined for every 
scanner/sequence combination for both, 
female and male healthy volunteers. A rea-
sonable approach would be to scan 20–50 
volunteers for each group and to define the 
range of normal values as the mean +/- of 
two standard deviations1.
Mapping T2* is a robust clinical tool and typ-
ically based on multi-echo gradient recalled 
Figure 1
Short axis T2*-maps from two different patients referred for assessment of iron overload. Relaxation times were measured in 
the septum to minimise confounding magnetic field inhomogeneities. In the patient with genetic haemochromatosis (A) T2* 
was normal (39 ms). In the patient with myelodysplastic syndrome (B) T2* was abnormal (9 ms), thus indicating a high risk of 
developing heart failure.
Figure 2
Short axis maps in a 17-year-old boy with acute myocarditis three weeks after gastroenteritis. Native T1 (A) and T2 (B) are 
prolonged indicating oedema in acute disease. Post-contrast T1 (C) is shortened and late Gadolinium enhanced image (D) show 
subepicardial late enhancement with non-ischaemic pattern.
A
A B C D
B
Figure 3
Short axis maps in a 62-year-old man with infarct in the inferolateral wall. Native T1 (A) is prolonged, post-contrast T1 (B) is 
shortened and late gadolinium enhancement shows subendocardial injury with ischaemic pattern.
A B C
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are required to introduce this application 
into clinical routine.
EMERGING APPLICATIONS
Perfusion imaging based on native T1 
mapping might be useful to distinguish 
normal from abnormal perfusion reserve. 
Response to adenosine stress native T1 times 
increases in normal myocardium but remains 
unchanged in ischaemic myocardium. The 
first results support the notion that native T1 
mapping may be useful to detect ischaemia. 
Further clinical studies, however, are required 
to explore this interesting application.
CONCLUSION
Parametric mapping adds another dimension 
to cardiac MR beyond function and morphol-
ogy. Today T2*-mapping is recommended 
in clinical guidelines, whereas T1-, T2- and 
ECV-mapping are not yet fully integrated in 
clinical workflows. Their clinical impact, how-
ever, appears very promising.
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echo (GRE) sequences, which are now avail-
able for breath-hold acquisitions. This tech-
nique is recommended in clinical guidelines 
for management of iron overload. Unlike 
other parametric mapping parameters, T2* 
values are not classified as normal versus 
abnormal, but rather stratified in a 3-tier risk 
model for developing heart failure (T2* > 20 
ms = low risk; 10–20 ms = intermediate risk; 
and < 10 ms = high risk).
CLINICAL APPLICATIONS
Abnormally thickened myocardium may be 
a diagnostic challenge because it can have 
several causes. Parametric tissue mapping 
can help to specify the aetiology. Myocardial 
thickening is frequently associated with ECV 
expansion, which can occur in amyloidosis, 
hypertrophic cardiomyopathy, aortic stenosis, 
and hypertensive heart disease2. The role of 
ECV for diagnosis and its impact on thera-
peutic decisions, however, still needs to be 
clarified in more detail.
Among conditions with ECV expansion, amy-
loid disease is particularly remarkable, since 
expansion may be massive and may reflect 
different subtypes with different outcomes3. 
Expansion of ECV is also observed in acute 
myocarditis or in scarring such as after 
infarction. Moreover, ECV mapping has been 
shown to enable distinction of primary hyper-
trophic cardiomyopathy from hypertrophy 
secondary to arterial hypertension which has 
implications for treatment4.
Anderson-Fabry disease is character-
ised by native T1 shortening, reflecting 
intramyocardial sphingolipid storage. Short-
ening of native T1 is found in few conditions 
only, thus raising the suspicion of this rare 
disease even in the absence of myocardial 
thickening5. In the same patient, areas with 
prolonged native T1 and T2 associated with 
LGE may be present. These findings may be 
interpreted as active inflammation and scar 
formation.
Iron overload is also among the few condi-
tions presenting with the shortening of native 
T1. Unlike Anderson-Fabry, iron overload is 
associated with substantial T2* shortening. 
This marker is well established to identify 
iron deposition after repeated blood trans-
fusions such as in thalassaemia major or in 
increased intestinal iron absorption in heredi-
tary haemochromatosis. Although potentially 
resulting in heart failure, these diseases can 
be treated efficiently when detected early. 
This underlines the importance of early 
diagnosis. Parametric T2* mapping is recom-
mended in clinical guidelines.
Diffuse myocardial fibrosis with excess 
collagen is another application, because 
parametric mapping may identify cardiac 
involvement before functional changes 
occur. Unlike replacement fibrosis after 
infarct, diffuse fibrosis may be related to 
chemotherapy with cardiotoxic agents that 
stimulate collagen proliferation. Early detec-
tion of cardiac damage is helpful to modify 
therapy and avoid an outcome of cured can-
cer but damaged heart. Diffuse fibrosis is 
suspected in prolonged native T1, expanded 
ECV and shortened T1 after contrast admin-
istration. Among these parameters, ECV 
expansion seems to be the most sensitive 
parameter. More clinical studies, however, 
PROF. JENS 
BREMERICH, MD, 
EBCR, MHBA, FSCMR 
is Professor of Radiol-
ogy and section head 
of Cardiothoracic 
Imaging at University 
Hospital Basel, Swit-
zerland. He attended 
medical school in Montpellier in France, Edin-
burgh in the UK, Indianapolis in the USA, and Hei-
delberg in Germany, where he received his MD in 
1991. Following a residency in cardiovascular and 
pulmonary medicine at Heidelberg, he trained in 
nuclear medicine and radiology at Basel Univer-
sity Hospital. Moreover, he researched cardiopul-
monary MRI at the University of California in San 
Francisco during a two-year research fellowship 
with Dr. Charles B. Higgins. He explored the dis-
tribution and magnetic effects of various contrast 
agents in the myocardium and pulmonary vessels.
Currently, Professor Bremerich is president of 
the European Society of Cardiovascular Radiol-
ogy. Professor Bremerich is a strong advocate 
of a fruitful cooperation between radiology, MR 
physics and clinical disciplines as is carried out at 
Basel University Hospital.
1010TREATMENT OF  AORTIC VALVE  STENOSIS
Chapter 10 | TREATMENT OF AORTIC VALVE STENOSIS 105
THE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONS
EVOLVING TREATMENT 
OPTIONS
Elective surgical valve replacement remains 
the standard of care for symptomatic aortic 
valve stenosis, replacing the diseased native 
valve with a new prosthetic heart valve. While 
this type of cardiothoracic surgery is now-
adays a routinely performed procedure in 
specialised centres, it remains nevertheless 
an extensive operation with associated risks, 
and given the nature of the condition, often 
performed in patients of older age.
As such, some patients have a significantly 
elevated risk of surgery-related complications 
and death, making them unsuitable candi-
dates for surgery. Until recently, no other 
curative therapies remained for these patients, 
leaving them only supportive palliative care.
Fortunately, recent developments in tran-
scatheter-based therapies now offer an alter-
native therapeutic strategy for this nonsurgical 
patient population, as the native aortic valve 
can now be replaced by the deployment of a 
new bioprosthetic transcatheter heart valve 
(THV), brought in place via a nonsurgical end-
ovascular, transaortic, or transapical pathway.
This procedure is known as transcatheter 
aortic valve replacement (TAVR) (also called 
transcatheter aortic valve implantation (TAVI) 
or percutaneous aortic valve replacement).
Despite such an increasing number of patients 
eligible for curative treatment, not every 
individual can receive such a THV. Several 
anatomic and technical criteria must be met 
in order to safely receive such a prosthetic 
device, including a suitable THV size (Figure 1). 
In contrast to surgical valve replacement, 
valve selection and matching to the patient’s 
anatomy is now not performed under direct 
surgical inspection but on the basis of 
pre-procedural imaging findings. Therefore, 
non-invasive imaging plays a crucial role in 
both patient selection and evaluation of the 




Basically, a TAVR procedure consists of 
deploying a THV in the aortic root after trans-
porting the device from a chosen entry point.
Device transport can be in a retrograde fash-
ion using the femoral or subclavian artery as 
an endovascular access point (the most com-
monly implemented and preferred approach), 
or anterograde through the apex of the left 
ventricle. Evidently, these transport pathways 
must be free of luminal narrowing or any other 
pathology that may obstruct the passage of 
the device. Also, even extensive tortuosity 
with kinking and coiling of the iliac arteries 
without narrowing, a phenomenon which can 
be seen in older patients with long-standing 
arterial hypertension, can pose significant 
problems during device transport.
Therefore, other access options also exist 
as new ways are explored to increase the 
number of eligible patients with inaccessible 
first-choice entry pathways. These including 
a suprasternal approach through the brachio-
cephalic trunk, an anterior approach through 







Aortic valve stenosis is the most common valvular heart disease in the 
Western world. This condition is especially significant considering the 
ageing Western population. The overall prevalence is estimated to be 
5%, with 2%–3% of individuals over the age of 75 developing severe 
aortic valve stenosis, evolving from a non-symptomatic valve with 
thickened and calcified leaflets into an increasingly degenerative valve 
with extensive calcified and immobile leaflets. Concomitantly, symptoms 
progress from mild to severe, with increasing fatigue and shortness of 
breath being common complaints, eventually invariably leading to heart 
failure and death. The final symptomatic stage is short and rapidly pro-
gressive and is associated with a 2-year survival rate of 50% or less. By 
comparison, even some metastatic malignancies have a better progno-
sis at this point.
The final diagnosis is routinely made with Doppler echocardiography, 
providing a functional and morphological assessment of the aortic 
valve. Aortic valve stenosis is hereby defined as an obstruction of the 
left ventricular outflow tract at or near the level of the aortic valve, 
with an aortic stenosis jet velocity of over 4 m/sec, a mean gradient 
of over 40–50mm Hg, and an aortic valve area of less than 1.0 cm2. 
Critical aortic valve stenosis is reached when the valve area is less than 
0.6 cm2.
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PRE-PROCEDURAL 
CT IMAGING OF THE 
AORTIC ROOT
A true 3D imaging modality like computed 
tomography (CT) allows exquisite visualis-
ation of the aortic root, providing all neces-
sary anatomical information (Figures 2–5).
Firstly, in order to achieve the best possible 
outcome and avoid peri- and post-proce-
dural complications, the new THV must of 
course fit the native anatomy as closely as 
possible, avoiding the associated problems 
arising from over- or undersizing of the 
prosthetic valve. If the valve is too large, 
several complications can occur, including 
aortic rupture and device migration. Con-
versely, a valve that is too small can lead to 
leakage of blood between the THV and the 
aortic wall, the so-called paravalvular leak-
age. There is well-established evidence that 
this leakage may be related, at least in part, 
to preoperative undersizing of the aortic 
partial mini-sternotomy for transaortic place-
ment through the ascending aorta.
Once the device is transported to the aortic 
root, it will be deployed using a device-specific 
method. All current clinically implemented 
THV fall into two categories: balloon-expand-
able or self-expandable valves. The two most 
used and most clinically implemented THV 
worldwide are currently the balloon-expand-
able Sapien series from Edwards Lifesciences 
(Irvine, California, USA) and the self-expand-
able Corevalve/Evolut range from Medtronic 
(Minneapolis, Minnesota, USA) (Figure 1). 
During deployment, a balloon-expandable 
valve will expand using the radial strength of 
the accompanying balloon, and commonly 
force its circular design on the pre-existing 
oval-shaped annular morphology. Conversely, 
a self-expandable valve will deploy until it 
encounters the resistance of the annular wall, 
conforming itself to the mostly oval-shaped 
anatomy of the aortic annulus.
After deployment, the THV will have crushed 
the native valve against the aortic root wall, as 
such functionally replacing the diseased valve 
and restoring valve function.
Figure 1
Current available sizes of the two most commonly clinically implemented transcatheter heart valves, the Sapien series of 
Edward Lifesciences (A) and the Corevalve/Evolut series of Medtronic (B). The indicated size ranges correspond to the required 
aortic annulus diameter, assuming a circular morphology of this anatomic landmark. With the two models combined, a patient 
is currently able to receive this kind of prosthetic heart valve when the annular diameter lies in the range of 16–29 mm. The 
development of these devices is a continuous work in progress, and new models and sizes are already in the clinical test phase 




3D volume-rendered image of the heart illustrating the 
double-oblique orientation of the aortic root (asterisk). 
The horizontal line corresponds to a true axial image as 
acquired with CT. This figure clearly illustrates that, in 
order to correctly obtain critical measurements required to 
maximise procedural success, a re-orientation of the meas-
urement plane in a double-oblique fashion along the axis 
of the aortic root is necessary. This is one of the reasons 
that currently CT is considered an essential imaging tool, 
improving pre-procedural planimetry of the annulus and 
aortic root over conventional ultrasound measurements.
Figure 3
Composite image illustrating the crown-like configuration 
of the aortic valve leaflets within the aortic root, extending 
from the sino-tubular junction (blue) to the most basal 
attachment plane, hereby defining the so-called annular 
plane (green). The CT images on the right illustrate the 
varying cross-sectional morphology of the aortic root, 
being mostly circular at the level of the sino-tubular junc-
tion, but becoming more clover-leaf shaped at mid-level 
and usually ending in an ellipsoid or oval morphology at 
the annular level.
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accessible access routes. A carefully cho-
sen access route is therefore one of the 
key components of procedural eligibility 
and success, since in a given case, different 
pathways may be associated with poten-
tially different risks for peri- and post-
procedural vascular and embolic cerebro-
vascular complications.
Modern CT equipment allows the com-
plete anatomical evaluation of a TAVI can-
didate in one examination, delivering with 
only one intravenous contrast-medium 
injection all necessary pre-procedural 
information. As technology progresses, 
the latest CT-scanners allow this investiga-
tion with as little as 30–50 cc of contrast 
medium, as such minimising the impact on 
an often already depressed renal function. 
Furthermore, ECG-gated scan techniques 
allow evaluation of the aortic valve at dif-
ferent phases of the cardiac cycle, provid-
ing measurements in the preferred systolic 
phase.
annulus, with the subsequent choice of an 
undersized transcatheter valve and incor-
rect device positioning. Furthermore, other 
reports indicate that even mild leakage, 
which was previously generally considered 
to be of little clinical significance, is never-
theless an underappreciated contributor to 
late all-cause mortality. Finally, this leakage 
has been also associated with extensive 
native valve calcifications which may limit 
proper THV expansion when displaced dur-
ing prosthetic valve deployment (Figure 6).
A correctly chosen valve size will therefore 
lead to the best functional recovery with the 
least complications.
Secondly, non-invasive CT imaging is 
essential to evaluate the patency of a safe 
transport path for the THV to the aortic 
root. Any obstruction along a specific path-
way, e.g. a significant tortuosity or luminal 
narrowing of the iliac arteries (Figure 7), is 
clearly visualised, guiding the performing 
physician or surgeon to safer and more 
Figure 4
Volume-rendered CT image of the so-called annulus. The 
aortic annulus is a virtual structure, formed by connecting 
the nadirs of the basal insertion sites of the aortic leaflets 
(dashed red line). The sinuses of Valsalva are here coloured 
in red (left sinus) and purple (non-coronary sinus), with the 
different coronary arteries also labelled. LAD: left anterior 
descending artery; LCX: left circumflex artery; RCA: right 
coronary artery.
Figure 5
Volume-rendered image of a Med tronic Corevalve tran-
scatheter heart valve in place, extending from the annular 
plane in the ascending aorta. The coronary arteries are 
coloured in red.
Figure 6
Post-procedural image of a deployed Medtronic Corevalve 
in the aortic root. The deployment of this valve is here 
clearly compromised by extensive calcifications (asterisk) 
limiting expansion and deforming the valve (arrow). As 
such, extensive calcification may under certain conditions 
compromise valve deployment and diminish its functional 
effect, sometimes leading to paravalvular leakage between 
the incompletely deployed valve and the aortic wall.
Figure 7
Volume-rendered CT image of the 
abdominal aorta and iliac arteries. 
The prominent tortuosity of the 
left common iliac artery (arrow) 
forms an additional risk factor for 
safe device transport. Therefore, 
pre-procedural screening of the 
different access routes with CT 
is essential for procedural safety, 
indicating in this case that for this 
patient, the right iliac arteries pro-
vide a less hazardous route.
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Finally, as this is an invariably older popula-
tion, CT provides simultaneous evaluation of 
sometimes unsuspected but clinically relevant 
non-vascular incidental findings, with varying 
degrees of impact on the TAVI procedure and 
clinical outcome.
RECENT DEVELOPMENTS 
AND FUTURE  
PERSPECTIVES
As our understanding of the pathophysiol-
ogy of aortic valve stenosis evolves, a clear 
relation has been established between the 
amount of valve leaflet calcifications and the 
likelihood of having severe valve stenosis. 
This is important, as in certain conditions 
(e.g. patients with low left ventricular output) 
the clinically suspected diagnosis of valve 
stenosis cannot be confirmed using Doppler 
ultrasound, due to paradoxical results falsely 
indicating less severe stenosis (the so-called 
low-flow, low-gradient subpopulation). In 
these specific patients, recent investigations 
have shown that a simple quantification of 
leaflet calcification can provide diagnostic 
information in confirming the diagnosis of 
severe valve stenosis independently of the 
ultrasound results.
Finally, recent multicentre studies have indi-
cated the at least non-inferiority of the TAVI 
procedure compared to surgical replacement 
in the population of only intermediate surgi-
cal risk. While at this stage it is still not com-
mon practice to use TAVI outside the patient 
population with high surgical risk, these 
results indicate that the potential population 
which may benefit from TAVI may expand in 
the future, potentially leading to fewer open 
surgical procedures. Nevertheless, important 
questions remain to be solved, including still 
unknown data regarding the long-term dura-
bility of THV. This is a crucial point before 
applying this technique in younger patients.
CONCLUSION
One cannot deny that the introduction of 
transcatheter valve replacement techniques 
has a significant impact on the treatment 
of aortic valve stenosis, providing a ther-
apeutic option in patients who previously 
could only be offered palliative supportive 
care. While currently it is only indicated in 
high-risk patients, recent reports suggest 
a potential expansion of the applicable 
population in the future. Therefore, it is 
safe to state that the impact of TAVI on the 
treatment of valvular heart disease will only 
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associated risks. Prosthetic heart valve dys-
function may occur and known mechanisms 
of dysfunction include thrombus formation on 
the valve, pannus tissue ingrowth underneath 
the valve causing obstruction, and structural 
valve failure. The gravest and most feared 
complication after prosthetic valve implan-
tation is an infection of the prosthetic heart 
valve which is called endocarditis. The infec-
tion may lead to severe damage and destruc-
tion of the tissue surrounding the valve. Fur-
thermore, vegetations may form on the valve 
that both can hamper valve leaflet motion as 
well as embolise to other parts of the body 
thereby causing abscesses in organs such as 
the brain or spleen. Unfortunately, prosthetic 




Traditionally, echocardiography has been the 
technique of choice for valve assessment. 
It offers many advantages as it is non-inva-
sive, readily available, non-expensive and 
provides not only anatomical but also func-
tional information on valve function. However, 
echocardiography has its limitations and the 
artefacts generated by the prosthetic heart 
valves may hamper assessment. Therefore, 
in case of (suspected) prosthetic valve dys-
function, echocardiography can often not 
determine the exact cause of dysfunction, or 
in case of endocarditis, detect perivalvular 
mycotic aneurysms or abscesses.
In the last decade, CT has emerged as a val-
uable tool for prosthetic heart valve assess-
ment, providing detailed anatomical assess-
ment as well as functional analysis of valve 
leaflet motion1. Most valve types generate 
limited artefacts and CT offers unparalleled 
detail of the (peri)valvular regions (Figure 1). 
CT has earned its reputation in the assess-
ment of prosthetic heart valves and provides 
information on the cause of prosthetic valve 
dysfunction that is complementary to echo-
cardiography, especially since reduced dose 
acquisition protocols are now available2. 
Furthermore, it can be used to monitor the 
effects of treatment as illustrated in Figure 2.
For endocarditis, CT is especially well suited 
to visualising mycotic aneurysms in the aortic 
root and to demonstrating their relation to 
the coronary arteries and extension towards 
other parts of the heart. Positron emission 





BY RICARDO P.J. BUDDE
HEART VALVE REPLACEMENT
Hundreds of thousands of patients annually undergo heart valve replace-
ment to replace a defective native heart valve. Traditionally, heart valve 
replacement required open heart surgery. After opening the sternum, the 
heart is exposed and opened to excise the defective native valve and sub-
sequently implant a prosthetic valve. There are two main groups of surgical 
prosthetic heart valve types: biological and mechanical. Mechanical valves 
often have two semi-lunar discs that are mounted in a ring, whereas biolog-
ical valves are made of porcine or bovine tissue. The mechanical valves are 
designed to last for decades but require lifelong anticoagulation with all its 
inherent risks. Biological valves do not require anticoagulation but degener-
ate and need to be replaced after approximately 15 years.
In the last decade, a minimally invasive alternative procedure was devel-
oped called transcatheter aortic valve implantation (TAVI, see also chapter 
10). In TAVI, the native aortic valve is not excised but a new stent-mounted 
biological valve is placed within the diseased native valve. Since data on 
long-term valve durability are not yet available TAVI is currently limited to 
older and high-risk patients. However, with improvements in valve design, 
it will likely also be employed in younger and lower risk patients.
Although valve replacement is a very effective way to treat valve disease, 
it also presents the patient with artificial material in their heart with all 
Figure 1
Three-dimensional volume-rendered CT image of two 
mechanical prosthetic heart valves. Note the detail of the 
valve that can be seen including the hinge points of the 
valve leaflets.
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Figure 2
Thrombus formation on a mechanical heart valve pros-
thesis. In the left upper and lower hand panels, the valve 
is seen en face and perpendicular to the valve leaflets. 
Note that one of the two leaflets does not open at all 
due to thrombus formation (arrowheads) on the valve, 
whereas the other leaflet opens incompletely. After 
thrombolysis (right-hand images) there is complete open-
ing of the right-hand valve leaflet. The left-hand leaflet 
is still stuck, but there is a reduction in the amount of 
thrombus on the valve leaflet (arrowheads) demonstrat-
ing the effects of the treatment.
Figure 3
Endocarditis PET/CT. PET/CT image 
of an infected aortic valve pros-
thesis. Note the avid tracer uptake 
around the valve indicative of active 
infection.
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tomography (PET) with CT (PET/CT) pro-
vides another dimension to a diagnosis 
of endocarditis3 (Figure 3). Using labelled 
glucose which accumulates in infected tissue, 
endocarditis can now even be diagnosed 
before structural damage occurs.
CONCLUSION
As outlined above, both CT and PET/CT have 
established their role for assessment of pros-
thetic heart valves in daily clinical practice. 
However, especially for endocarditis, the pos-
sibilities of PET/CT have only scratched the 
surface. With the development of new very 
specific tracers that bind to specific strains of 
bacteria, or even antibiotics, patient-tailored 
diagnosis, treatment monitoring and adapta-
tions are on the horizon. Furthermore, a base-
line CT scan in each patient who underwent 
prosthetic heart valve implantation may prove 
beneficial4. The future is bright for prosthetic 
heart valve assessment with CT and PET/CT.
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substrate of atherosclerosis, are already seen 
in many children. It progresses throughout 
adult life and is activated by changes that 
trigger lipoprotein dysregulation and inflam-
matory response. The disease progresses in 
young adulthood (<40 years) with exposure 
to unhealthy modifiable lifestyle factors (sed-
entary lifestyle, unhealthy diet, obesity, smok-
ing; see Figure 1) and other cardiovascular 
risk factors such as hypertension, diabetes, 
high cholesterol and dyslipidaemia. The PESA 
(Progression of Early Subclinical Atheroscle-
rosis) study2, which evaluates the systemic 
extent of atherosclerosis in the carotid, coro-
nary, abdominal aortic and iliofemoral arter-
ies, showed that subclinical atherosclerosis 
was present in 63% of asymptomatic persons 
aged 40–54 years of age (Figure 2).
Atherosclerosis remains a subclinical process 
in most people, with clinical atherosclero-
sis only being the tip of the iceberg. Many 
people with atherosclerosis will not have 
obvious clinical symptoms. More than half of 
the persons who die suddenly because of a 
heart attack do not have forewarning of their 
coronary heart disease. Only a minority of 
people who experience an ischaemic brain 
stroke have experienced earlier symptoms 
such as a transient ischaemic attack (TIA), a 
temporary neurological dysfunction caused 
by focal ischaemia but without acute infarc-
tion. As a consequence, we face an enormous 
challenge to know which asymptomatic 
persons are at risk and should be screened 
and receive appropriate lifestyle advice and 
possibly even medication. Although pre-
ventive strategies and improved treatment 
have reduced death rates of ischaemic heart 
and brain disease, they still remain in the top 
causes of death3.
Traditional risk scores are good at identifying 
people at high risk, but poor at differentiat-
ing intermediate and low risk. Imaging can 







“A good heart these days is hard 
to find”, sung by Feargal Shar-
key in 1985, rings increasingly 
true in our ageing population. 
In addition, if you don’t have a good heart, what are the chances that 
your brain will still function well at an advanced age? The two are more 
strongly connected than most people realise. With the older population 
growing, an increasing number of people will suffer from cardiovascular 
disease, myocardial and brain infarction, heart failure, atrial fibrillation, 
cognitive decline or eventually dementia. This combination of cardiac and 
brain disease is a growing global health burden with a large socioeco-
nomic impact1.
ATHEROSCLEROSIS
Atherosclerosis is a systemic disease that develops over decades and 
forms a major component of multi-organ cardiovascular disease, mor-
bidity and mortality. The initial phase of endothelial dysfunction starts in 
childhood. Autopsy studies have revealed that the fatty streaks, an early 
Figure 1
Atherosclerosis is a systemic disease which progresses 
during a lifespan with exposure to lifestyle factors such as 
smoking, obesity, and a sedentary lifestyle.
Figure 2
Cardiovascular diseases of the brain and heart are espe-
cially affected by atherosclerosis of the carotid (yellow 
arrow) and coronary (red arrow) arteries.
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FROM HEART TO BRAIN
Emboli from the heart (cardioemboli) are one 
of the main causes (20–30%) of acute ischae-
mic brain stroke9. Atrial fibrillation is preva-
lent in the older population and is the main 
source of cardioemboli (Figure 3). Other 
causes include ventricular thrombi, often in 
patients with ischaemic or non-ischaemic 
heart failure, valve disease, and paroxysmal 
right-to-left venous emboli through an open 
connection between the right and left side 
of the heart (patent foramen ovale or atrial 
septal defect). Another source of ischaemic 
stroke is atherosclerotic plaque or dissection 
of the aorta or carotid/vertebral arteries.
Current CT scanners enable coverage of the 
heart to the brain in seconds using one con-
trast bolus. Imaging the heart, thoracic aorta, 
neck arteries and intracranial arteries in 
patients admitted with acute ischaemic brain 
stroke symptoms can not only demonstrate 
the site and extent of the occlusion, but also 
the possible causes of the stroke, which may 
assist short-term treatment decision-making.
FROM BRAIN TO HEART
Stress is a well-known phenomenon that can 
affect the heart. Acute emotional and even 
physical stress can lead to a detrimental cas-
cade of events, including release of catecho-
lamines, which can result in a stress cardio-
myopathy (Figure 4). Stress cardiomyopathy 
is also called Takotsubo cardiomyopathy, 
as the ventricle with apical hypokinesia and 
ballooning resembles a Japanese pot used to 
catch an octopus, or broken-heart syndrome 
due to the association with acute emotional 
stress. This occurs most often in middle-aged 
women and is usually a self-limiting disease 
with a good prognosis.
An intracranial aneurysm is found in 3% of 
the population. Acute subarachnoid haem-
orrhage due to the rupture of an intracranial 
aneurysm is often associated with the worst 
headache a patient has ever experienced 
and an acute rise of intracranial pressure, and 
thereby acute stress. These patients often 
show a temporary cardiac dysfunction and 
rise in troponines, similar to other forms of 
stress cardiomyopathy. Although the cardiac 
dysfunction is temporary, those with signs of 
stress cardiomyopathy have perfusion defi-
cits of the brain in the acute phase, a higher 
chance of delayed cerebral ischaemia, and a 
worse long-term prognosis10.
CONCLUSION
In conclusion, the heart-brain axis is often 
overlooked, but remains essential in under-
standing the aetiology of cardiovascular 
disease, assessing systemic disease such 
as atherosclerosis, and improving diagnosis 
and prognosis both in the asymptomatic and 
symptomatic population. “A good heart these 
days is hard to find, so please be gentle with 
this heart of mine.”
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Atherosclerosis is best viewed using CT 
imaging when it is in an early phase. A 
non-contrast coronary artery calcium score 
is the most effective imaging tool to modify 
risk score calculation with only a minimal 
radiation dose. Additional contrast-enhanced 
CT angiography can depict the non-calcified 
plaque, and thereby the total atherosclerotic 
burden, and can also assess high-risk plaque 
characteristics associated with plaque rup-
ture and luminal stenosis. Although additional 
coronary calcium scoring testing is only 
advocated for persons with intermediate 
risk, there is also benefit in populations with 
traditional low-risk classification6. ‘Low-risk’ 
subgroups that may benefit from a low dose 
calcium score are middle-aged women with a 
history of hypertensive pregnancy complica-
tions such as preeclampsia and middle-aged 
sportspersons engaged in high-level endur-
ance sports7, 8.
especially at young to middle age when one 
can still expect preventive measures to have 
the most effect. The European Society of 
Cardiology guidelines do not recommend 
routine screening with imaging modalities 
to predict future events in clinical practice. 
They consider imaging to be a risk modifier 
in cardiovascular risk assessment, i.e. it helps 
reclassify risk in individuals with calculated 
cardiovascular risks based on the major 
conventional risk factors around the deci-
sion-making thresholds4.
One of the earliest measures of vascular 
disease is increased arterial stiffness. This 
can be measured in various indirect ways 
but magnetic resonance imaging (MRI) is 
the most effective direct measurement. MRI 
measures of arterial stiffness are associated 
with future cardiovascular events according 
to the Dallas study5.
Figure 3
Atrial fibrillation is prevalent in the elderly, and thrombus 
formation in slow flowing parts of the heart such as the left 
atrial appendage (red arrow) is the most important source 
of cardioembolic brain stroke (yellow arrow).
Figure 4
Acute stress, including a subarachnoid haemorrhage 
(yellow arrow) from a ruptured cerebral aneurysm, can 
cause temporary dysfunction of the heart (red arrows), a 
so-called stress cardiomyopathy.
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However, according to the annual German 
Heart Report1 from 2016, approximately 1 
million invasive cardiac catheterisations were 
performed in 2014 in Germany, but percuta-
neous coronary interventions (PCIs) followed 
only in 40%.
Note
This means that up to 60% of invasive cardiac 
catheterisations would not have been neces-
sary if alternative methods for diagnosing cor-
onary artery disease or other heart diseases 
could do the job just as well.
NON-INVASIVE 
ALTERNATIVES TO CARDIAC 
CATHETERISATION
Despite the fact that nowadays diagnostic 
cardiac catheterisation is a ‘low-risk’ pro-
cedure in experienced hands, the risk is not 
‘zero’. Therefore it is desirable to reduce the 
burden on both the patient and on the health 
system. This describes not only the situation in 
Germany, but also in almost the entire Euro-
pean Union. The goal is to decrease invasive 
procedures in favour of non-invasive diagnos-
tic testing, without jeopardising diagnostic 
and therapeutic safety. The latter has already 
been proven in the last decade for almost all 
other non-invasive imaging tests like the func-
tional techniques stress echocardiography, 
myocardial perfusion SPECT, and in recent 
years also for stress perfusion or dobutamine 
stress magnetic resonance imaging (MRI), 
without the need for radiation exposure. But in 
recent years also the morphological technique 
cardiac computed tomography (CCT) has 
rapidly developed in terms of speed, spatial 
resolution and radiation dose reduction and is 
therefore nowadays the main direct compet-
itor of invasive coronary angiography (ICA). 
Like in ICA, direct visualisation of the coronary 
arteries is possible with CCT without the use 
of an invasive procedure and with lower or at 
least comparable radiation exposure.






To replace ICA, the following prerequisites 
have to be fulfilled:
 − Widespread use and availability of the 
alternative techniques in clinical routine
 − High-quality services provided by the 
radiologist
 − Important results not only in academic 
centres
 − Full coverage by health insurance compa-
nies, in particular by compulsory health 
insurance
FOUNDING OF THE 
ESCR CARDIAC MR/
CT REGISTRY IN 2012
In September 2012, the European Society of 








Can it help us to avoid  unnecessary 
invasive catheterisation?
BACKGROUND
Cardiovascular diseases and especially coronary artery disease (CAD) are 
still the most common diseases in industrialised countries and the number 
of people suffering from these diseases is still increasing. Early diagnosis 
and adequate treatment is crucial and has helped to reduce mortality over 
the last decades dramatically. The first invasive cardiac catheterisation was 
performed in 1929, almost 100 years ago, by Werner Forßmann, a sur-
geon in Berlin as a self-experiment. However, it took an additional 30 years 
before the first left heart catheterisation and the first selective coronary 
angiography were successfully performed by the paediatric cardiologist 
Mason Sones and the radiologist Melvin Judkins, respectively. Another 
almost 20 years were then needed before the first coronary angioplasty 
was successfully executed by Andreas Grüntzig in 1977. From that time on, 
the success story of minimal invasive treatment of heart diseases began 
and has certainly not come to an end with the minimal invasive cathe-
ter-based treatment of valve diseases.
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the MR/CT Registry in which a representa-
tive sample of cardiac magnetic resonance 
imaging (CMR) studies as well as cardiac 
computed tomography (CCT) examinations 
from all over Europe could be documented 
(https://www.mrct-registry.org). The sub-
mission of data is now a pre-requisite for the 
accreditation and certification process in 
Germany. It also serves as a tool for quality 
control in cardiovascular radiology (Figure 1) 
and may help to establish a database for big 
data analysis, deep learning and the use of 
artificial intelligence to improve diagnosis.
A SUCCESS STORY!
Almost six years after the start of the ESCR 
Cardiac MR/CT Registry, more than 220,000 
cardiac MRI and cardiac CT studies from all 
over Europe have been submitted. A slight 
imbalance in favour of cardiac magnetic 
resonance imaging (CMR) has developed 
over the recent years with approximately 
118,000 CMRs and 93,000 submitted CCTs. 
The majority of participating institutes and 
contributing users are from Germany. How-
ever, the 300 contributing institutes come 
from 33 different European countries. The 
majority of centres are not academic centres 
anymore, but larger community hospitals, and 
also radiologists in private practice; meaning 
that a widespread use and availability of these 
new and fascinating non-invasive techniques 
is accomplished in clinical routine already in 
most European countries. According to the 
MR/CT Registry only 2% of CMRs and as few 
as 0.3% of CCTs are performed in clinical 
trials, all other examinations were performed 
due to a real clinical indication and a real 
clinical need.
To maintain a high image quality besides 
well-trained radiologists (i.e. ESCR Diploma 
holders – members of the European Board 
of Cardiovascular Radiology – EBCR) ade-
quate equipment is needed. A 1.5T scanner 
for CMR and for CCT at least a 64-row CT is 
recommended. Fortunately, this prerequisite 
is already fulfilled according to the ESCR MR/
CT Registry data. Almost 80% of contributing 
users used a 1.5T system and approximately 
20% even a 3.0T system. On the CT side 
approximately 99% of the users are using a 
64-row CT or higher.
MAIN INDICATIONS
As the direct competitor of ICA, it is unsur-
prising that CCT is mainly performed in 
known or suspected coronary artery disease 
(CAD) and accounts for more than 2/3 of all 
cardiac CT examinations, followed by valve 
and aortic diseases, mainly to plan interven-
tional or surgical procedures. Actually, CCT 
has the potential to evaluate CAD even bet-
ter than ICA, because it cannot only visualise 
the vessel lumen, but also the vessel wall 
(Figure 2).
The main indications for CMR are the 
evaluation or differential diagnosis of car-
diomyopathies and myocarditis, closely 
followed by the evaluation of known or 
suspected CAD. Both account for more 
Figure 1
Cover page of the recent ESCR 
Cardiac MR/CT Registry booklet, 
which can be downloaded for free 





Non-invasive imaging by coronary computed tomography angiography (CCTA) in a male patient with a high-degree stenosis 
(narrowing of the vessel) of the middle section of the right coronary artery (RCA) using a 3D-visualisation method, that shows 
only the inner lumen of the three coronary vessels (‘coronary vessel tree’) and the aortic root (A) and the corresponding ‘curved 
multiplanar reformats’ (CPRs) in (B, C) from different views, which also allows assessing the vessel wall two-dimensionally. Here 
you can see that the high degree stenosis (blue arrow) is caused by a non-calcified, so-called ‘low-attenuation’ plaque, which 
has a worse prognosis than calcified plaques. A direct visualisation of the vessel wall is not possible with ICA.
A B C
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than 80% of all indications. Around 20% 
of indications are equally distributed 
between congenital heart disease and 
valve disease. Therefore, the strength of 
CMR is the differential diagnosis and the 
strength of Cardiac CT the fast and relia-
ble rule out of CAD, especially in patients 
with a low intermediate pre-test probabil-
ity (PTP)1.
An estimate of the PTP can be achieved 
only by taking the age, gender and symp-
toms into account (Table 1). According to 
the current guidelines for the manage-
ment of patients with suspected stable 
CAD, only patients with an intermediate 
pre-test probability between 15–85% 
should be referred to a non-invasive imag-
ing test, patients with a high PTP > 85% 
of CAD should be referred directly to ICA 
and in patients with a low PTP < 15% other 




CCT and CMR are very safe methods. 
According to the documented cases in the 
ESCR Cardiac MR/CT Registry, the overall 
adverse event rate in CCT was as low as 
0.44% and in CMR slightly higher with 
0.5%, because it includes stress MRI with a 
pharmacological stressor like adenosine in 
91%, regadenoson in 7% or dobutamine in 
2% (Figure 3) to evaluate myocardial per-
fusion in suspected or known CAD with an 
intrinsically higher risk3. However, severe 
adverse events such as an allergic shock 
or resuscitation occurred only in 1:10,000 
patients.
CLINICAL CONSEQUENCES
One of the major goals of using differ-
ent non-invasive imaging methods is to 
avoid unnecessary ICAs, which could be 
achieved in approximately 1/3 of CMR 
examinations and approximately 37% of 
CCTs. 22% of all CCTs and 6% of CMRs 
had a direct impact on interventional 
procedures. A direct referral to the cath 
lab was only necessary in 2.5–4.9%. All 
other patients could be discharged or 
only required a change of drug regime 
(Table 2).
RADIATION EXPOSURE
In clinical trials, CCT can be performed 
under certain circumstances (low and 
stable heart rate, latest CT equipment etc.) 
with a radiation exposure as low as < 1 mSv. 
However, in a clinical standard scenario 
this can’t be always achieved, especially if 
not only the heart, but also the aorta, i.e. 
pre-interventionally before transcatheter 
aortic valve implantation (TAVI), has to be 
assessed. Nevertheless, the results of the 
ESCR Cardiac MR/CT Registry revealed 
that even in a clinical scenario dose reduc-
tion protocols, like ‘step-and-shoot’ or the 
so-called ‘flash-mode’ are used in more 
than 50% of all patients, resulting in a 
Table 2
CLINICAL CONSEQUENCES CARDIAC MR CARDIAC CT
No further invasive diagnostics 32.5% 36.6%
Impact on interventional  
procedure
6% 21.7%
Direct referral to catheter  
laboratory
2.5% 4.9%
Patient discharge 4.4% 3.3%
Change of drug regime 5.6% 2.4%
Multiple clinical consequences for one imaging study possible
Figure 3
Distribution of the different pharmacological substances 
used in stress-MRI according to the documented cases 
in the ESCR MR/CT Registry. Figure from the MR/CT Reg-
istry booklet 2018.
Table 1
Pre-test probability of obstructive CHD in patients with stable chest pain to estimate the need for further diagnostic tests on 
the cardiology care level
TYPICAL ANGINA PECTORIS ATYPICAL ANGINA PECTORIS NON-ANGINAL CHEST PAIN
Age* [years] Men Women Men Women Men Women
30–39 59% 28% 29% 10% 18% 5%
40–49 69% 37% 38% 14% 25% 8%
50–59 77% 47% 49% 20% 34% 12%
60–69 84% 58% 59% 28% 44% 17%
70–79 89% 68% 69% 37% 54% 24%
>80 93% 76% 78% 47% 65% 32%
 
This data is based on the following definition of anginal symptoms: (A) squeezing pain located either retrosternally or in neck, 
shoulder, jaw or arm, (B) aggravated by physical exertion or emotional stress, (C) improved with rest and/or nitro-glycerine 
within 5 minutes. The combined presence of the following features define typical angina pectoris if three of the features are 
present and atypical angina pectoris if two are present, while one or none of the features defines non-cardiac chest pain.
* The calculated probabilities for the age groups represent the estimates for patients aged 35, 45, 55, 65, 75, and 85 years, 
respectively (modified from reference 1).
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tomography angiography (CCTA) as the 
first line method in suspected stable coro-
nary artery disease, which is therefore also 
covered by the National Health Service 
(NHS). On the other hand, unlike the NHS, 
CMR and CCT is not covered by the com-
pulsory health insurance in Germany and 
an affected patient has to apply for health 
insurance coverage individually. Therefore, 
these valuable methods can be provided 
in Germany and other European countries 
mainly in inpatients during their hospital 
treatment, and during their ambulatory 
treatment only if privately insured or as a 
self-paying patient.
CONCLUSION
According to the results of the ESCR Car-
diac MR/CT Registry, non-invasive imaging 
techniques, especially CMR and CCT have 
the potential to replace unnecessary inva-
sive catheterisation for diagnosing cardio-
vascular diseases. Invasive cardiac cathe-
terisation should only be used to guide and 
perform cardiovascular interventions in the 
near future. The non-invasive methods CMR 
and CCT have proven their widespread use 
in clinical routine by radiologists alone or 
together with cardiologists and its bene-
fits for our patients. Especially cardiovas-
cular CT helped up to 2/3 of the patients 
to avoid invasive cardiac catheterisation. 
The ESCR cardiovascular MR/CT Registry 
is one example of how carefully collected 
and documented medical data provides 
evidence that new radiological techniques 
help to improve medical care and especially 
to ensure optimal patient care and maybe 
replace other less cost-effective and less 
gentle methods in the near future.
Furthermore, the documentation and 
being a pre-requisite for accreditation and 
certification of medical personnel and 
institutions help to maintain certain quality 
standards in performing these new diag-
nostic tools. We hope that these new and 
very beneficial methods for the patients 
will be reimbursed by more and more 
health services throughout Europe in the 
near future.
The ESCR Cardiac MR/CT Registry may 
also serve us to build the future by estab-
lishing a database for big data analysis, 
deep learning and the use of artificial intel-
ligence to improve diagnosis.
References 
See page 236
median radiation exposure of 4.21 mSv and 
lower (Figure 4), which is within the range 
of a median radiation exposure with ICA.
WHO IS PERFORMING 
AND REPORTING IT?
Most CMRs and CCTs are performed and 
reported on by radiologists (Figure 5) 
according to the ESCR MR/CT Registry 
data. But up to 1/3 of the examinations 
are reported on together, in consensus 
reading between cardiologists and radiol-
ogists, which might be a very good way to 
keep high-quality standards in less experi-
enced or not yet certified imaging centres.
WILL MY INSURANCE 
COMPANY PAY FOR 
CARDIAC MR AND/
OR CARDIAC CT?
Despite the proven value and support by 
national and international guidelines to 
perform non-invasive imaging techniques 
in diagnosing cardiovascular disease 
rather than using invasive procedures like 
ICA, the reimbursement policy of health 
insurance systems and companies varies 
substantially throughout Europe. The most 
progressive approach was introduced in 
the UK in 2016 by the National Institute 
for Health and Care Excellence (NICE). 
On the one hand the NICE-Guidelines 
recommend using coronary computed 
Figure 4
‘Box-plots’ of the mean effective dose for the most 
commonly used four acquisition techniques in cardiac 
computed tomography (CCT). It demonstrates that even 
in a clinical scenario, dose reduction protocols, like ‘step-
and-shoot’ or the so-called ‘flash-mode’ are used in more 
than 50% of all patients, resulting in a median radiation 
exposure of 4.21 mSv or lower, which is within the range 
of a median radiation exposure with invasive coronary 
angiography (ICA).
Figure 5
Pie charts of the distribution of radiologists reporting 
on cardiac CT and cardiac MRI and consensus reading 
together with cardiologists according to the ESCR Car-
diac MR/CT Registry (from the 2018 Booklet).
ESCR Cardiac MR/CT Registry
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Chair of the ESCR Steering Committee for the 
Cardiac MR/CT Registry and a member of the 
current writing committee for the National Care 
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interpret and report cardiac CT and MR 
examinations independently. The EBCR 
Diploma represents a recognised qualification 
in cardiovascular radiology (CR). The EBCR 
Diploma will assist cardiovascular radiologists 
in the promotion of their skills and experi-
ence in CR when dealing with other clinical 
colleagues and with the general public. Since 
its conception in 2011, the EBCR Diploma has 
officially been endorsed by the European 
Society of Radiology (ESR)2.
REQUIREMENTS
According to the ESR criteria for subspe-
cialty diploma endorsement, candidates for 
the EBCR diploma should be board certified 
radiologists with a radiology residency which 
preferably lasts no less than five years. After 
that time, a subspecialty training of at least 
two years is necessary. This provides the can-
didates with an in-depth training and experi-
ence in cardiovascular radiology.
EVIDENCE OF TRAINING 
IN CARDIOVASCULAR 
RADIOLOGY
The evidence of training in cardiovascular 
radiology is as follows: all candidates pres-
ent a documentation or logbook with a total 
record of their experience in cardiovascular 
CT and MR examinations. This documenta-
tion can be done in three ways, either by a 
RIS statistic printout of cardiovascular MR 
and CT cases or a logbook self-declaration 
with names of patients (initials) and nature of 
examination or an active participation in the 
CT/MR Registry of the ESCR (for details on 
this registry see chapter 13). The minimum 
qualifications required for entry to the exami-
nation are the following:
The candidate should have experience in
 − At least 150/300 (life-cases/data-base-
cases) cardiac CT studies; at least 100 
of the CT life-cases should be contrast 
enhanced scans
 − At least 100/300 (life-cases/data-base-
cases) cardiac MR studies
 − At least 100 non-coronary vascular CT 
cases
 − At least 50 vascular MR cases
The curriculum vitae should include the 
records of training posts in cardiovascular 
radiology, scientific and educational activi-
ties in particular. A letter of support is also 
needed from the candidate’s cardiovascular 
radiology programme director or head of the 
department, confirming the candidate’s train-
ing, especially after their board certification.
EVIDENCE OF EDUCATION 
IN CARDIOVASCULAR 
RADIOLOGY
The evidence of education in cardiovascu-
lar radiology consists of various activities: 
50 CME credits category 1 in cardiovascular 
imaging with various modalities (e.g. 50% 
CT and 50% MR) are required. Furthermore, 
CERTIFICATE OF  
EXCELLENCE:  







The European Society of Cardiovascular Radiology (ESCR) introduced the 
European Board of Cardiac Radiology Diploma in 2011 in Amsterdam. The 
aim of this initiative was to standardise training and expertise in cardiac 
radiology across Europe. Therefore, the level of knowledge requested 
for the diploma corresponds to the curricular content for full subspe-
cialisation in the field of radiology provided by the European Society of 
Radiology (ESR) European Training Curriculum for Subspecialisation in 
Radiology (Level III)1. As this training curriculum also includes the part of 
vascular radiology, the society changed the name of the diploma to the 
European Board of Cardiovascular Radiology (EBCR) Diploma.
AIMS
The EBCR Diploma is a common European qualification in cardiac radi-
ology and confirms specific competence of radiologists to perform, 
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each candidate a series of – at least two 
– cases, where the examiners will test the 
candidate’s knowledge of all aspects of the 
cases under discussion – indication, clinical 
background, diagnosis, differential diagno-
sis, technical parameters, limitation, etc.
After the written and oral examination, 
an examiners meeting will be held. At this 
meeting, the results of both components of 
the exam will be added together to produce 
a total score for the examination for each 
candidate. The scores for each candidate 
will be reviewed and potential fail candi-
dates will be discussed. At the end of the 
meeting, a list of pass and fail candidates 
will be produced and candidates informed 
accordingly by email. There will be no pub-
lication of the scores, but just of ‘passed’ or 
‘failed’.
Successful candidates will be awarded the 
EBCR Diploma and may add EBCR (Euro-
pean Board of Cardiovascular Radiology) 
to their name. The diploma is granted for a 
period of five years. After five years, renewal 
is requested after proof of continuous activ-
ity in cardiovascular radiology. The examina-
tion itself does not need to be retaken after 
five years.
CONCLUSION
The European Diploma in Cardiovascular 
Radiology is undoubtedly a certificate of 
excellence and helps to improve the stand-
ard of cardiac imaging in Europe. The aim 
must be that the number of diploma hold-
ers is sufficiently high in every European 
country in order to guarantee a nationwide 
supply of high expertise in this important 
field of radiology.
Since the start of the Diploma on the occa-
sion of the Annual ESCR Meeting in Amster-
dam in 2011, there have been 179 colleagues 
that successfully passed the examination. 
Only one candidate failed up to now. Per 
year, between 20 and 25 colleagues apply 
for the diploma. Currently, there are 159 
diploma holders who have a valid certificate 
and there are 20 colleagues who need to 
renew their diploma.
We are on the right path to achieving our 
aims, but nevertheless, this requires the 
enthusiasm and continuous support of all 




the candidates should take part in the ESCR 
Educational Programme that includes educa-
tional webinars, educational workshops and 
ESCR Educational Courses:
 − ESCR offers online webinars on a monthly 
basis, about 50% of them are dedicated 
to education. From 2019, the education 
webinars will each concern a main topic.
 − ESCR is offering a growing number of 
educational hands-on workshops for 
small groups. There are workshops pro-
vided as pre-conference workshops prior 
to the Annual Meetings as well as prior 
to the European Congress of Radiology 
(ECR). Additionally, there are further 
workshops on different occasions in 
preparation. Details of these workshops 
can be checked on the ESCR website 
for continuous updates on endorsed or 
ESCR-organised workshops.
 − The main ESCR educational course is 
integrated into the annual meeting of 
the ESCR with a multiple choice exam-
ination (Cardiovascular Imaging – CI 
Examination) at the end. Additionally, the 
ESCR will endorse educational courses 
as organised by other ESCR members 
and ESCR member societies, and may 
organise additional educational events to 
prepare for the diploma.
 − The Cardiovascular Imaging Examination 
was introduced by the ESCR during the 
Annual Scientific Meeting 2009 in Leipzig 
as a written multiple choice examina-
tion. In 2010, on occasion of the Annual 
Congress in Prague, the examination was 
offered on a computer-based system, 
using the online self assessment tool by 
the ESR. The examination is offered on a 
regular basis at the ESCR Annual Scien-
tific Meetings every year. The CI Exam-
ination is a web-based test; candidates 
are asked 24 multiple choice questions 
(MCQ). Questions are related to the 
topics covered by educational sessions 
during the respective congress. Some 
general/basic questions, not related to 
the educational sessions, may also be 
included.
DIPLOMA EXAMINATION
If all of the above-mentioned requirements 
are fulfilled, the applicant may undergo the 
written and oral examinations for the Euro-
pean Diploma in Cardiovascular Radiology 
that are offered at the annual meeting of the 
ESCR as well as during ECR.
Only a limited number of candidates can be 
accepted for these exams at each meeting. 
Therefore, applications will be accepted on 
a first come, first served basis depending on 
the date of receipt of the appropriate appli-
cation form. Early application is therefore 
recommended.
The written examination consists of 30 
multiple choice questions and lasts 45 min-
utes. Candidates will be tested in all aspects 
relevant to cardiovascular radiology such as 
anatomy, physiology, embryology, clinical 
practice, pathology, and cardiovascular CT 
and MR. The oral exam consists of a 20-min-
ute oral examination by ESCR represent-
atives in English. The examiners will show 
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Mainz, Johannes Gutenberg University in Mainz, 
Germany.
He received his medical degree from that same 
institution in 1985 and was board certified in 
diagnostic radiology in 1991; since 2008 he has 
held a full professorship. He held visiting pro-
fessorships at the University of Toronto and at 
McMaster University, Hamilton, Ontario, Canada 
(2011), at the University of Zürich (2013) and the 
University of Vienna (2018).
Professor Kreitner has authored more than 200 
publications in peer-reviewed journals, more than 
20 book chapters and has delivered more than 
500 talks at national or international meetings.
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computerised analysis. In this chapter, we 
will try to outline some basic concepts and 
what we think will be the impact of these 
developments in cardiovascular radiology.
WHAT IS AI? – SOME 
BASIC CONCEPTS
Artificial intelligence can be defined as 
computer systems that can perform tasks 
that normally require human intelligence. 
Machine learning (ML) refers to a branch 
of AI in which computers are trained to 
make a decision based on data without 
being programmed with explicit rules. In 
other words, it is not necessary to define 
all the relevant features associated with a 
certain condition or disease in the com-
puter programme, the computer learns 
these from examples. In order to better 
understand the way ML works it is impor-
tant to briefly review the key differences in 
the way ML algorithms are trained.
ML algorithms can be trained in a num-
ber of ways, depending on the availabil-
ity of labelled data. Supervised learning 
refers to training an algorithm based on 
a large number of examples with labels, 
for instance the presence or absence of 
coronary stenosis in a coronary computed 
tomography (CT) dataset. Based on the 
training dataset a model or classifier is 
built that can process new, unseen cor-
onary CT data and generate an output 
that states whether or not a stenosis is 
present. Conversely, unsupervised learning 
does not rely on labelled data but seeks to 
find patterns in the data. Based on these 
observed patterns, groups or clusters can 
be identified that are similar and separable 
from other groups. Subsequently, a model 
can be built that can assign group or 
cluster membership to new, unseen data. 
There is a range of learning paradigms 
between supervised and unsupervised 
learning. In some cases, labels may be 
available on for instance the patient level 
but not on a vessel level. Finding a vessel 
with stenosis categorises then as weakly 
supervised learning. In other cases, labels 
may be available for a subset of training 
data that may not be sufficient for accu-
rate classification. This is also known as 
semi-supervised learning.
Modern ML techniques differ in the way 
that information is extracted from the input. 
Radiomics is a process typically referring 
to supervised ML learning that consists of 
extracting a large number of quantitative 
features from radiology images and subse-
quent classification using an ML classifier 
to determine diagnosis or perform predic-
tion. An important issue with radiomics is 
that many of the extracted features may 
be redundant or suboptimal for the task 
at hand. In contrast, deep learning (DL) 
techniques extract descriptive features 
from data at increasing levels of abstraction 
and immediately use these for the given 
classification task. The most popular DL 
techniques are based on artificial convolu-
tional neural networks (CNNs) with multiple 
(also known as ‘hidden’) layers between the 
input and output layers (Figure 1). Over the 
past years, it has become clear that DL is 
very well suited for many relevant tasks in 
radiology such as detecting abnormalities 
in images, delineating anatomical struc-








BY TIM LEINER, JELMER M. WOLTERINK AND IVANA IŠGUM
Every medical conference these 
days has sessions and keynote lec-
tures on ‘artificial intelligence’ (AI), 
‘machine learning’ and/or ‘deep learn-
ing’. The tremendous impact of these 
technologies in many domains of life 
from searching the internet to lan-
guage translation and discovery of 
the Higgs boson is undeniable and it 
is certain that they will also change 
the medical profession substantially. 
Disciplines such as radiology and pathology are especially well-suited 
for the application of AI because these specialists now almost exclu-
sively work with digital images which lend themselves very well to 
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especially advantageous for less-experi-
enced radiographers, for follow-up imaging 
as well as complex cases.
Image reconstruction  
and improvement of  
image quality
Machine learning has great promise in 
CT and MR image reconstruction. Deep 
learning with CNNs has been successfully 
applied for very fast reconstruction of 
highly accelerated cardiac MR acquisitions 
as an alternative to much slower current 
state of the art methods such as com-
pressed sensing. Conversely, DL has been 
applied in CT image reconstruction as well. 
Several research groups have shown that 
high-quality CT images of the heart can be 
reconstructed from low-dose acquisitions 
with an up to 80% lower radiation dose 
(Figure 2).
Post-processing and  
image analysis
One of the most obvious applications of ML 
and DL in cardiovascular imaging is image 
post-processing and analysis. One of the 
most important and also labour-intensive 
tasks in cardiac MR is contouring of the 
left and right ventricles at end-systole and 
end-diastole in order to obtain cardiac ejec-
tion fractions and myocardial mass (Figure 
3). Many research groups have now shown 
that this process can be fully-automated with 
highly reliable results using ML algorithms 
and several commercial software packages 
have already incorporated this technol-
ogy. Another application in cardiovascular 
AI AND CARDIOVASCULAR 
IMAGING
AI has many potential uses in cardiovascular 
imaging. Although detection of abnormalities 
and image interpretation are the first appli-
cations that may come to mind, the impact 
will be much broader. Virtually all steps of the 
radiological workflow, from decision support 
with regard to the indication to perform an 
imaging test to predicting prognosis from the 
resulting images, can be improved by using 
ML. Below we briefly review how ML is and 
potentially can be used in clinical practice.
Decision support
Cardiovascular medicine is increasingly 
guideline driven. Many professional socie-
ties have issued guidelines with the aim of 
providing standardised and evidence-based 
care to patients with suspected or known 
cardiovascular disease. Using this informa-
tion in clinical practice can be a daunting 
task. The European Society of Cardiology 
currently lists 49 categories of guidelines 
for example. It is self-evident that no sin-
gle person can master the intricacies of all 
these guidelines on a day to day basis. It is 
expected that ML-based decision support 
systems can help the clinician and radiolo-
gist select the best imaging tests in individ-
ual patients.
Image acquisition
Hardware vendors are now selling the first 
AI-based commercial products that help 
the technologist select the optimal imag-
ing protocol in individual patients, including 
the selection of the precise location and 
extent of image acquisition. Automated 
identification of the heart and prescription 
of scan planes is now possible. This may be 
Figure 2
Deep learning methods can be used to transform a CT image acquired at an extremely low dose (20% of routine dose) into a 
high-quality image resembling an image of the same patient acquired at a routine dose.
Figure 1
Neural networks consist of input layers to which input signals are clamped, and hidden and output layers containing processing 
elements that transform input from the previous layer using non-linear activation functions. This way, the input is transformed 
into the desired output, such as a classification label.
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imaging that comes to mind is automated 
determination of aortic volumes to determine 
the degree of expansion due to pumping 
action of the heart or to assess volume and 
rate of growth of an abnormally enlarged or 
aneurysmal aorta.
Interpretation and diagnosis
Researchers are now attempting to gen-
erate complete radiology reports from 
images only. DL algorithms are being 
trained to do this by showing them large 
datasets of hundreds of thousands to mil-
lions of combinations of imaging and the 
corresponding radiology reports. Although 
this has not been attempted specifically in 
cardiovascular radiology, it is expected that 
this will happen in the future. However, in 
many patients, information obtained with 




One of the most promising applications 
of AI and ML in cardiovascular imaging 
is fully automated detection, quantifica-
tion and reporting of relevant prognostic 
information. This may be more detailed 
information relevant to the clinical problem 
for which imaging was requested, but also 
information visible in the images outside 
of the organ of interest. For instance, more 
detailed analysis of cardiac motion pat-
terns in patients with pulmonary hyper-
tension has been shown to have a better 
predictive value for adverse outcomes 
compared to right ventricular ejection 
fraction, which is currently used for this 
purpose. Another example is fully auto-
mated identification of vascular calcifica-
tions in lung cancer screening CT scans 
(Figure 4).
Combining imaging with 
other data sources
A final area where AI can be of high value 
in the future is by combining the results 
from imaging examinations with other data 
such as information in electronic health 
records, laboratory data, genetic analyses 
and medication use. Combining these data 
will for instance yield new insights into 
which combinations of clinical variables are 
associated with certain imaging findings 
or effectiveness and side effects of new 
cardiovascular drugs.
AI – FRIEND OR FOE?
The way radiology is being practised will 
fundamentally change over the next years 
as ML and DL algorithms make their way 
into clinical practice. There is no doubt that 
some tasks that are now performed by 
radiologists or radiographers will be per-
formed by computers in the near future. 
We strongly believe, however, that AI offers 
an opportunity to make radiologists more 
accurate, more productive and to deliver 
better care precisely tailored to individual 





Results of fully automatic segmen-
tation of the left ventricular cavity 
(green), left ventricular myocar-
dium (blue) and right ventricular 
cavity (yellow) in cardiac cine MR. 
Manual reference annotations are 
shown in red.
Figure 4
Fully automatically identified calci-
fications in the thoracic aorta and 
coronary arteries in chest CT.
YELLOW: Thoracic aorta, RED: Left anterior descending artery,  
GREEN: Left circumflex artery, BLUE: Right coronary artery
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prevalence of cardiomyopathies and channel-
opathies, myocarditis and substance abuse, 
while in older populations, chronic degen-
erative diseases like coronary artery disease 
(CAD), valvular heart diseases and heart 
failure (HF) predominate.
Attempts to predict SCD and to provide relia-
ble markers of SCD represent one of the most 
active areas of investigation in cardiology 
during recent years.
The complex pathophysiology of SCD is 
based on the presence of a specific abnor-
mal, structural or electrophysiological sub-
strate that interacts with a functional trigger, 
resulting in acute haemodynamic collapse, 
which can differ widely based on the under-
lying cause.
SCD primary prevention involves the 
implantation of ICDs (implantable cardio-
verter defibrillators); however, the difficulties 
in understanding the direct pathophysio-
logic markers of arrhythmic substrate of 
SCD make precise and individualised pre-
ventive therapies an enormous challenge.
Current practice guidelines for selecting 
candidates for ICD therapy rely on left 
ventricular (LV) ejection fraction (EF) <35% 
as the criterion to determine candidacy. EF, 
however, is an inadequate surrogate of the 
underlying myocardial substrate predispos-
ing to SCD and thus is neither sensitive nor 
specific. Moreover, in the vast majority of 
patients who receive ICD, the device may 
never be utilised for the treatment of sponta-
neous ventricular arrhythmias. Moreover, an 
inappropriate ICD implantation could result 
in a very low quality of life.
Therefore, new diagnostic tools for better 
risk stratification are necessary, and they 
should aim to reveal the direct markers of 
arrhythmogenic substrates, by recognising 
structural heart disease (SHD).
IMAGING TECHNIQUES
In clinical settings, echocardiography is 
the first imaging modality of choice as it 
is inexpensive and non-invasive. It is also 
easily accessible and it is routinely used 
in the assessment of patients with sus-
pected SHD, allowing for the evaluation of 
regional and global ventricular function, 
myocardial wall thickness and thickening 
and chambers diameters.
However, in patients with a structurally 
normal heart and potentially increased 
SCD risk, CMR and CT are advisable as 
they can significantly improve diagnostic 
accuracy. For example, in SHD such as 
arrhythmogenic right ventricular dysplasia 
(ARVD) or anomalous origin of coronary 
arteries, CMR or CT can be of particular 
value.
Cardiac magnetic resonance (CMR) 
represents a non-invasive technique to 
characterise myocardial tissue and provide 
important details about myocardial struc-
ture and composition, abnormalities of 
which define the direct pathophysiologic 
substrate for SCD.
The presence and extent of myocar-
dial tissue heterogeneity with regions 





BY LUIGI NATALE AND VERONICA BORDONARO
DEFINITION AND EPIDEMIOLOGY
Sudden cardiac death (SCD) / sudden cardiac arrest (SCA) refers to an 
unexpected death or arrest from a cardiovascular cause that occurs rapidly 
outside of the hospital or the emergency room.
More precisely, according to the 2015 ESC guidelines, “the term SCD is used 
when: (1) a congenital, or acquired, potentially fatal cardiac condition was 
known to be present during life, (2) autopsy has identified a cardiac or vas-
cular anomaly as the probable cause of the event, (3) no obvious extra-car-
diac causes have been identified by post-mortem examination and there-
fore an arrhythmic event is a likely cause of death”.
SCD represents a devastating public health problem that is responsible 
for 15%–20% of all deaths and, although resuscitation rates are generally 
improving, the majority of individuals who experience a sudden cardiac 
arrest will not survive.
The majority of SCDs occurs in the adult population, with the absolute rate 
increasing with age, while 1% occurs in people who are under 35 years old. 
There are also recognised differences in SCD incidences in certain popu-
lation groups: the risk of SCD is higher in men than in women and it is also 
increased among people of colour.
Cardiac diseases associated with SCD differ between young and older 
individuals: in young subjects, and particularly in athletes, there is a 
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arteries but it also represents a non-in-
vasive technique which allows for the 
quantification of stenosis and which 
provides information about character-
istics of plaques and their vulnerability 
(Figure 1).
CMR in ischaemic cardiomyopathy (ICM) 
can accurately quantify left ventricular EF 
and mass, which are strong predictors of 
ventricular arrhythmias. Also, the pres-
ence and extent of LGE correlates with 
outcomes. The myocardial scar extent, 
assessed by CMR-LGE, correlates closely 
with pathological quantification of irrevers-
ible myocardial injury at all stages of infarct 
evolution beyond the acute event period 
(Figures 2 and 3).
The infarcted myocardium can be divided 
into 1) core infarct zone; 2) grey or peri-in-
farct zone; and 3) total infarct core peri-in-
farct zones. Recent evidence suggests that 
the heterogeneity in scar tissue can create 
electrical dispersion and areas of slow 
conduction that are a substrate for elec-
trical re-entry and malignant arrhythmia 
(Figure 4).
This leads to an increasing use of CMR not 
only for risk stratification but also to guide 
ICD implantation or ablation therapy.
Non-atherosclerotic CAD
Many non-atherosclerotic CADs, includ-
ing anomalous origin of coronary arteries, 
acute dissection, myocardial bridging, 
vasculitis and coronary artery spasm, can 
be the pathophysiologic substrate for SCD, 
especially in young people and particularly 
in athletes.
More specifically, coronary artery anomalies 
can be divided into haemodynamically signifi-
cant anomalies, which may be associated with 
shunting, ischaemia, or sudden cardiac death, 
and anomalies that are usually not haemody-
namically significant.
Haemodynamically significant anomalies 
include: 
 − Coronary artery atresia, which is a rare 
condition with only a handful of cases 
recorded in the literature (Figure 5)
 − Anomalous origin from the pulmonary 
artery, also known as ALCAPA/ARCAPA 
(anomalous origin of the left/right coro-
nary artery from the pulmonary artery), in 
which the development of a collateral cir-
culation from the right pulmonary artery 
to the anomalous left coronary circulation 
and the decrease of pulmonary vascular 
resistance result in the steal of blood flow 
from the myocardium to the pulmonary 
trunk (Figure 6)
 − Interarterial course, in which a coronary 
artery arises off a contralateral sinus 
of Valsalva, with a course between the 
aortic root and pulmonary artery. This is 
the coronary anomaly more commonly 
associated with SDC, leading to it being 
described as ‘malignant’ (Figure 7). Sev-
eral reasons have been suggested for the 
association between this coronary anom-
aly and SCD, but the most important 
include the associated presence of a slit-
like orifice or otherwise stenotic ostium, 
an acute angle between the anomalous 
coronary artery and the aorta and an 
intramural aortic segment
a substrate for ventricular arrhythmias, 
both in ischaemic and non-ischaemic 
cardiomyopathies.
Furthermore, the extent and architecture of 
fibrosis, even in the absence of contractile 
dysfunction, leads to electrophysiological 
derangements that increase the risk of 
scar-related re-entry ventricular arrhyth-
mias and of SCD.
CMR allows the visualisation of myocardial 
scars with the late gadolinium enhancement 
(LGE) technique, with proven histopatholog-
ical correlation. Furthermore, the geographic 
distribution of LGE helps distinguish among 
different types of cardiomyopathies.
Because of its high spatial resolution, CMR 
can differentiate different scar patterns 
and detects areas with interstitial fibro-
sis or oedema with T1- and T2-mapping 
techniques.
SCD AND CORONARY 
ARTERY DISEASE (CAD)
Atherosclerotic CAD
About 75–80% of SCD in patients over 40 
years of age is caused by atherosclerotic 
CAD; SCD in these individuals is often 
the consequence of cardiac arrhythmia, 
induced by an abrupt condition of throm-
bosis and acute myocardial event, caused 
by coronary artery plaque rupture, fissur-
ing or haemorrhage.
The risk of SCD is increased in the presence 
of lipid-rich vulnerable plaques with posi-
tive remodelling, multivessel involvement or 
in the case of abrupt proximal obstruction 
rather than progressive diffuse stenosis with 
collateral vessels formation.
In this setting, coronary CT angiography 
(CCTA) does not only provide informa-
tion about the anatomy of the coronary 
Figure 1
Case of a 51-year-old male with 
effort-induced chest pain. Coronary 
CT angiography shows a significant 
stenosis of the left main trunk due 
to a non-calcified eccentric plaque 
with positive remodelling (vulnera-
ble plaque). An angled appearance 
of the vessel at the level of its origin 
from the cusp is also evident.
A B
C
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 − Congenital fistula, an uncommon anomaly 
characterised by an abnormal communi-
cation between the coronary artery and a 
cardiac chamber or a great vessel, result-
ing in arterial blood bypassing the normal 
myocardial capillary network
Coronary CT angiography has emerged as 
the standard of reference for the evaluation 
of coronary artery anomalies and several 
studies have confirmed its superiority to 
conventional angiography in this field, allow-
ing non-invasive depiction of the coronary 
arteries anatomy, as well as their course and 
relationships with other mediastinal vascu-
lar structures. It may lead to a potential use 
of this imaging technique in the context of 
screening for sudden cardiac death, espe-
cially in young individuals.
There is also a growing role for cardiac mag-
netic resonance (MR) imaging in the demon-
stration of the coronary arteries; however, 
coronary MR imaging is not yet widely used in 
clinical settings.
SCD AND NON-ISCHAEMIC 
CARDIOMYOPATHIES
Non-ischaemic cardiomyopathies (NICM) 
are myocardial disorders defined by struc-
tural and functional abnormalities of the 
Figure 2
Case of a 72-year-old patient with acute myocardial 
infarct (AMI). CMR images of (A) short axis T2 short tau 
inversion recovery (STIR), (B) resting first-pass perfusion 
sequence, (C) short axis LGE image, all acquired at the 
mid-left ventricular level, and (D) three-chamber LGE 
sequence, show a large area of oedema with microvascu-
lar obstruction and transmural necrosis in the septum and 
the anterolateral LV wall.
Figure 3
CMR-LGE views in a 69-year-old patient with CAD show a 
large transmural ischaemic scar in the territory of the left 







Case of a 67-year-old female with AMI; the so-called 
‘doughnut’ pattern is visible both in the LGE short axis 
image and STIR short axis image, representing a core of 
microvascular obstruction and haemorrhage within the 
transmural infarcted area.
Figure 5
Volume rendered (A) and maximum intensity projection 
(B) images of a CCTA show the atresia of a left main 
coronary artery in adult patients with a positive stress 
test. The left anterior descending (LAD) coronary artery 
and left circumflex (LCX) coronary artery are diminutive 
relative to the right coronary artery (RCA), with right to 






ARCAPA syndrome in a 67-year-old female. Coronal (A) 
and oblique axial (B) CT images show a right coronary 
artery which abnormally arises from the anterolateral 
wall of the pulmonary artery; several coronary-coronary 
collateral arteries are also present. A volume-rendered 
image (C) shows an entire coronary arterial system 




Interarterial coronary artery in a 48-year-old man with 
atypical chest pain. Axial maximum intensity projection 
CT image (A) and volume-rendered image (B) show an 
interarterial RCA artery coursing between the aorta and 
pulmonary artery. An apparent narrowing is present at 
the origin of the RCA, which has a separate ostium off the 
left coronary cusp. The RCA has a slit-like orifice, which 
may be seen in interarterial coronary arteries and has 
been associated with a higher risk of SCD.
BA
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Histologically, HCM is characterised by 
abnormalities in small arteries, myocar-
dial fibres disarray and interstitial fibrosis; 
increased LV wall thickness is accompanied 
by an increased percentage of fibrosis and a 
subsequent decrease in LV function.
The amount of LV myocardial fibrosis 
assessed by pathology and in vivo by CMR 
is an important outcome predictor in HCM 
because it is closely related to the primary 
arrhythmogenic substrate of SCD. LGE pat-
tern in HCM is heterogeneously distributed 
but most commonly occurs in regions of 
hypertrophy and tends not to follow a coro-
nary artery territory (Figure 8). Furthermore, 
pre- and/or post-contrast T1 values (myo-
cardial T1 mapping) can allow a quantitative 
assessment of the amount of fibrosis and can 
be useful for risk stratification.
Recent studies showed that the extent of LGE 
was independently associated with increased 
risk for SCD even after controlling for tradi-
tional risk factors (family history, syncope, 
multiple repetitive episodes of non-sustained 
ventricular tachycardia, blood pressure drop 
during exercise, massive hypertrophy): it has 
a clinical importance when making a deci-
sion about implanting an ICD in patients who 
would be falsely labelled as lower risk on the 
basis of clinical features alone. By contrast, 
the absence of LGE in clinical intermediate risk 
patients was associated with a low likelihood 
of adverse events and the decision to implant 
an ICD might be deferred in this group.
Cardiac CT can be used in these patients as 
a screening for detecting LV crypts, which 
seem to be an early finding in preclinical 
HCM.
Dilated cardiomyopathy (DCM) is defined 
as LV dilation and systolic dysfunction in 
the absence of abnormal loading conditions 
or CAD sufficient to cause global systolic 
impairment.
Histologically, it is characterised by the loss 
of myocytes and their replacement by inter-
stitial fibrosis.
The first manifestation of DCM can be the 
SCD, probably with the onset of non-sus-
tained ventricular tachyarrhythmia caused by 
bundle-branch re-entry.
For these reasons, a routine diagnostic 
workup with CMR in suspected DCM is 
needed. In particular, cine imaging can give 
an assessment of biventricular volumes, wall 
thinning and LV function while LGE can reveal 
myocardial fibrosis, often located in the mid-
dle layer of the myocardium with a patchy or 
longitudinal pattern. This finding can help in 
the differentiation from a CAD-related dila-
tion, in which LGE is typically subendocardial 
or transmural (Figure 9).
Similar to HCM, myocardial mapping is 
proving a promising tool in the quantification 
of diffuse myocardial fibrosis that is often 
missed by LGE.
Arrhythmogenic right ventricular cardiomy-
opathy (ARVC) is a progressive heart muscle 
disorder characterised by the replacement 
of cardiomyocytes by adipose and fibrous 
tissue. Clinically, ARVC is defined by struc-
tural and functional abnormalities of the right 
ventricle (RV), but LV involvement occurs in 
over half of patients. In most cases, ARVC is 
inherited as an autosomal dominant genetic 
ventricular myocardium that are not solely 
explained by flow-limiting coronary artery 
stenosis or abnormal loading condition.
Nearly all NICM can be associated with an 
increased risk of SCD that varies with the 
aetiology and the severity of the disease and 
they have been consistently implicated as 
the primary cause of sport-related cardiac 
arrest in young competitive athletes.
Hypertrophic cardiomyopathy (HCM) is an 
inherited autosomal dominant condition 
characterised by an unexplained diffuse 
or segmental increased LV wall thickness 
(>12–15mm), with an absence of any detect-
able cardiac or systemic cause of abnormal 
LV loading conditions.
This entity represents one of the most 
common causes of SCD in young adults and 
the pathophysiological mechanism in these 
cases may include a malignant arrhythmia, 
syncope from the abrupt haemodynamic 
deterioration of the LV outflow tract gradi-
ent, and ischaemia.
Figure 9
CMR images of DCM. The left ventricle is significantly 
dilated in these three patients, with globally reduced sys-
tolic function. Delayed contrast-enhancement sequences 
are able to characterise the myocardium and differentiate 
DCM from LV dysfunction related to other causes. The 
three different LGE patterns include non-enhancement 
(A), patchy enhancement (B) and longitudinal striae of 
mid-wall enhancement in non-coronary territories (C).
Figure 8
CMR in a symptomatic patient with HCM. Short axis T1 
weighted image (A) shows a concentrically hypertrophied 
LV myocardial wall with tissue oedema in the mid-myo-
cardial anterior LV wall on T2 short tau inversion recovery 
(STIR) short axis image (B); short axis (C) and 4 chamber 
(D) LGE images show focal fibrosis in the same segment 
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trait caused by mutations in genes encoding 
for desmosomal proteins.
Generally, patients with ARVC are asymp-
tomatic and unexplained syncope or SCD 
can be the first clinical manifestation.
The diagnosis of ARVC is based on the com-
bination of multiple parameters, including (1) 
global or regional dysfunction and structural 
alteration of the RV demonstrated on imag-
ing; (2) tissue characterisation by endomy-
ocardial biopsy (EMB); (3) repolarisation 
and (4) depolarisation electrocardiographic 
(ECG) abnormalities; (5) arrhythmias; (6) 
familial history of SCD or SCA.
CMR plays an important role in the diagno-
sis of ARVC and it has been included in the 
2010 Revised Task Force Criteria, for the 
qualitative assessment of abnormalities on 
cine images (RV regional akinesia, dyskine-
sia, dyssynchrony), combined with specific 
quantitative cut-off values of RV dilatation/
dysfunction.
Furthermore, the presence of LGE is a 
marker of inducible ventricular tachyar-
rhythmia in 75% of patients, whereas 
its absence is associated with a lower 
incidence of inducible arrhythmia 
(Figure 10).
SCD AND MYOCARDITIS
Acute myocarditis may account for a 
large proportion of SCD in young peo-
ple. Myocarditis is an acute or chronic 
inflammatory disease of the myocar-
dium triggered by an infectious agent 
(enteroviruses such as Coxsackie B, 
adenoviruses, parvovirus B19 and human 
herpesvirus type 6) but also by many 
other causes, for example opportun-
istic infections, autoimmune response 
or drug-related cardiac toxicity. In the 
initial phase of viral infection, active viral 
replication leads to direct injury and lysis 
accompanied by innate immune activa-
tion. In some patients, disease activity 
persists and triggers an adaptive auto-
immune response with profound myo-
cardial inflammation, causing HF and 
arrhythmias. Acutely, active myocardial 
inflammation is arrhythmogenic, caused 
by triggered activity and abnormal auto-
maticity, leading to a refractory malignant 
ventricular tachyarrhythmia in the context 
of severe acute HF.
In chronic myocarditis, myocardial replace-
ment fibrosis promotes re-entrant arrhyth-
mic mechanisms, resulting in a high risk of 
SCD similar to that for DCM.
In patients with suspected myocarditis, 
CMR can visualise necrosis or scar on LGE 
(frequently located in sub-epicardial or 
intramural regions, with a non-ischaemic 
distribution pattern) and tissue oedema 
in the acute phase with T2-STIR or the 
T2-mapping technique (Figure 11). Fur-
thermore, CMR allows a reliable quan-
tification of LV dysfunction in order to 
appropriately choose the treatment strat-
egy (anti-arrhythmic drugs, pacemaker or 
ICD implantation, radiofrequency cathe-
ter ablation etc.), improving the SCD risk 
stratification.
Figure 10
A 26-year-old male with a history of dyspnoea, exercise 
intolerance and left bundle branch block at ECG. No 
abnormal enhancement is present. Short axis (A) and 4 
chamber (B) CMR-LGE images show a huge right ven-
tricular dilation with multiple aneurysms in the free wall 
and diffuse contrast enhancement.
Figure 11
Case of a 45-year-old female with acute myocarditis who 
presented with acute chest pain and mildly increased 
troponin-I. Short axis (A) and 4-chamber (B) CMR-LGE 
images show a sub-epicardial enhancement at the infero-
lateral wall with endocardial sparing.
A AB B
CONCLUSION
The role of imaging, namely non-invasive 
imaging, is pivotal in SCD/SCA prevention; in 
young subjects, particularly professional and 
non-professional athletes, pre-participation 
screening is mandatory (as for example in 
Italy) and, if needed, imaging should be widely 
used for prevention. In subjects who are over 
35 years old, the information that can be 
obtained by echo, CT, MR and nuclear tech-
niques have already gained a clinical role, both 
for diagnosis and for prognosis; consequently, 
imaging can be used as an effective gate-
keeper for personalised treatment approaches 
and appropriate ICD implantation.
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IMAGING IN ACUTE 
CORONARY SYNDROME
The basic aim in the treatment of acute myo-
cardial infarction is the revascularisation of the 
culprit artery to restore the myocardial blood 
flow. Strong evidence exists that early revas-
cularisation is an important factor for a good 
clinical outcome and for prevention of ischae-
mic heart failure. Thus, after the – usually 
preclinically established – diagnosis of ACS, 
patients are directly sent to the cath lab for 
revascularisation, and no additional imaging 
tests are carried out so as not to lose any time.
However, in up to 30% of patients with myo-
cardial infarction, functional myocardial 
recovery is not reached despite good primary 
technical success at acute percutaneous cor-
onary intervention (PCI). Possible reasons for 
this unfavourable result of acute revasculari-
sation are manifold: the time between coro-
nary artery occlusion and technical successful 
revascularisation could have been too long, 
which could lead to early myocardial necrosis 
in combination with lack of collateral vessels. 
Another possible reason could be the persis-
tent occlusion of microvasculature regardless 
the restored perfusion within the main epi-
cardial vessels. The reperfusion can also lead 
to additional myocardial damage, and in 30% 
of the patients the revascularisation is not 
complete. Furthermore, in case of multives-
sel disease and multiple coronary lesions, the 
usual attempt at the revascularisation of only 
the culprit artery might have been insufficient 
for full recovery of myocardial function.
The lack of functional recovery after success-
ful revascularisation is known to be a pre-
dicting factor for dismal outcomes like heart 
failure and for a high probability of recurring 
major cardiovascular events, especially of 
re-infarctions. Therefore, the early identifica-
tion of patients with limited or lack of func-
tional recovery is important to improve the 
clinical situation, and to prevent complications 
and further cardiovascular events.
WHEN THE ACTION IS OVER 
– IMAGING AFTER ACUTE 
CORONARY SYNDROME
Several studies have been published during 
the last decade demonstrating the outstand-
ing potential of cardiac MR derived biomark-
ers in the risk stratification and management 
of patients after technically successful treat-
ment of ACS. The aim of using cardiac MR 








While cardiovascular imaging by 
means of cardiac CT and cardiac MR 
plays almost no role in the diagnosis 
of acute coronary syndromes (ACS), 
the importance of cardiac MR in the 
management of patients after treatment 
of an ACS is continuously increasing. 
The probability of early complications, of delayed or missing recov-
ery and risk of secondary events could be estimated and predicted 
by cardiac MR derived biomarkers, underlining the outstanding 
potential of cardiac MR in the management of this rather vulner-
able patient population. With further evidence, the guidelines for 
patient management after treatment of an ACS could be changed 
to include cardiac MR in the near future.
Figure 1
LGE thickness: 57-year-old man. MR performed on day 4 after STEMI (acute 
occlusion of LAD). LGE imaging obtained 15 min after administration of 0.2 
mmol/kg body weight Gadovist® shows non-transmural subendocardial. Func-
tional recovery of this area is very likely.
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and established. It is an index calculated by the 
relation between the myocardial tissue at risk 
(as assessed by using T2 STIR) and the ‘really’ 
necrotic tissue (as identified by means of LGE). 
The higher the MSI, the more myocardial tissue 
was ‘saved’ by the early revascularisation, and 
the better the prognosis will be with regard to 
re-infarctions and functional recovery. How-
ever, despite rather good evidence about the 
correlation between MSI and outcome, the 
technique itself is still under major discussion: 
first, the extent of oedema after revascularisa-
tion is dependent on time; it makes a differ-
ence if the post-ACS MR scan is performed 
on day 2 or on day 6. Second, cooling of the 
patients, as used for brain ischaemia for years, 
is applied at least in several studies to ACS 
patients as well, and reduction of body tem-
perature will reduce the oedema (and possibly 
the tissue at risk) leading to a virtual decrease 
of the MSI. Third, as mentioned previously, 
the technique of oedema quantification is not 
finally optimised and established and is still a 
matter of investigation.
Regardless all these known limitations and 
pending questions about optimal imaging 
technique, the MSI is a very accurate and 
clinically useful test to prove the success of 
the revascularisation and to foresee dismal 
clinical outcome providing the possibility 
for early adaption of the individual patient’s 
treatment plan.
LGE transmurality
Whereas the MSI is a main indicator for the 
success of the revascularisation procedure 
itself, the LGE transmurality is an indicator for 
the severity of the ACS and the extent of the 
myocardial death. A transmural LGE, as well as 
an LGE involving four connected myocardial 
treatment success, to predict the outcome, 
to indicate the early need for further treat-
ment and to assess treatment or event related 
complications.
The calculation of the 
myocardial salvage index
Cardiac MR is able to directly visualise the 
myocardial necrosis. The extent of late gad-
olinium enhancement (LGE) in the ischaemic 
myocardial territory represents an important 
predictor of the functional recovery of the 
ischaemic myocardium. Although it has been 
shown recently that MR-LGE overestimates 
the ‘real’ necrosis in the acute setting within 
few days after the ACS and revascularisation 
due to additional inflammatory processes and 
haemorrhage, LGE is one of the most powerful 
biomarkers for the assessment of treatment 
success and prediction of functional recovery.
However, in patients with recurrent events, 
the differentiation between acute and pre-ex-
isting necrotic changes can be challenging. 
Despite this, it is of major importance for 
outcome prediction. For this differentiation, 
oedema imaging has to be added to the LGE. 
Traditionally, oedema imaging was performed 
using T2-STIR sequences, but it has been 
shown that T2-STIR is vulnerable to artefacts 
and inhomogeneities in the signal intensity. 
Therefore, T2 mapping was introduced as a 
powerful alternative and is currently under 
investigation for this application. Addition-
ally, diffusion-weighted techniques are under 
evaluation as well for accurate diagnosis of 
myocardial oedema.
To sensitively assess the treatment success of 
an acute revascularisation for ACS, the myo-
cardial salvage index (MSI) was introduced 
Figure 2
LGE transmurality and MSI: 
54-year-old man. MR performed 
on day 5 after STEMI (acute occlu-
sion of RCA). (A) T2-STIR shows 
extensive myocardial oedema in 
the posterior wall. (B) LGE imaging 
obtained 15 min after administra-
tion of 0.2 mmol/kg body weight 
Gadovist® shows transmural LGE 
indicating transmural scar at the 
posterior wall. However, the area of 






LGE and MVO: 47-year-old man. 
MR performed on day 4 after 
STEMI (acute occlusion of LAD). 
(A, B) LGE imaging obtained 15 min 
after administration of 0.2 mmol/
kg body weight Gadovist® (short 
axis). There is extensive LGE in 
the anterior septum as well as the 
anterior wall. However, there is a 
huge ‘black’ area within the LGE 
indicating extensive MVO. 
B
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segments, represent a clear predictor for 
lack of future functional recovery. Conse-
quently, these patients are at high risk for a 
reverse remodelling of the left ventricle and 
the generation of a left ventricular aneurysm. 
These patients are in need of very special 
follow up care to quickly adapt their medica-
tion (including anti thrombotic medication!) 
to the unfavourable myocardial situation and 
to give early indication regarding cardiac 
surgery if required. Additionally, the proof of 
lacking transmurality by means of MR LGE 
can be the basis for decision making of further 
revascularisation.
Visualisation of microvascular 
obstructions
After a successful revascularisation of the 
culprit artery by means of acute PCI, so-called 
microvascular obstruction (MVO) might occur 
in the region of the re-perfused myocardium 
due to microemboli of plaque material during 
PCI. Although the exact pathogenesis of MVO 
is not fully understood yet and although it is 
not clear if it is really caused by the reperfusion 
or by microemboli during the initial rupture 
of the culprit plaque, it is well known that the 
presence of MVO is a predictor for unfavoura-
ble outcomes. Patients with MVO have a higher 
likelihood of early complications, show a 
higher incidence of reverse LV remodelling and 
even a higher mortality. Cardiac MR allows the 
direct visualisation of areas with MVO, which 
can easily be identified as non-enhanced 
areas within the ischaemic LGE. There is an 
excellent correlation between the presence 
of MVO and TIMI flow graduation at invasive 
angiography. The presence and extent of MVO 
is not only dependent upon the initial situation 
(duration of occlusion and size of infarction) 
but also from the timing of the imaging after 
the procedure and will continuously decrease 
during the first weeks. To accurately assess the 
MVO and to use it accordingly to predict risk 
of complications and outcome, the MR study 
should be performed between day 2 and day 
7, underlining again the value of an early car-
diac MR after acute PCI for ACS.
Evaluation of complications
The early MR after acute PCI for ACS should 
also be used to identify possible treatment-re-
lated complications early. These possible 
complications include papillary necrosis, mitral 
regurgitation, aneurysms and pseudo-aneu-
rysms. All of these complications have the 
potential to deteriorate the clinical situation 
of the patients and to negatively affect the 
clinical outcome. Early identification allows for 
early secondary intervention, intensified follow 
up and/or medical intervention.
CONCLUSION
Whereas MR imaging does not play any role 
prior to acute PCI in ACS, a lot of substantial 
information about treatment success, the pres-
ence of complications and expected outcome 
and recurrent events can be gained by means 
of cardiac MR after the treatment of ACS. LGE 
transmurality, the myocardial salvage index 
and detection of microvascular obstruction 
are the most powerful MR derived biomarkers. 
Based on the already existing evidence, car-
diac MR should become a standard procedure 
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The dose delivered by CCTA can vary sub-
stantially depending on patient characteristics 
and the settings of multiple scanner operating 
parameters. The major configurable CCTA 
settings that can affect the dose are: tube 
voltage (kV), tube current (mA), and various 
other parameters of the scan protocol, such as 
type of ECG-gating, pitch, slice thickness, scan 
length, and the type of image reconstruction 
(standard or iterative).
STRATEGIES TO REDUCE 
RADIATION DOSES IN CCTA
Today CCTA should be carried out with low-
dose protocols whenever possible. There are 
a number of different strategies to reduce or 
minimise the radiation exposure to a patient 
during CCTA.
The most important ones are as follows:
 − Prospective ECG-gating
 − Reduction of tube voltage (kV) and tube 
current (mA) in combination with iterative 
image reconstruction
 − Tube current modulation (in case of retro-
spective gating)
 − Adjustment of pitch settings
 − Tailoring of the scan length to the 
necessary parameters (avoidance of 
overscanning)
 − Faster data acquisition (high-pitch 
scanning)
In the case of CCTA, radiologists have to find 
an optimal balance between image quality, 
good contrast to noise ratio, and acceptable 
low radiation dose.
Prospective ECG-gating
In the case of CCTA, ECG-gating is oblig-
atory in order to get movement-free diag-
nostic datasets of the heart and vessels. 
Coronary CTA can be performed with retro-
spective and prospective ECG-gating (Figure 
1). CCTA with retrospective ECG-gating 
allows for data reconstruction of the whole 
scan volume at any time point within the 
cardiac cycle. But employing this technique 
makes high radiation doses (range 8–16 
mSv) unavoidable, unless special measures 
to decrease radiation are taken. In the case 
of CCTA with prospective ECG-gating, the 
images are obtained only in predetermined, 
fixed R-R intervals (usually 60–70%). With 
this approach, it becomes impossible to 
obtain reconstructions in all the phases of 
the cardiac cycle, but radiation doses can be 
reduced significantly. CTA performed with 
a prospective ECG-gating (as opposed to 
a retrospective one) provides a substantial 
(3–6 fold) decrease in the effective radiation 
dose without compromising on image qual-
ity. Prospective-gated CCTA works very well 
in patients with low heart rate (HR) (60–65 
beats per minute); though, in cases of high 
HR, the use of prospective ECG-gating can 
lead to non-diagnostic images due to motion 
artefacts. Low dose CCTA with prospective 
gating has become a new standard for diag-
nostic evaluation of CA and the heart cham-
bers’ morphology when there is no need 
for functional information. It is suitable even 
for static (single-shot) studies of myocar-
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We are living in the era of low-
dose cardiac and coronary CT
Coronary and cardiac computed tomography angiography (CCTA) is a 
non-invasive modality that is used more and more frequently in mod-
ern healthcare as a valid alternative to invasive coronary angiography 
for assessment of coronary atherosclerosis and many other cardiac dis-
eases, as well as targeted indications like left atrium and pulmonary vein 
assessment or cardiac and aorta imaging before transcatheter aortic valve 
replacement (TAVI). There is a general trend towards increased use of 
CCTA for diagnostic imaging of the heart and coronary arteries (CA). CCTA 
has been included in different national and international cardiac referral 
guidelines. However, wider use of this modality has been criticised by some 
experts because of the relatively high levels of radiation to which patients 
are exposed. Yet the situation with regards to radiation exposure associated 
with CCTA has changed dramatically: we have entered the era of low-dose 
CCTA, and it is important that radiologists be aware of how to perform low-
dose cardiac and coronary CT.
Chapter 18 | RADIATION EXPOSURE 183182 Chapter 18 | RADIATION EXPOSURE
THE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONSTHE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONS
retrospective gating is used when one needs 
information about the function of heart 
chambers and valves or in patients with 
arrhythmias. Recently, novel motion-cor-
rection (MC) algorithms have been devel-
oped by several manufacturers. These MC 
algorithms use information from adjacent 
cardiac phases obtained with prospectively 
gated CCTA within a single cardiac cycle. 
Such an approach minimises the artefacts 
related to CA motion. These MC algorithms 
can improve the image quality of prospective 
gated low-dose CCTA even in patients with 
higher HR (Figure 2).
Reduction of tube voltage 
and current combined with 
the iterative reconstruction
Reduction of tube voltage (kV) decreases 
radiation dose roughly proportionally to 
the square of the voltage settings. Thus, 
decreasing the tube voltage from 120 
to 100 kV reduces the radiation dose by 
almost 40% whilst decreasing it from 120 
to 80 kV reduces the dose by 60–70% (if 
the tube current remains constant). The kV 
settings are predefined or selected by the 
operator according to the subject’s body 
mass index (BMI) and indications of the 
study. There are some simple rough recom-
mendations for selecting the optimal tube 
voltage for CCTA: 120 kV for patients with 
a BMI of more than 30 kg/m2, 100 kV for 
a BMI from 21 to 29 kg/m2, and 80 kV for 
a BMI of less than 21 kg/m2. Consequently, 
the selection of tube voltage settings is in 
some way a trade-off between image noise 
and radiation dose. Modern CT scanners 
with iterative image reconstruction CCTA 
can, in most cases, be performed with a 
low tube voltage without any loss in image 
quality. It is well known that low tube cur-
rent/voltage leads to reduced exposure to 
radiation for patients, but also to increased 
image noise. Due to the introduction of 
iterative image reconstruction, the radi-
ation dose can be substantially reduced 
(by 30–70% in comparison to traditional 
filter back projection) without any losses 
of fine details on images (Figure 3). Com-
bined application of prospective ECG-gat-
ing, low tube current voltage and iterative 
reconstruction allows for significant reduc-
tions in radiation dose – to below 1–2 mSv 
(Figure 4).
Tube current modulation
Tube current modulation is an important 
tool for decreasing the radiation dose in 
cases where retrospective cardiac gating is 
necessary – for example, when the evalu-
ation of cardiac chambers, valve function, 
or dynamic myocardial perfusion studies 
are needed. The tube current is selected 
and modified based upon patient weight 
and/or BMI, thoracic diameter or noise 
measurement. Most modern scanners offer 
tube current modulation based upon the 
thickness of the body estimated from the 
topogram. For CCTA with retrospective 
ECG-gating, the tube current can be mod-
ulated at different phases of the cardiac 
cycle, for example, full tube current can be 
applied at the end- or mid-diastolic phases 
used for imaging of CA and decreased 
tube current can be used in other phases 
for heart chamber visualisation where 
lower image quality is acceptable. ECG-
tube current modulation can reduce the 
radiation dose of coronary CTA by up to 
60% in comparison to scans with fixed 
tube current settings.
Figure 2
65-year-old male patient with an 
average HR >65 bpm. The VR and 
MPR made with standard prospec-
tive-gated CCTA show motion 
artefact in the middle segment of 
RCA (A). In the case in which the 
MC algorithm was applied (B), no 





Coronary CTA with prospective (A) and retrospective (B) gating. In the case of (A), the centre of the triggering window was 
set at 70–80% of the RR interval. For (B), images could be reconstructed in every phase of the cardiac cycle without any corre-
sponding increase of radiation exposure.
A
B
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Adjustment of pitch value
Distance travelled by the CT table divided 
by x-ray beam width denotes pitch. Radi-
ation exposure for helical scanning at a 
pitch of 1 is comparable to that obtained 
during axial scanning. Scanning with pitch 
settings >1 is associated with a decrease 
of radiation exposure. A specialised form 
of helical scanning (‘high pitch’ or ‘super-
helical’) has been developed for use 
in new ‘fast’ CT systems like the latest 
generation of dual-source CT (DSCT), 
or wide-detector, systems. According to 
different studies, the mean dose during 
high pitch scanning is very low (it could 
be in sub-millisievert range) without any 
associated decrease in image quality. High 
pitch scanning is particularly beneficial 
in diagnosis of CA anomalies and cardiac 
anatomy assessment of congenital heart 
diseases in children and young patients. So 
far, the main limitation of this technique is 
its dependence on low HR (typically less 
than 65 bpm), but this disadvantage may 
disappear with further improvements in CT 
techniques.
CONCLUSION
Just ten years ago, CCTA was associated 
with relatively high radiation exposure. 
According to the data from the ACC/
HRS/NASCI/SCAI/SCCT Expert Consen-
sus Document on Optimal Use of Ionising 
Radiation in Cardiovascular Imaging (2018)1, 
the radiation dose during cardiac CTA can 
range from 0.5 to 30 mSv (Table). However, 
in most cases of CCTA, this is no longer a 
big problem.
In summary, we would like to stress the most 
effective ways to decrease radiation expo-
sure in coronary and cardiac imaging2, 3:
1. Selection of the right indications for the 
examination (e.g. use iGuide4 from ESR)
2. Details such as the patient’s age, sex, 
weight, and height must be taken into 
consideration
3. Scan length should be tailored according 
to the aim of the study
4. Prospective ECG-gated CTA should be 
used in most cases when sufficient image 
quality can be expected
5. Retrospective ECG-gated CCTA should 
be done with tube current modulation
Figure 4
Coronary CTA with prospective (A) 
and retrospective (B) ECG-gating. 
The radiation dose was decreased 
from 19.4 to 1.37 mSv thanks to 
prospective ECG-gating and low 





Low-dose CCTA with prospective ECG-gating and low tube voltage (100 kV) in 
a patient with a BMI of 30.5 kg/m2. Iterative reconstruction allows the study to 
be performed with low radiation exposure without any loss of image quality due 
to the use of iterative image reconstruction. Radiation dose 1.59 mSv.
Table
Typical effective doses for different CCTA scanning 
 protocols
SCANNING PROTOCOL RANGE OF 
EFFECTIVE 
DOSES (MSV)
CCTA, retrospective gating, 
no tube current modulation
8–30
CCTA, retrospective gating, 
with current modulation
6–18
CCTA, prospective triggering 0.5–7
CCT, high-pitch helical <0.5–3
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6. Iterative image reconstruction (com-
bined with appropriate decreases of tube 
voltage and current) is recommended for 
CCTA in all examinations (if the scanner 
has this option)
7. New technical features (e.g. high-pitch 
scanning, motion correction algorithms) 
should be used when possible and 
appropriate
ABOUT EUROSAFE IMAGING
EuroSafe Imaging is the European Society of 
Radiology’s flagship campaign to promote 
quality and safety in medical imaging. The 
mission of EuroSafe Imaging is to support 
and strengthen medical radiation protection 
across Europe following a holistic, inclusive 
approach. Radiation protection focuses on 
three cornerstones, namely justification of 
any medical exposure, optimisation of the 
imaging task to keep the exposure as low 
as reasonably achievable, as well as dose 
limits. EuroSafe Imaging has launched its 
Call for Action 2018 to guide all activities, 
which build upon these principles. The ESR’s 
EuroSafe Imaging campaign is pleased to 
present this article focusing on protocol 
optimisation in cardiac imaging.
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and wall motion abnormalities, and is the 
gold standard for evaluating ventricular func-
tion and volume in both left and right ventri-
cles, making it an ideal imaging modality for 
serial monitoring (Figure 1).
Non-contrast tissue characterisation utilises 
T1 black-blood imaging to show fatty infiltra-
tion or deposition (Figure 2) and T2 black-
blood imaging for oedema from acute myo-
cardial infarct (MI) (Figure 3A) or myocarditis 
(Figure 3B). These techniques are also useful 
in soft tissue differentiation for assessing 
myocardial and extra-cardiac structures and 
masses (Figure 4). T2* imaging can be used 
to demonstrate iron deposition in patients 
with haemochromatosis or thalassaemia.
Myocardial fibrosis or infiltration can be 
assessed after the administration of a gado-
linium-based contrast agent. It is possible to 
assess three phases – first pass (which can be 
acquired at stress using a pharmacological 
stress agent), early enhancement and late 
enhancement. Late gadolinium enhancement 
(LGE) imaging is acquired 5–10 minutes after 
the administration of a contrast agent. The 
LGE technique allows for the differentia-
tion between ischaemic and non-ischaemic 
cardiomyopathies depending on the specific 
patterns of focal fibrosis (Figure 5) and pro-
vides valuable information on the aetiology 
of pathology to help guide treatment and 
predict adverse outcomes.
FUTURE DIRECTIONS
T1-mapping is a technique for paramet-
ric mapping of myocardial relaxation 
times in CMR. It is used for imaging focal 
and diffuse fibrosis and, in combination 
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INTRODUCTION
Cardiac magnetic resonance imaging (CMR) is a rapidly growing area of 
cardiac imaging throughout the world. Rapid technological advances and 
developments have seen it provide unique imaging capabilities and accu-
racy. It provides high spatial and temporal resolution imaging which is 
non-invasive and which produces no ionising radiation. CMR uses different 
pulse sequences to visualise the myocardium, valves and great vessels. In 
a single scan, ventricular volumes and function can be assessed together 
with evaluation of myocardial fibrosis, iron loading, flow quantification, tis-
sue characterisation and myocardial perfusion.
TECHNIQUES UTILISED
Cine imaging can be acquired in any plane, provides highly reproducible 
imaging of cardiac morphology and function as well as myocardial mass 
Figure 1
Cine images showing (A) asymmetrical myocardial hypertrophy in the basal septum due to hypertrophic cardiomyopathy (B) 
thinned anterior wall due to previous left anterior descending infarct (C) double inlet right ventricle.
A B C
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blood haematocrit, calculating the extra-
cellular volume (ECV) fraction. Oedema, 
from inflammation or acute infarction, and 
increased interstitial space from fibrosis 
or amyloid deposition are the two most 
important reasons for an increased native 
(non-contrast) T1. Lipid or iron overload 
are the two most important for decreased 
native T1. Native T1-mapping is possible 
in patients where poor renal function is a 
contraindication to contrast administration 
and so LGE cannot be performed. ECV 
is a marker of tissue remodelling and an 
increased ECV is most often due to exces-
sive collagen deposition1.
Blood flow in the heart and great vessels is 
multidirectional and pulsatile and 4D phase 
contrast CMR has enabled visualisation of mul-
ti-directional flow features. In the aorta, areas 
of high-velocity flow close to vessel walls may 
indicate altered fluid mechanical effects on 
the vessel wall, and in complex congenital 
heart disease studies using 4D flow, imaging is 
showing potential applications2.
CMR has also become an important com-
ponent of risk stratification and procedural 
planning in congenital and paediatric heart 
diseases. Innovative approaches to image 
acquisition and reconstruction are leading 
Figure 2
T1 axial image showing fatty fibrosis 
of right ventricular free wall in 
arrhythmogenic right ventricular 
cardiomyopathy.
Figure 3
T2 short axis images showing (A) oedema in right coronary 
artery territory (inferior wall) due to late presentation myo-
cardial infarct, with microvascular obstruction, (B) oedema 
in non-coronary artery territories in acute myocarditis.
A B
Figure 4
Axial image of cardiac mass with (A) T1 weighting and (B) T2 weighting.
A B
Figure 5
Late gadolinium enhancement images showing (A) subendocardial LGE due to myocardial infarct in right coronary artery territory and 
(B) epicardial LGE in acute myocarditis.
A B
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The process of undergoing a CMR exam-
ination may be a daunting experience for 
patients. The CMR radiographer must have 
the necessary skill set to effectively com-
municate with patients in order to both allay 
anxiety of undergoing the examination and 
in relation to the potential outcomes of the 
examination. This soft skills set is vital in order 
to maximise patient compliance, which is 
essential for the examination. Patients must be 
able to cooperate with the process by remain-
ing still and repeatedly holding their breath. 
The MR radiographer plays a crucial role in 
preparing the patient for this by explaining the 
MR procedure and educating and reassuring 
them regarding the different aspects of it, for 
example, the effects of pharmacological stress 
agents, to a level that is appropriate for each 
individual patient regardless of age. Whilst 
advances in technology have reduced scan 
times or negated the need to breath-hold 
entirely, patient compliance is still essential.
In order to tailor the examination to the 
patient presentation and pathology, the radi-
ographer must have knowledge of pathologi-
cal processes – the presentation of conditions 
and also CMR imaging appearances. In con-
junction with this, the radiographer must also 
have knowledge and understanding of con-
trast agents used in MRI, and pharmacological 
stress agents which may be used within the 
CMR department. In order to optimise the 
examination, the radiographer must tailor the 
image acquisition parameters to the patient’s 
physiology e.g. the use of differing ECG gating 
and triggering techniques when arrhythmias 
are present, and adjustment of parameters 
to alter sequence acquisition times for the 
patient’s breath-holding capability, whilst still 
maintaining image quality. In order to ensure 
accurate measurements and flow quantifi-
cation, the CMR radiographer must acquire 
imaging in correct and appropriate planes, 
and where serial monitoring is required it is 
essential that the images be reproducible.
In some CMR centres, it is the radiographer 
who supervises particular CMR scan lists, 
including vasodilator stress CMR, so advanced 
knowledge is needed for decision making and 
safe practice.
Whilst carrying out this role the radiographer 
must also make sure that all hardware and 
software is operating appropriately. As such 
the radiographer has an important role to 
play, in conjunction with other professions in 
the quality assurance programme of the CMR 
department. An appropriate and timely qual-
ity assurance programme is necessary and 
indeed required for some newer CMR tech-
niques, such as parametric mapping3.
CONCLUSION
The rapid advances and continued devel-
opments in CMR now see it provide unique 
imaging capabilities and accuracy. It has 
changed the work-up of patients, aids 
diagnosis and assists in determining appro-
priate treatment paths, therapeutic response 
and risk stratification. The MR radiographer 
plays a crucial and vital role in this, ensuring 
patient safety and compliance when under-
going the examination and undertaking the 
examination with a high level of skill and 
technical expertise. They must also provide 
accurate and reproducible images, tailor 
the examination to the patient’s needs, and 
the way toward fast, high-resolution, 3- and 
4-dimensional datasets for delineation of 
cardiac anatomy, function, and flow. Moreover, 
techniques for assessing the composition of 
the myocardium may help clarify the patho-
physiology of late complications, identify 
patients at risk of heart failure and assist in the 
evaluation of therapeutic strategies. Tradi-
tional techniques account for cardiac motion 
due to respiration by tracking the diaphragm, 
but newer techniques, such as self-navigated 
3D whole heart imaging, track the cardiac 
position itself and provide robust 3D clinical 
datasets in patients with congenital heart 
disease.
Improvements in reconstruction algorithms 
allow for accelerated, time-resolved, 3D 
velocity-encoded flow imaging whilst main-
taining spatial and temporal resolution. These 
novel techniques, along with the use of newer 
contrast agents that afford better signal 
to noise ratio, may eventually allow for the 
fusion of anatomic and flow data into a single, 
comprehensive dynamic 3D dataset that can 
be reformatted in order to analyse cardiac 
structure, function, and blood flow. The CMR 
guided cardiac catheterisation in congenital 
heart disease may eventually allow for simul-
taneous measurements of pressure and flow, 
providing insights into chamber compliance, 
vascular impedance, and myocardial contrac-
tility. As spatial resolution improves, foetal 
CMR may produce valuable information on the 
link between foetal blood flow derangements 
in congenital heart disease and neurode-
velopmental outcomes. CMR based feature 
tracking may yield new knowledge on regional 
and global myocardial function and defor-
mation, allowing for a further refinement of 
patient-specific risk of adverse outcomes.
New developments in hardware include res-
piratory detection through the scanner table 
and receiver coil developments to allow for 
detection of a vectorcardiogram, eliminating 
the need for respiratory bellows, navigator 
bands or an ECG. The combined develop-
ment of rapid, real-time MRI sequences, 
together with MR compatible catheters and 
guidewires, show promising potential for MR 
guided catheter-based interventions.
THE ROLE OF THE MR 
RADIOGRAPHER
The advent of CMR has changed the 
work-up of patients with suspected cardiac 
and cardiac-related pathologies, aiding 
diagnosis and assisting in determining 
appropriate treatment paths, therapeutic 
response and risk stratification. The CMR 
exam is tailored to the patient presenta-
tion and pathology and produces many 
challenges that the MR radiographer must 
overcome.
The MR radiographer must have a deep 
understanding and knowledge of the prin-
ciples of MRI, MRI sequences and dedicated 
CMR sequences, and detailed anatomical 
knowledge of the cardiovascular system. 
This information must build upon the 
knowledge already gained in undergraduate 
education and experience, through higher 
education and training. The high magnetic 
field strengths used in MRI present signif-
icant safety considerations and radiogra-
phers must have extensive knowledge and 
understanding related to MRI safety in order 
to ensure patient and staff safety.
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also fully image any pathology that may 
be present, all in a single scan sitting. By 
using this skill and expertise, and through 
a combination of the sequences available, 
CMR is an ideal imaging modality for both 
adults and paediatrics. In addition, the 
implementation of radiographers core skills 
enables new and advanced techniques to 
be implemented effectively and efficiently 
for improved patient outcomes.
References 
See page 237
ALISON FLETCHER   
qualified as a diag-
nostic radiographer 
in 1992 from Bristol 
University, UK. She 
has 22 years of expe-
rience in MRI with 16 
years dedicated to 
cardiac MRI. She has 
worked in all areas of CMR and is currently the 
lead research radiographer at the Acute Vascular 
Imaging Centre, University of Oxford, UK.
Ms. Fletcher is extensively involved in CMR edu-
cation nationally and internationally and was the 
radiographer member of the Board of Trustees of 
the Society of Cardiovascular MR from 2014–2017, 
and is still actively involved with SCMR.
Ms. Fletcher was invited to co-author this chapter 
on behalf of the European Federation of Radiog-
rapher Societies (EFRS).
AIDEEN FALLON   




at the Centre for Car-
diovascular Magnetic 
Resonance at Black-
rock Clinic, Dublin, 
Ireland; the only dedicated CMR imaging centre 
in Ireland. She is a member of the Irish Institute of 
Radiography and Radiation Therapy. Ms. Fal-
lon is committed to the provision of healthcare 
and CMR imaging of the highest standards and 
has been continually committed to furthering 
the education and professional development of 
radiographers. She has undertaken further post-
graduate studies in the area of MRI and has con-
ducted research in CMR, leading to a Research 
Master’s degree award (NFQ Level 9). Her special 
areas of interest are T1 and T2-mapping. She has 
presented aspects of the T1-mapping research 
she has undertaken and has spoken on the topic 
of CMR imaging at national and international 
conferences.
Ms. Fallon was invited to co-author this chapter 
on behalf of the European Federation of Radi-
ographer Societies (EFRS). Through its member 
organisations, the EFRS represents more than 
100,000 radiographers and 8,000 radiography 
students in Europe.
VASILIS 
 SYRGIAMIOTIS   
is a radiographer in 
the MRI-CT depart-
ment of the General 
Children’s Hospital in 
Athens. He obtained 
his BSc degree in the 
Radiography Depart-
ment of the ATEI Institute of Athens. He special-
ised in MRI in Karolinska – Huddinge University 
Hospital of Stockholm, Sweden. He has a Master 
degree from the Faculty of Medicine in the Uni-
versity of Athens. His thesis was about the effect 
of ionising radiation in children and pregnant 
women. He is currently a candidate PhD student 
at the Faculty of Medicine.
His research interests include optimisation in 
paediatric medical imaging and radiation protec-
tion. He is a lab assistant in the Faculty of Health 
and Welfare professions in the Department of 
Radiographers in the ATEI Institute of Athens. 
He teaches MRI and CT for BSc students. He 
supervises and coordinates the work of several 
radiographer students in the medical imaging 
field. He also teaches medical physicists.
Mr. Syrgiamiotis is a European Federation of 
Radiographer Societies (EFRS) Board member 
and was invited to co-author this chapter for the 
EFRS.
2020CARDIAC CT: THE RADIO-GRAPHERS’ PERSPECTIVE
Chapter 20 | CARDIAC CT: THE RADIO GRAPHERS’  PERSPECTIVE 201
THE HEART REVEALED RADIOLOGY IN THE DIAGNOSIS AND MANAGEMENT OF CARDIAC CONDITIONS
imaging the coronary arteries is the use 
of CT. CT has accomplished something 
very important; the ability to capture the 
moving heart without motion in a non-in-
terventional procedure.
EXAMINATION PROCESS
The coronary CT angiography (CCTA) is 
a method that first appeared in the year 
2000, with a 4-slice CT system and later in 
2002 with a 16-multidetector (MD) CT. Next 
generation CT scanners with 64-detector 
rows were implemented in 2004. These 
CT scanners integrated new and improved 
manufacturing features that introduced a 
better temporal resolution by decreasing the 
rotation time, improving the spatial resolu-
tion that offered a more accurate imaging 
of the heart. The introduction of isometric 
voxel increased the image quality by making 
it possible to have the same spatial resolution 
in every plan. In 2016 the 320-detector CT 
scanner was implemented with new possibil-
ities to scan the entire heart in one rotation, 
increasing spatial and temporal resolution as 
lowering artefacts.
As CCTA is a non-invasive imaging method, 
the patient does not need any medical obser-
vation, nor hospitalisation, after its comple-
tion. The diagnostic efficacy of CCTA keeps 
improving, but CCTA still has limitations, even 
if all the new technical developments are 
used. In case of no findings, CCTA is 100% 
accurate, whereas in case of any stenosis, the 
degree of stenosis is usually overestimated 
due to the method’s barriers. Therefore, 
other modalities such as digital subtraction 
angiography, magnetic resonance imaging, 
optical coherence tomography or intravascu-
lar ultrasound could be taken into considera-
tion in order to compare findings.
The examination of CCTA consists of three 
main parts:
1. Patient preparation:  
The patients’ blood pressure and heart 
rate are measured and a venflon (18G) is 
placed in a vein in the preparation room. 
To obtain the best image quality, the 
heart rate should be below 65-75 BPM, 
depending on the individual CT scanner. 
If the heart rate is too high, beta-block-
ers are administered (in absence of con-
tra-indications). These low heart rates 
are maintained for the whole procedure, 
to avoid motion artefacts. In the newer 
CT scanners, however, it is possible to 
scan the patient with a higher heart 
rate, but then the scan is reconstructed 
in two phases (40 and 75%) to ensure 
diagnostic quality without motion arte-
facts. 
 
At this preparation stage, specific 
breath-hold instructions or extended 
breath hold exercises are given to the 
patient. A clear communication and 
close cooperation between the patient 
and the radiographer is made to obtain 
a stable and low heart rhythm. The 
patient is correctly centred in all three 
plans with arms above the head. If pre-
ferred, nitro-glycerine could be given 
just before the examination to enhance 
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TECHNOLOGY EVOLUTION AND CORONARY 
COMPUTED TOMOGRAPHY ANGIOGRAPHY
The vast technological advancement over the past decades has helped 
with the evolution of medical imaging. Especially in the field of com-
puted tomography (CT), fast rotation time, larger and more sensitive 
detectors, newly developed x-ray tubes and more advanced process-
ing software have been established for more precise CT images. To use 
the full extent of the CT scanner and focus on the individual patient, 
the radiographer’s work has become more diverse and complex 
according to the technological development.
This technological evolution has been of great importance to the 
field of coronary artery disease (CAD). Contemporary lifestyle, con-
sumption habits (non-healthy food, smoking, etc.) and mostly stress 
are some of the elements that have led to a noteworthy increase in 
the number of cardiovascular patients. One very reliable choice for 
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Figure 4
Non-iodine-contrast calcium scoring with the calcium 
marked in the coronary arteries.
Figure 1
Placement of the ECG electrodes on the patient placed on 
the scanner bed.
Figure 2
Heart rate planning prospective ECG triggering, scanning in 
the 75% phase of the cardiac cycle and R-R interval.
Figure 3
CCTA acquisition planning showing the field of view 
(FOV).
A B
2. Main examination (acquisition):  
This part of the examination consists of 
the calcium scoring scan (CS) and the 
main CCTA (Figure 3). During CS, plain 
non-contrast images from the heart 
are made (Figure 4). The calcium score 
scan shows and allows calculation of the 
amount of calcification in the coronary 
artery wall. The CS images are used to 
plan the main CCTA protocol that takes 
place right after the CS acquisition. For 
the main CCTA, the heart-beat-trigger-
ing images are acquired, with simulta-
neous intravenous contrast medium 
administration. See Table for specific 
technical CCTA and iodine contrast 
information.
3. Post-processing:  
The acquired image data undertake further 
post-processing techniques to achieve the 
best possible diagnostic images for the 
individual patient. These include iterative 
reconstructions in order to form a series of 
images of the coronaries arteries’ multi-
planar reconstruction (MPR, Figure 5) and 
vessel tracking is used and combined with 
3D rendering, fly-through and other types 
of vessel presentation images (Figure 6).
Table
Protocol examples used in clinical CCTA for an average 60-year-old cardiac patient (175cm and 90kg)
INDICATIVE TECHNICAL PROTOCOLS FOR CCTA
CT technique Greece Denmark
CT scanner Toshiba Aquilion Prime Revolution CT from GE Healthcare
Detectors 80 256 Gemstone (GSI)
kV Auto-kV 100
mA Auto-mA 412
Collimation 80 x 0.5mm 256 x 0.625mm
Slice thickness 0.5mm 0.625mm
Rotation time Auto, according to pitch selection from breath 
exercise prior to CCTA (~0.35 sec)
0.28 sec
Pitch Auto adjusted from breath exercise Axial
Scan length 120mm 140mm
Scanning time 4 sec 0.28 sec
Effective dose 2-4 mSv (according to heart rate) 1–1.3 mSv
Iodine contrast protocol flow 5-6 mL/sec (according to heart rate) 6 ml/sec
Iodine contrast According to BMI
Approx. 90mL iodine contrast /  
50 mL saline flash
60 ml iodine contrast /  
50 ml salty water
Iodine contrast timing Bolus tracking Scan in smart prep mode, contrast  
tracked manually and scan started
R R RR
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FUTURE DEVELOPMENTS
The latest MDCT scanners provide an 
extended range of both hardware and 
software advances, as the processing power 
of computers has reached an extremely 
high level. The great speed of computing 
processing has allowed vendors to produce 
model-based iterative reconstruction algo-
rithms for image processing. The radiogra-
pher can hereby maximise image quality in 
order to make a more accurate diagnosis 
possible by increasing the spatial resolution, 
while at the same time maintaining radiation 
dose at a minimum level.
Another very useful feature is the automatic 
tube voltage adaptation and the organ-
based tube current modulation. This allows 
system software to select a kV according 
to patient size and to reduce the mA in the 
anterior-posterior position. These two fea-
tures can reduce the radiation dose and still 
keep the image quality high. In other words, 
a full volumetric calculation of the scanning 
anatomic region takes place in real time, 
with the goal being to protect the patient 
from radiation. In accordance with the latest 
developments of the improved and more 
sensitive material used for the detectors, 
highest image quality is achieved in combi-
nation with the necessary radioprotective 
techniques.
Recent technical advances can assess 
dynamic myocardial perfusion by scanning 
the heart multiple times over the same area. 
Hereby CCTA does include haemodynamic 
information on ischaemia and infarction. 
This gives physiology information based 
on the dynamic procedure in the imaging 
technique but does result in a higher radi-
ation dose to the patient. An additional 
new technical feature is dual energy (DE) 
technique. DE CCTA exploits the fact that 
tissues in the human body and the intra-
vascular iodine-based contrast media have 
unique spectral characteristics when pene-
trated by different x-ray energy levels. This 
property could enable the mapping of the 
iodine (and thus blood) distribution within 
the myocardium at a lower radiation dose 
but without dynamic information of the 
myocardium. Another development is frac-
tional flow reserve (FFR) C. This enables the 
calculation of rest and hyperaemic pressure 
fields in coronary arteries without additional 
imaging and modification of CT acquisition 
protocols. The FFR is a physiologic measure 
of coronary stenosis expressing the amount 
of coronary flow still attainable despite the 
presence of a stenosis and could potentially 
identify ischaemia in CAD patients.
THE RADIOGRAPHER’S 
ROLE
It would be no exaggeration to mention 
that cutting-edge technology needs to be 
handled by specially trained personnel. The 
radiographer’s role involves special educa-
tion and skills in order to provide patients 
with high-quality healthcare services. They 
aim to reach a quick and accurate diagnosis, 
with a minimum of radiation dose.
A CCTA is a quite demanding examination, 
requiring the radiographer’s active par-
ticipation. CCTA is by no means a routine 
exam. Thus, as they are participating in a 
Figure 5
Curved multiplanar reconstruction (MPR) of the left coronary artery.
A B
Figure 6
Volume rendering technique (VRT) images showing the coronary tree with and without the myocardium.
A B C
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special examination, the radiographer is 
required to show certain communication 
skills, to make the patient feel comfortable 
in the examination room and successfully 
cooperate for the breath-holding involved, 
so that motion-free images are produced 
for an accurate diagnosis. The radiographer 
also has to demonstrate adequate compre-
hension of the patient’s ECG, iodine con-
trast protocol and knowledge of how the 
differentiation of the heart rate during the 
scan can affect image quality, especially in 
previous CT systems (e.g. 64-MDCT) where 
more than one heart cycle is needed for 
reconstruction.
Furthermore, the radiographer needs to be 
fully aware of the CT system’s capabilities. 
They should continuously be technically 
informed of the CT scanner’s hardware 
and software applications, to combine all 
technical parameter with the best process-
ing software to provide cardiologists and 
radiologists with the highest possible CCTA 
image quality. Therefore a patient-centred 
healthcare system should always be the 
radiographer’s priority.
THE EFRS’S CONTRIBUTION 
TO THE SPECIALISED 
CT RADIOGRAPHER
The European Federation of Radiographer 
Societies (EFRS) has always supported this 
expanding role of radiographers since its 
foundation. The annual general meetings and 
the annual European congress of the EFRS 
during each year’s European Congress of 
Radiology (ECR) are only some of the EFRS’s 
acts to keep the professionals up-to-date.
A very important accomplishment of the 
EFRS has been the benchmarking of the 
standards a radiographer should meet in 
their department, establishing the criteria, 
knowledge and skills to have for a success-
ful practice of the profession. Additionally, 
the EFRS official journal Radiography keeps 
radiographers informed about the latest sci-
entific research of the profession worldwide. 
On top of the broadened research network 
that the EFRS maintains, where any regis-
tered radiographer is able to actively partic-
ipate, annual events also take place, where 
radiographers obtain continual professional 
education (CPD) to keep up-to-date with 
the current trends and learn new imaging 
protocols and therapies.
CONCLUSION
A CCTA is a quite demanding examination 
regarding anatomy, physiology and new 
technical developments, requiring the radi-
ographer to have in-depth knowledge and 
experience to produce optimised images for 
diagnosis.
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HISTORY
The cath lab has come a long way since 1929 
when Nobel Prize winner Werner Forssmann 
performed the first cardiac catheterisation on 
himself. Under local anaesthesia, Forssmann 
inserted a catheter into a vein in his arm. Not 
knowing if the catheter might pierce a vein, 
he walked downstairs to the x-ray depart-
ment where, under the guidance of a fluoro-
scope, he advanced the catheter 65cm into 
his right ventricular cavity3. Medical imaging 
and invasive cardiology have been insepara-
ble ever since.
CATH LAB RADIOGRAPHER
Radiographers specialising in the cath 
lab possess a broad knowledge base and 
refined psychomotor skills. However, the 
cath lab radiographer’s responsibilities 
are unique and extend far beyond that of 
medical imaging. A cath lab radiographer 
is a multi-talented professional who liter-
ally works side-by-side with cardiologists. 
Radiographers share the knowledge and 
skills necessary to assist in a collection 
of increasingly sophisticated procedures. 
Lifesaving procedures often create an 
environment of high stress and emotion, 
and the cath lab radiographer demon-
strates poise and a level of composure not 
common among other medical imaging 
professionals. The anxiety of the patient 
during these life-changing procedures is 
well documented4, 5 and is associated with 
worse outcomes in coronary artery disease 
patients. Fortunately, the European Federa-
tion of Radiographer Societies (EFRS) Level 
6 radiographer is well prepared to “appraise 
the needs of patients and exercise sound 
clinical reasoning skills in order to provide 
appropriate, holistic and context-specific 
care in a broad range of situations within the 
clinical setting”6.
Working under the guidance of a licensed 
physician, the cath lab radiographer:
 − performs or reviews a baseline patient 
assessment
 − evaluates patient response to diagnos-
tic or interventional manoeuvres and 
medications
 − provides patient care and often drug 
administration commonly used in the car-
diac catheterisation laboratory
 − provides procedural (scrub) assistance
 − operates all imaging technology
 − performs physiologic monitoring and case 
documentation
 − performs pre-cardiac and post-cardiac 
patient care activities and procedures
 − contributes to the cath lab team’s efforts 
to provide emotional support prior to, 
during and after the procedure
The radiographer also coordinates access 
to supporting imaging such as computed 
tomography and ensures the availability of 
a wide range of equipment ensuring diag-
nostic and interventional procedures are 







BY CHRISTOPHER STEELMAN AND DIEGO CATANIA
INTRODUCTION
The cardiac catheterisation laboratory is one of the most unique med-
ical environments in existence today. Also known as the ‘cath lab’, it is 
where a multidisciplinary team diagnoses and treats congenital and 
acquired heart disease. Since the emergence of the cath lab in the 
1980s, the use of percutaneous intervention, a minimally invasive proce-
dure that uses only small incisions to access the heart, has grown expo-
nentially. With rapidly evolving technology and expanding indications, 
percutaneous transluminal coronary angioplasty (PTCA) has grown to 
equal stature with coronary artery bypass grafting as the number of 
annual PTCA procedures grew to 300,000 in 19901. Today, coronary 
angioplasty is performed on more than 2 million patients in the world 
annually2. And from the beginning, the radiographer has played a fun-
damental role in the multi-professional teams who treat patients with 
life and limb threatening diseases. Contributing far more than an exper-
tise in imaging, today’s cath lab radiographer has accepted the chal-
lenge of rapidly developing technology and the incredible procedures 
they enable.
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of developing radiation-induced cancer and 
cataracts for medical staff, and there is the 
potential for cancer and tissue reactions 
(erythema, dermal atrophy, and ulcers) 
for patients. Although increasingly com-
plex procedures demand longer fluoros-
copy time, cineradiography time or both8, 
innovative technologic advancements 
and diligent adherence to best practices 
have greatly reduced the radiation dose to 
patients and operators. The radiographer 
plays a central role in ensuring the proper 
use of radiation protection tools and tech-
niques ensure that the radiation doses to 
patients and staff are as low as possible.
RADIATION SAFETY 
ADVOCATE
Radiographers are specifically trained to 
operate medical imaging equipment in a 
manner that optimises image quality and 
minimises patient and clinical personnel 
exposure. ALARA stands for ‘as low as 
reasonably achievable’. This fundamental 
principle of radiation protection is taught 
to radiographers on their first day. It is 
the primary goal of all radiographers, but 
there are few places where this principle is 
more important than the cath lab. Radia-
tion exposure to patients in diagnostic and 
interventional procedures has been esti-
mated to be hundreds to a thousand times 
more than a chest radiograph9. It is the 
radiographer who is educationally prepared 
and clinically competent to ensure that not 
only the patient’s but the entire cath lab 
team’s exposure is ‘as low as reasonably 
achievable’.
CATH LAB RADIOGRAPHER  
TRAINING
It takes many years for a radiographer to 
become astute in this clinically complex envi-
ronment. Radiographers who perform medi-
cal imaging examinations have met stringent 
educational and credentialing standards. The 
Education Qualifications Framework Level 6 
published by the EFRS and the International 
Society of Radiographers and Radiologi-
cal Technologists (ISRRT) defines the core 
knowledge, skills, and competences that ena-
ble the radiographer to contribute to the care 
of the patient6. Today’s cath lab radiographer 
is equipped with knowledge of radiation 
physics, radiation biology, x-ray image forma-
tion, and the operation of an x-ray cinefluoro-
graphic unit.
The radiographer is responsible for under-
standing each level of complexity relative to 
radiation safety, cardiac anatomy, physiol-
ogy, and haemodynamics, and the technical 
aspects of all the equipment utilised during 
any cardiac or vascular procedure. They are 
masters of the delicate interplay of technol-
ogy and anatomy that is required to achieve 
optimum outcomes. The competent radiolog-
ical technologist is informed about current 
modifications and advances in procedures, as 
well as developments in the industry itself.
To keep pace with new and increasingly 
sophisticated procedures, the cath lab radi-
ographer commits to a career-long contin-
uing educational process. The EFRS recom-
mends lifelong learning for all radiographers 
to support service and personal develop-
ment. Continuous Professional Development 
(CPD) is defined as “the continuous learning 
The modern cath lab employs an array of 
imaging technology, all of which must be 
mastered by the radiographer. Intravascular 
ultrasound (IVUS) and optical coherence 
tomography (OCT) provide detailed images 
and critical information necessary for 
accurate vascular assessment. As a proce-
dural assistant, the radiographer displays 
an exceptional knowledge of the prepa-
ration and use of wires, balloon catheters, 
stents and a myriad of other devices. The 
radiographer employs not only their knowl-
edge but also their skills to ensure opti-
mum outcomes. In addition to the cardiac 
cath lab, you will also find radiographers 
assisting with procedures in interventional 




The increasingly complex procedures of 
the cath lab require highly coordinated 
multidisciplinary teams. Recent develop-
ments in cardiac surgery and interven-
tional cardiology and new percutaneous 
alternatives have led to the creation of 
integrated, hybrid cath lab/operating 
rooms that enable both surgical and 
intravascular procedures. The radiogra-
pher works with a team of professionals 
including cardiologists, cardiac surgeons, 
sonographers, vascular surgeons, anaes-
thesiologists, engineers and nurses. There 
is mutual trust in the cath lab and an 
expectation that each member excels in 
their area of expertise for the benefit of 
the patient. The cath lab team performs 
their tasks with efficiency and precision, 
moving about the cath lab in a well-chore-
ographed routine. And although the radi-
ographer is associated mainly with their 
expertise in medical imaging skills, they are 
a vital member of the cath lab team and 
contribute to all phases of patient care.
CATH LAB PROCEDURES
The minimally invasive treatment that 
continues to define the cardiac cath lab 
is angioplasty and the use of coronary 
stents. Arteries once thought to be for-
ever occluded are now being restored 
with sophisticated techniques enabled by 
novel technology. For a great number of 
patients, a procedure in the cath lab is a 
welcome alternative to coronary artery 
bypass surgery. However, in recent years 
there have been striking advancements in 
the number of procedures that the cath lab 
offers as an alternative to surgery. It has 
been predicted that 50% of the financial 
return from cardiac cath labs will be from 
non-coronary procedures by 20207. Heart 
valve repairs and replacements, left atrial 
appendage (LAA) occlusions, heart failure 
interventional device therapies, closures of 
atrial septal defects (ASDs) and ventricular 
septal defects (VSDs) and patent foramen 
ovale (PFOs) can all be treated in the cath 
lab.
There are many new interventional tech-
nologies on the horizon. However, these 
procedures are only possible with the appli-
cation of ionising radiation. Radiation dose 
has been associated with an additional risk 
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process required to maintain, develop and 
improve one’s knowledge, skills and compe-
tences to work effectively and safely”10.
Credentialing in this healthcare setting has 
grown proportionally to the new forms of 
treatment that are enabled by advancing 
technologies. Many of these specialties and 
subspecialties have national and interna-
tional exams which healthcare workers can 
pursue. This is also true in the cath lab. The 
Registered Cardiovascular Invasive Special-
ist11 is one example of a credential earned by 
cath lab radiographers around the world. In 
addition to their radiography training, the 
cath lab radiographer often seeks creden-
tials in sonography, electrophysiology and 
a growing list of other areas. The cath lab 
radiographer who earns these secondary 
credentials demonstrates not only funda-
mental knowledge but also a dedication to 
their professional development.
THE FUTURE
Mortality from myocardial infarction has 
dropped dramatically – by 80% since the 
1950s – due to technological advancements, 
and the cath lab has contributed to that 
success12. Future technology capability will 
enable more sophisticated procedures, 
improving patient and operator safety, 
and expand the use of minimally invasive 
cardiovascular procedures into areas that 
were previously only the domain of sur-
geons. The fusion of x-ray and MRI/CTA are 
already changing the way catheterisations 
are performed on patients with cardiovas-
cular disease. Radiographers will soon be 
performing advanced 3-D imaging to facili-
tate more accurate navigation inside vessels 
and device placement. Advanced visual-
isation will include free-floating and 3-D 
holographic images, and robotic systems 
for peripheral, coronary and electrophysiol-
ogy procedures will soon become standard 
practice in the cath lab. Ionising radiation 
could soon be eliminated from the cath lab 
as the use of MRI image guidance replaces 
x-ray based imaging. The ability to visualise 
all the patient’s anatomy, not just an x-ray 
of unblocked coronary artery lumens, holds 
tremendous potential.
From the first cardiac catheterisation, when 
Werner Forssmann walked to the x-ray 
department to confirm the placement of a 
catheter in his arm, to the use of sophisti-
cated three-dimensional imaging to replace 
valves in a heart, the radiographer has con-
tributed to the diagnosis and treatment of 
millions of patients.
CONCLUSION
This chapter attempts to demonstrate the 
rapidly evolving role of the radiographer. 
Although the challenges are many, with 
the support and guidance of the EFRS and 
ISRRT and an unwavering dedication to 
patient care, the radiographer will continue 
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to ionising radiation are described4. Med-
ical physicists are responsible for the 
standardisation and calibration of medi-
cal equipment, so as to further ensure the 
accuracy and safety of the applications and 
physical methods used in clinical settings3. 
Emphasised by the on-going technological 
development of healthcare equipment and 
applications, the successful execution of 
tasks fulfilled by medical physicists builds 
increasingly upon clinically relevant parame-
ters and multiprofessional collaboration. The 
need to increase multiprofessional working 
also extends to other healthcare profes-
sions. Cardiac radiology is a good example 
of a field where these high technical and 





In CAD, catheterisation angiography has been 
the gold standard for a long time. However, 
there is a small but real risk of complications 
arising from invasive coronary angiography 
and because of that, non-invasive imaging 
examinations have been developed for the 
diagnostics and treatment chain of more 
stable and medically treatable states of 
diseases1, 2, 5. Luckily, imaging modalities such 
as computed tomography (CT), magnetic 
resonance imaging (MRI), gated single photon 
computed tomography (GSPECT), positron 
emission tomography (PET) and ultrasound 
have evolved significantly over the past couple 
of decades and can provide what is needed 
for non-invasive and reliable imaging of the 
heart6–12. In this chapter, we will refrain from 
going into extensive technical details regard-
ing cardiac imaging technology. Instead, we 
will only briefly review the aspects of CT and 
MRI relevant for the considerations of medical 
physicists when they purchase new scanners 
and optimise their applications.
COMPUTED 
TOMOGRAPHY (CT)
The evolution of CT technology has moved 
quickly in various directions among CT ven-
dors. Generally, cardiac applications with CT 
were boosted over a decade ago by scanners 
with 64 slices and above9, 13. In recent years, 
CT gantry rotation times have been reduced 
to less than 0.3 seconds, reaching 0.25–0.27 
seconds in several scanner models, and a new 
goal of a 0.2 second rotation time is currently 
being pursued14. Rotation time has a clear 
impact on cardiac CT imaging because it 
directly affects the temporal resolution, which 
is an essential factor in image quality and 
relates to the clinical range of cardiac pulse 
rates.
In addition to the reduced rotation times, 
dual-source scanners, wider detector cover-
age, iterative reconstructions and motion-ar-
tefact corrections have made improvements 
to cardiac CT image quality and coverage 
of the whole heart in one fast axial or helical 
scan possible7, 14. Examples of 3D coronary CT 
images obtained with dual-source scanner are 
shown in Figure 1.
In order to acquire a comprehensive 




– THE EFOMP 
PERSPECTIVE
BY MIKA KORTESNIEMI AND TOUKO KAASALAINEN
INTRODUCTION
Medical imaging of the heart involves high temporal and spatial resolu-
tion1. It also affects patient populations in modern society with a higher 
prevalence of cardiac diseases. This in turn has an effect on the overall 
economy and quality of life. Coronary artery disease (CAD) causes more 
than 17 million deaths per year and is the leading cause of mortality glob-
ally2. Therefore, the technical, clinical, and socio-economical stakes are 
high when we consider cardiac imaging. Along with the technical devel-
opment and demands of cost-efficiency in healthcare services, there is a 
continuous pressure to improve competence and patient safety, as well 
as the specialisation and efficiency of the diagnostic process. This also 
affects medical physicists3. The optimal usage of equipment described 
by patient flow, the optimal utilisation of equipment features indicated by 
specialised diagnostic protocols and radiological optimisation (for radia-
tion protection) are all relevant topics in which medical physicists must be 
competent.
The requirements for sufficient competence for medical physicists and 
a definition of their professional responsibility are also laid down by the 
European Union Council Directive 2013/59/Euratom. Here the basic 
safety standards for protection against dangers arising from exposure 
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dynamics to determine the blood flow for 
all segments of the coronary circulation 




Cardiovascular magnetic resonance (CMR) 
imaging has become a routinely used imag-
ing modality in the diagnosis of cardiovascu-
lar diseases without exposing the patient to 
ionising radiation22. CMR does not only make 
accurate assessment of myocardial morphol-
ogy and function possible, but also shows 
focal fibrosis and infiltration. Late gadolin-
ium-enhancement (LGE) imaging is one of 
the most important applications of CMR. It is 
widely used in predicting adverse cardiovas-
cular outcomes e.g. in ischaemic and non-is-
chaemic heart diseases as LGE has proved to 
be associated with increased risk of all-cause 
mortality and sudden cardiac deaths23. Thus, 
LGE imaging is used to guide risk stratifica-
tion and patient management.
Improvements in MRI technology and the 
introduction of novel MRI sequences have 
enabled more reliable quantitative myocar-
dial tissue characterisation. For example, 
pre- and post-contrast pixel-wise T1 map-
ping has become a promising technique for 
non-invasive evaluation of diffuse myocardial 
fibrosis and inflammation, whereas T2 map-
ping and T2* mapping are used for oedema 
imaging and iron deposition determinations 
respectively24–27. The T1 relaxation time (a 
measure of how fast the nuclear spin magne-
tisation recovers back to its equilibrium state 
after a radiofrequency pulse) of myocardium 
is becoming an essential biomarker for a 
variety of pathological conditions24. By using 
both pre- and post-contrast T1 mapping and 
patient haematocrit, it is possible to deter-
mine extracellular volume (ECV), which in 
turn aims to quantify the relative expansion 
phases for left ventricle function and wall 
motion evaluation, continuous exposure 
and scanning is required. This involves a 
higher radiation exposure for the patient. 
However, if the image data is only required 
from a certain cardiac phase, the ECG-
gated scan may reduce radiation dose 
considerably, because the exposure is 
given only for a fraction of the overall 
scan time5. These dose saving features are 
included in all modern cardiac CT scanner 
configurations.
Contrast-enhanced CT provides anatomical 
data and it may extend to cardiac CT perfu-
sion studies (CCTP) with functional stenosis 
assessment during vasodilation stress typ-
ically induced with adenosine15, 16. Dual-en-
ergy CT cardiac perfusion scans may 
further improve diagnostic quality by pro-
viding iodine maps and by decreasing the 
beam hardening artefacts in the images17–19. 
The more recent cardiac imaging applica-
tions also include CT fractional flow reserve 






Volume renderings of the cardiac CT data showing an anomaly where all coronary arteries begin from the right coronary cusp 
and the left main branch follows the interarterial route between the pulmonary branch and the aorta. Accurate 3D representa-
tion during the CT examination facilitates the interpretation of the complex cardiac anatomy for the clinicians. The cardiac CT 
scan was performed with a dual-source CT scanner (120 kVp, CTDIvol 11 mGy, DLP 190 mGycm, effective dose 3 mSv, 75 ms 
temporal resolution, 55 bpm pulse rate). Images courtesy of Dr. Sari Kivistö, HUS Medical Imaging Center, Finland.
A B
Figure 2
A pre-contrast T1 map (A), post-contrast T1 map (B), 
calculated ECV map (C) and LGE image (D) of a patient 
with suspected sarcoidosis. 3T CMR examination revealed 
hypertrophy in the anterior septum, and in the same area, 
a large enhancement in LGE image was seen (marked 
with *). The post-contrast T1 map showed significantly 
decreased T1 relaxation time (~220 ms) in this area of the 
myocardium compared to the normal myocardium (~520 
ms). The corresponding ECV was increased up to a value 
of 75, whereas ECV was less than 30% in the normal 
myocardium. Patient haematocrit was 42%. Images were 
acquired in HUS Medical Imaging Center, Finland.
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optimally connected to an ECG-signal 
source for clinically relevant testing30, 31.
The dosimetry for the determination of 
radiation exposure in x-ray cardiac imaging 
may also require the use of more developed 
methods, especially when dosimetry results 
are used for the optimisation of clinical scans. 
Patient-specific dosimetry goes beyond the 
standard methods by definition. All these 
aspects indicate that medical physicists need 
to have sufficient training and knowledge to 
make an effective contribution to the multi-
professional imaging team.
This also calls for appropriate continual 
professional development of the medical 
physicists currently working in radiology and 
cardiology departments, so as to update and 
maintain their knowledge32. This knowledge 
must be paralleled by technical develop-
ments in cardiac imaging modalities, covering 
angiography equipment, CT, MRI, and ultra-
sound systems – and should extend to hybrid 
devices used in the middle ground between 
radiology, cardiology, and nuclear medicine. 
Such a unique level of multidisciplinarity and 
multi-professionality also makes for excellent 
research topics (e.g. Euramet 15HLT05 Empir 
project33), and further down the line, may 
demonstrate the increasing value of modern 
diagnostics to healthcare.
CONCLUSION
Cardiac imaging in radiology is highly 
demanding both technically and profession-
ally. The medical physicists’ professional role 
in cardiac imaging mainly involves quality 
assurance, dosimetry and optimisation. Opti-
misation of cardiac imaging technique should 
be a multiprofessional effort with adequate 
combined knowledge and competence, so 
as to utilise the advanced features of mod-
ern diagnostic modalities, which in turn 
emphasise the benefits of latest CT and MRI 
applications.
ACKNOWLEDGEMENTS
Dr. Marco Brambilla (President of the Euro-
pean Federation of Organisations for Medical 
Physics – EFOMP) is acknowledged for valua-
ble comments in the preparation of this chap-
ter. Dr. Sari Kivistö and Dr. Miia Holmström 
(radiologists in HUS) are acknowledged for 
their guidance in the image examples.
References 
See page 239
of the extracellular matrix as a result of dif-
fuse fibrosis (Figure 2). CMR can also be used 
for myocardial perfusion imaging in diagnos-
ing CAD.
Traditionally, clinical CMR studies have 
been performed at 1.5T due to artefact-free 
images. However, recent developments in 
MRI technology (e.g. multi-transmit paral-
lel radiofrequency transmission technol-
ogy) have shifted clinical studies more and 
more towards 3T, as higher magnetic field 
strength is known to improve signal-to-noise 
and contrast-to-noise ratios. Regardless 
of the benefits and developments in MRI 
technology, 3T CMR may still suffer from the 
presence of image artefacts due to B1 inho-
mogeneity and also because of problems in 
ECG-gating.
MEDICAL PHYSICIST ROLE 
IN CARDIAC RADIOLOGY
In radiology, medical physicists are mainly 
involved in quality assurance, dosimetry 
and optimisation3. Optimisation is a com-
prehensive task and is a cornerstone of the 
responsibilities of a medical physicist. In 
any radiological examination there should 
be a joint effort to bind the knowledge of 
radiologists, cardiologists, technologists 
and medical physicists together in order 
to reach optimal image quality compared 
to cost or risk parameters. Cardiac imag-
ing forms a specific sub-field of radiology, 
which also includes implementation of new 
imaging methods and clinical applications. 
Optimisation of imaging parameters is a 
common and highly demanding challenge 
in CT protocols as well as in MRI sequences. 
Depending on the indication, appropriate 
cardiac cycle specific gating of raw data 
acquisition affects both image quality 
through motion artefacts, and radiation 
exposure in CT due to the effective cumu-
lative scan time. Selection of the optimal 
temporal scan window is not a straightfor-
ward task in CT because the most static 
phase of the cardiac cycle may occur in 
the phase of diastole, usually in stable and 
lower <70 bpm pulse frequencies – or dur-
ing the end-systolic phase with faster and 
more irregular beat patterns28, 29. Therefore, 
in-depth knowledge of the scanner features 
and clinical process is needed in order to 
handle the overall patient flow and to main-
tain consistent image quality with various 
individual patients.
In CMR, image quality may also be lower 
than ideal due to heart and respiratory 
motion, not forgetting the impacts of 
implants and prosthesis on image quality. 
For example, CMR examinations in patients 
with cardiac pacing devices may require the 
presence of a medical physicist to opti-
mise pulse sequences. Cardiac imaging in 
radiology may also involve methods where 
standard quality assurance does not provide 
full coverage through standard metrics, e.g. 
in iodine maps in dual-energy CT, dynamic 
ECG-triggering or gating for motion com-
pensation, blood flow and volume quanti-
fication, and also spectroscopic and meta-
bolic imaging extending to specifics such as 
iron loading levels. Therefore, more elabo-
rate quality assurance methods relating to 
cardiac imaging require specific equipment 
such as dynamic motion, flow-controlled, 
or material specific phantoms, which are 
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